Benzodiazepine receptors and the control of ingestive behaviour in the rat by Higgs, Suzanne
Durham E-Theses
Benzodiazepine receptors and the control of ingestive
behaviour in the rat
Higgs, Suzanne
How to cite:
Higgs, Suzanne (1996) Benzodiazepine receptors and the control of ingestive behaviour in the rat, Durham
theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/5441/
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or
charge, for personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in Durham E-Theses
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full Durham E-Theses policy for further details.
Academic Support Oﬃce, Durham University, University Oﬃce, Old Elvet, Durham DH1 3HP
e-mail: e-theses.admin@dur.ac.uk Tel: +44 0191 334 6107
http://etheses.dur.ac.uk
Benzodiazepine receptors and the 
control of ingestive behaviour in the 
rat 
Suzanne Higgs 
A thesis submitted in fulfilment of the requirements for 
the degree of Doctor of Philosophy 
The copyright of this thesis rests with the author. 
No quotation from it should be published without 
his prior written consent and information derived 
from it should be acknowledged. 
University of Durham 
Department of Psychology 
June 1996 
3 0 O C T 1996 
Statement of copyright 
The copyright of this thesis rests with the author. No quotation from it 
should be published without prior written consent, and information 
derived from it should be acknowledged. 
Declaration 
I hereby declare that this thesis has not been submitted, either in the same 
or different form, to this or any other University for a degree. 
SuzaOnne Higgs 
In press: 
Higgs, S. and Cooper, S. J. (1996). Increased food intake following 
injection of the benzodiazepine receptor agonist midazolam into the IVth 
ventricle. Pharmacology. Biochemistry and Behavior. 
Higgs, S. and Cooper, S.J. (1996). Hyperphagia induced by direct 
administration of midazolam into the parabrachial nucleus of the rat 
European Journal of Pharmacology. 
Thesis title: Benzodiazepine receptors and the control of ingestive 
behaviour in the rat 
Author: Suzanne Higgs 
Abstract 
When administered systemically, benzodiazepine receptor agonists have been 
shown to increase food intake in a number of species. Conversely, benzodiazepine 
receptor inverse agonists bring about reliable decreases in feeding. The aim of the 
experiments reported in this thesis was to investigate the brain and behavioural 
mechanisms involved in the effects of benzodiazepines on ingestion. 
The effect on food intake of microinjection of the benzodiazepine receptor agonist 
midazolam into the brainstem of the rat was investigated. A reliable hyperphagic response 
was elicited following injection of midazolam into both the IVth ventricle and the 
parabrachial nucleus (PBN). This increase in intake was reversed by pretreatment with 
the selective benzodiazepine receptor antagonist flumazenil. These results suggest that 
benzodiazepine receptors located in the brainstem, specifically in the PBN, may be 
responsible for the effects of benzodiazepines on ingestion. 
In further experiments, a microstructural approach was adopted which involved 
analyzing the effects of benzodiazepine ligands on the detailed pattern of licking for both 
a carbohydrate and a fat in the rat. The effects of midazolam were similar to the effects of 
increasing concentration. The effects of the benzodiazepine receptor inverse agonist 
Ro 15-4513 were similar to the effects of decreasing concentration. These results suggest 
that benzodiazepines influence ingestive behaviour by modulating palatability. 
The proposal that benzodiazepines may interact with opioids to influence feeding 
behaviour was examined in Chapters 7 and 8. Although the effects of the opioid agonist 
morphine and the opioid antagonist naloxone on licking behaviour were not the same as 
the effects of benzodiazepine ligands, naloxone blocked the effects of midazolam. These 
results suggest that the effects of benzodiazepine on palatability may depend on release of 
endogenous opioid peptides. 
This work has implications for understanding the neural control of ingestive 
behaviour and may help in developing new therapies for clinical disorders such as 
anorexia and bulimia. 
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Chapter 1 2 
The pharmacology of benzodiazepines and their role in the 
control of ingestion 
1.1 Chapter Overview 
The potent stimulation of appetite by drugs which act as agonists at 
benzodiazepine receptors is now a well-known phenomenon (Cooper, 1980a). However, 
despite an abundance of data documenting the hyperphagic effect of benzodiazepine 
receptor agonists, there has been little investigation of the brain mechanisms involved in 
these effects. One of the aims of this thesis is to identify potential neural substrates 
mediating benzodiazepine-induced changes in food intake. Such studies are essential for 
increasing our understanding the effects of benzodiazepines, but may also shed light 
more generally on the neural control of ingestive behaviour. 
Although many data have been gathered concerning the effects of benzodiazepines 
on ingestive responding, the behavioural mechanisms responsible for these effects have 
yet to be fully worked out. Such information could provide important insights into the 
contribution of specific processes to the control of food intake. Microstructural analysis 
of ingestive behaviour may be a useful tool in this respect. This technique involves the 
characterization of individual components of feeding, and is thought to provide 
information concerning the behavioural mechanisms involved in the control of food and 
fluid intake. However, microstructural analysis has not been widely used to study the 
effects of pharmacological manipulations on ingestion. Therefore, the second aim of this 
thesis is to use microstructural techniques to investigate in more detail the behavioural 
mechanisms responsible for the effects of benzodiazepines on ingestive behaviour. 
As an introduction to the experiments reported in this thesis, the pharmacology of 
benzodiazepine receptor ligands will first be discussed. Second, experiments concerning 
the effects of benzodiazepine receptor ligands on ingestion will be reviewed. Finally, 
research conducted to date into the potential brain mechanisms involved in the effects of 
benzodiazepines on ingestive behaviour will be presented. 
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1.2 Benzodiazepine pharmacology and molecular biology 
An understanding of the pharmacology of benzodiazepines is critical if these 
drugs are to be useful tools with which to investigate behaviour. Pharmacological studies 
are important because they may enable the development of more selective drugs with 
which to probe behaviour more precisely. However, behavioural studies may also have 
implications for pharmacology, and so it is essential that advances in the appreciation of 
benzodiazepine pharmacology proceeds in tandem with investigations of the behavioural 
effects of these drugs. Recent advances in the field of molecular biology have led to many 
novel pharmacological developments which may have implications for the mechanism of 
action of benzodiazepines. Therefore, the experiments reported in this thesis serve to 
complement progress in pharmacology and molecular biology by increasing our 
understanding of the behavioural and neural processes involved in the effects of 
benzodiazepines on ingestive behaviour. 
The following section is concerned with reviewing advances in benzodiazepine 
pharmacology and is divided into several broad areas. First, the literature concerning the 
discovery of benzodiazepines and the identification of specific binding sites for these 
drugs in the central nervous system (CNS) wi l l be reviewed. Second, the 
pharmacological effects of different classes of benzodiazepine receptor ligand will be 
discussed. Third, the relationship between benzodiazepine receptors and G A B A function 
will be assessed. Finally, exciting developments in the field of molecular biology which 
have revealed unanticipated diversity in the G A B A A receptor will be discussed, along 
with the implications of these results for the behavioural effects of benzodiazepines. 
1.2.1 The discovery and development of benzodiazepines 
The first benzodiazepine to be synthesised was chlordiazepoxide (CDP). Like 
many other drug developments, the discovery of the benzodiazepines owed more to 
serendipity than to rational drug design (Tinklenberg, 1977). Working at the 
pharmaceutical company Hoffman La Roche, the medicinal chemist Leo Sternbach 
discovered that a series of compounds he had synthesised were not benzheptoxdiazines 
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as he had thought, but instead were quinazolone 3-oxides. He tested the compounds for 
pharmacological activity and found that all but one of them was inert. This active 
compound was given to Lowell Randall who showed that it had distinctive 
pharmacological properties. In behavioural tests, it exhibited sedative, muscle relaxant 
and anticonvulsant activity (Randall et al., 1960), and was introduced to the market soon 
after under the trade name of Librium. CDP and other benzodiazepines with the same 
basic chemical structure are now used widely as therapeutic agents for many conditions 
including anxiety and insomnia. 
Since the discovery of benzodiazepines specific binding sites for these 
compounds have been identified, both in the brain and in the periphery. Additionally, 
many new compounds have been developed which differ in both affinity and efficacy at 
these sites. In the following sections, literature concerning the structure and function of 
the benzodiazepine receptor, and the nature of ligand/receptor-interactions will be 
reviewed to provide a basis for understanding the involvement of benzodiazepines in the 
control of ingestive behaviour. 
1.2.2 The identification of specific benzodiazepine receptors 
A major breakthrough in understanding the pharmacology of benzodiazepines 
was the identification of specific, high affinity binding sites in rat brain using the 
technique of radioligand binding assays (Braestrup and Squires, 1977; Mohler and 
Okada, 1977). This discovery generated great interest in the benzodiazepines. Within the 
space of a few years many papers were published reporting the results of benzodiazepine 
binding studies. It has been demonstrated that the binding is stereospecific, reversible and 
saturable. Additionally, a good correlation has also been shown to exist between the 
clinical potency of benzodiazepines and their ability to displace 3[H] diazepam from the 
membrane binding sites (Mohler and Okada, 1977). These criteria had to be satisfied 
before it could be suggested that the binding sites constitute physiological receptors 
responsible for the pharmacological and behavioural effects of benzodiazepine ligands. 
Importantly, specific benzodiazepine binding has also been demonstrated in vivo 
Chapter 1 4 
following injection of 3[H] diazepam in the intact animal (Williamson, Paul and Skolnick, 
1978). 
The location of benzodiazepine receptors in the CNS has been determined using 
autoradiographic binding studies. Benzodiazepine receptors have been shown to be 
widely distributed throughout the central nervous system and periphery. In the rat brain 
they are found in particularly high density in the cerebral cortex, cerebellum, 
hypothalamus and limbic structures (Young and Kuhar, 1980). 
Although the majority of eariy binding studies made use of membranes from rat 
brain, some experiments have compared the binding characteristics in both rat and human 
brain tissue. These investigations have revealed a great deal of similarity in the 
pharmacological properties of binding sites in rat and human brain (Sieghart, Eichinger, 
Riederer and Jellinger, 1985). 
1.2.3 Central versus peripheral binding sites 
Benzodiazepine receptors in the CNS are not the only binding sites which have 
been identified. Benzodiazepines also bind to receptors located in the periphery, and to 
micromolar sites. The peripheral-type binding sites are found in variety of tissues and are 
normally located in the mitochondrial membrane (Parola, Yamamura and Laird, 1993). 
No correlation between the affinity of benzodiazepine ligands for the peripheral site and 
their clinical effect has been shown. This suggests that peripheral benzodiazepine 
receptors are not responsible for the behavioural effects of benzodiazepines. The. 
properties of the micromolar binding sites have yet to be fully characterised, but they 
have been shown to differ from both the peripheral and central types in that they exhibit 
very low affinity for benzodiazepines (Bowling and DeLorenzo, 1982). 
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1.2 A Benzodiazepine ligands 
The identification of specific benzodiazepine binding sites encouraged the 
development of many novel compounds with which to probe the behavioural effects of 
these compounds. Drugs that interact with benzodiazepine receptors (benzodiazepine 
ligands) have been categorized based on the cellular response which is elicited upon 
binding. There are three main classes of ligand: agonists, antagonists, and inverse 
agonists. Within the category of agonists and inverse agonists there also exists a 
subdivision of compounds referred to as partial agonists. These different classes of 
ligand will be considered in turn in the following section. 
Benzodiazepine receptor agonists 
The term 'benzodiazepine' properly refers to a class of drugs with a particular 
chemical structure. It has also been taken to refer to drugs from the benzodiazepine class 
that have an agonistic action at benzodiazepine receptors (i.e. elicit a cellular response). 
However, a number of exceptions to this terminology are worth noting. First, some 
ligands, such as the p-carbolines and pyrazoloquinolines, have a non-benzodiazepine 
structure and yet bind with high affinity to benzodiazepine binding sites (Haefely, 
Kyburz, Gereke and Mohler, 1985). Second, not all drugs with a benzodiazepine 
chemical structure act via benzodiazepine receptors. For example, the benzodiazepine 
tifluadom does not bind to benzodiazepine receptors and instead interacts specifically with 
the K opiate receptor (Kley, Scheidemantel, Bering and Muller, 1983). Therefore, the 
term benzodiazepine receptor agonist is used preferentially to refer to compounds of any 
chemical structure that interact with the benzodiazepine receptor with agonist activity. 
Benzodiazepine receptor antagonists 
The first selective benzodiazepine antagonist to be described was the 
imidazobenzodiazepine derivative flumazenil (Ro 15-1788) (Hunkeler et al., 1981). This 
compound was found to have a high affinity for benzodiazepine receptor sites but 
possessed little or no intrinsic pharmacological activity (Bonetti et al., 1982). Flumazenil 
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blocks the effects of benzodiazepine receptor agonists by competing for the receptor 
sites. The development of selective antagonists like flumazenil was crucial for 
demonstrating the specificity of the benzodiazepine effects and supported the existence of 
specific pharmacological receptors mediating the behavioural effects of benzodiazepines. 
This is because the ability of a selective benzodiazepine receptor antagonist to block the 
effects of an agonist suggests that the effects of that agonist are mediated by the 
benzodiazepine receptor. 
Benzodiazepine receptor inverse agonists 
A novel class of benzodiazepine receptor ligands has been identified. These 
compounds act as agonists at the benzodiazepine receptor site (i.e. they possess intrinsic 
pharmacologic activity), but do not conform to the classical pharmacological profile of the 
benzodiazepines (for review see Sarter, Nutt, and Lister, 1995). One such compound is 
the 6-carboline ethyl-6-carboline 3 carboxylate (6-CCE) (Braestrup, Nielson, Honore, 
Jensen and Peterson, 1980). When tested in vivo this compound displays properties 
contrary to those of the benzodiazepines. 6-CCE binds with high affinity to 
benzodiazepine-like receptor sites, but has intrinsic anxiogenic (Dorow, Horowski, 
Pascheike, and Amin, 1983) and proconvulsant effects (Rossier et al., 1983). This 
contrasts with the anxiolytic and anticonvulsant actions of benzodiazepine agonists. To 
explain the unusual effects of 13-CCE and other related compounds, such as the 
6-carboline DMCM, the term inverse agonist was introduced. 
Until recently it was thought that the benzodiazepine receptor provided the only 
example of compounds with negative intrinsic activity. This was despite that fact that the 
concept of inverse agonism could have been predicted from traditional receptor theory. 
However, it is now recognised that ligands displaying inverse agonist properties may be 
relatively commonplace (Milligan, Bond and Lee, 1995). Additionally, it has been 
suggested that benzodiazepine inverse agonists may act at a binding site adjacent to that 
for agonists. For example, p-carbolines may not occupy the same site as 
benzodiazepines, but instead bind to a similar but overlapping site (Luddens and Wisden, 
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1991). The significance of inverse agonism has yet to be fully appreciated, but the 
increased range these compounds provide for receptor regulation could prove to be of 
enormous therapeutic benefit. 
Benzodiazepine receptor partial agonists 
Several benzodiazepine ligands have been described which exhibit activity 
intermediate to the actions of agonists and antagonists. An example of an agonist with 
intermediate activity is the p-carboline, ZK 91296 (Stephens et al., 1987). This 
compound differs from other agonists such as diazepam, because it exhibits a narrower 
pharmacological profile. It has been shown to be effective in anti-conflict tests but, 
unlike diazepam, produces little or no sedation or muscle relaxation. Another p-carboline, 
FG 7142 is an inverse agonist (Braestrup, Schmeichen, Neef, Nielson and Peterson, 
1982), but it differs from other compounds in this class because it does not normally 
induce convulsions (Jensen et al., 1983). 
The concept of partial agonism was initially evoked to explain the different 
profiles of activity of ZK 91296 and FG 7142 (Haefely, Martin and Pole, 1990). 
Partial agonists are low efficacy compounds that produce smaller responses than full 
agonists at the same level of receptor occupancy (Haefely et al., 1985). This theory can 
account for the selective effects of ZK 91296 and FG 7142 i f it is also assumed that the 
target cells responsible for different effects vary in receptor density. For example, in an 
area with a high receptor density (large receptor reserve) both partial and full agonists will 
achieve a maximal response. However, in a receptor population with a low receptor 
reserve (low density), partial agonists will not occupy enough receptors to produce a 
pharmacological effect. One prediction from this hypothesis is that neurons mediating the 
anxiolytic effects of benzodiazepine agonists should have a large receptor reserve, 
whereas neurons mediating the sedative effects should have a low receptor reserve 
(Martin, 1988). Partial agonists are important therapeutically because they do not cause 
undesirable side effects such as sedation but still possess anxiolytic properties. 
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1.2.4 Summary 
Benzodiazepines are therapeutically useful drugs that were synthesised 
serendipitously by the drug company Hoffmann La Roche in the 1950s. Specific binding 
sites for these drugs have been shown to exist in the brain, and it is now known that the 
benzodiazepine receptor not only recognizes benzodiazepines, but also drugs from other 
chemical classes (e.g. p-carbolines and pyrazoloquinolines), and ligands with different 
affinities and intrinsic efficacies. There are three types of benzodiazepine ligand: agonists, 
antagonist, and inverse agonists. Agonists bind to the benzodiazepine receptor and cause 
a cellular response. Antagonists bind to the receptor but do not display any intrinsic 
activity and competitively block the effects of agonists. Inverse agonists bind to the 
receptor and yet cause the opposite response to agonists. Additionally, the 
benzodiazepine receptor also binds compounds with efficacy that is either midway 
between antagonists and agonists (partial agonists), or between antagonists and inverse 
agonists (partial inverse agonists). As shown in Figure 1.1, the 6-carbolines provide an 
interesting example of functional activity spanning the whole range, from full agonist to 
full inverse agonist. 
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Agonist Partial agonist Antagonist Partial Inverse 
inverse agonist 
agonis t 
ZK 93423 ZK 91296 ZK 93426 FG7142 DMCM 
Intrinsic efficacy 
Benzodiazepine 
receptor 
Figure 1.1 Spectrum of p-carboline ligands with different 
intrinsic efficacies at the benzodiazepine receptor from full agonist to 
full inverse agonist. Adapted from Haefely (1994). 
1.2.5 GABAergic transmission 
There is evidence to suggest a close association between the action of 
benzodiazepines and the inhibitory neurotransmitter y-aminobutyric acid (GABA) 
(Haefely, Kulcsar, Mohler, Fieri and Pole, 1975). Therefore, to fully understand the 
effects exerted by benzodiazepines, it is necessary to understand the basic features of 
GABAergic neurotransmission. 
G A B A is the major inhibitory neurotransmitter in the vertebrate central nervous 
system. It is generally accepted that there are three classes of G A B A receptor: the 
G A B A A , G A B A B and GABAc receptor respectively. A distinction was first drawn 
between the G A B A A receptor and the G A B A B receptor by Hill and Bowery (1981). 
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These receptors were characterised by the different cellular effects observed upon binding 
of a ligand, and their affinities for specific agonists and antagonists. The G A B A A 
receptor is sensitive to the G A B A antagonist bicuculline, and is a ligand-gated chloride 
(C1-) ion channel. In contrast, the G A B A B receptor is one of a family of receptors which 
are coupled either to calcium or potassium channels (Bormann, 1988). The G A B A B 
receptor is activated selectively by the G A B A B agonist baclofen, and is not affected by 
drugs that modulate G A B A A transmission. A third class of G A B A receptor was identified 
as a result of further binding studies. The GABAc receptor is insensitive to both 
bicuculline and baclofen and has been localized to a subpopulation of retinal neurons 
(Feigenspan, Wassle and Bormann, 1993). 
The G A B A A receptor is part of a superfamily of ligand-gated ion channels which 
also includes the nicotinic acetylcholine receptor, the glycine receptor and the 5 - H T 3 
receptor. The structure of these receptors remains elusive since none of them have been 
studied using X-ray crystallography. However, structural models derived from electron 
microscopy (EM) suggest that these receptors are formed from the assembly of five 
distinct subunits. Each subunit is thought to span the membrane 4 times (Unwin, 1989, 
1995). These models are based on the nicotinic acetylcholine receptor but may be typical 
of other members of the superfamily. 
Synaptic inhibition occurs at the G A B A A receptor when G A B A binds and 
increases CI- conductance through the receptor ionophore. This leads to hyperpolarization 
of the neuronal membrane which makes it less likely that excitatory currents will reach the 
threshold required for the induction of an action potential. G A B A acts mainly at local 
interneurons to prevent over-excitation of neurons. However, the overall effect of G A B A 
need not necessarily be inhibitory, because an arrangement of two G A B Aergic neurons in 
series could lead to disinhibition of a target neuron. 
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Benzodiazepines and the G A B A A receptor complex 
It has been proposed that benzodiazepines bring about their behavioural effects by 
acting at GABAergic synapses in the brain (Haefely et al., 1975). In support of this, 
benzodiazepines have been shown to enhance GABA binding (Costa, Guidotti and 
Toffano, 1978). The specific nature of this interaction has been confirmed by the results 
of receptor purification studies. A protein complex was isolated which binds both 
benzodiazepines and G A B A A ligands (Schoch et al., 1985). This evidence indicates that 
the benzodiazepine receptor is an allosteric site on the G A B A A receptor complex. 
Allosteric modulators act at sites different and distant from the primary ligand binding 
site. Such modulators can function either by altering the kinetics of the channel (e.g. the 
probability of channel opening), or by altering the affinity of the primary ligand for its 
binding site. Benzodiazepine agonists affect GABAergic transmission by increasing the 
frequency of G A B A A receptor CI- channel opening (Haefely et al., 1985; Pole, 1988). 
The potency of G A B A at the G A B A A receptor complex is therefore increased. This effect 
can be seen when plotting a dose response curve for G A B A induced CI - conductance. 
Agonists induce a shift to the left in this curve (less G A B A is required to obtain the same 
CI- conductance), but do not increase the maximal response (Choi, Farb and Fischbach, 
1981). Studies using benzodiazepine antagonists have shown that these compounds do 
not affect CI- conductance (Pole, Ropert and Snyder, 1981). Benzodiazepine inverse 
agonists reduce the effect of G A B A by shifting the dose response curve to the right. 
These compounds also decrease the maximum CI- conductance (Pole, Laurent, 
Scherschlicht and Haefely, 1981). The effect of benzodiazepine ligands on G A B A 
conductance is shown in Figure 1.2. Benzodiazepine receptor agonists act as positive 
modulators of G A B A function, inverse agonists are negative modulators and antagonists 
are characterised by a lack of effect on G A B A receptor function. However, the 
benzodiazepine receptor is not the only modulatory site on the G A B A A receptor complex. 
Other sites include those for barbiturates, the convulsants picrotoxin and TBPS, 
neurosteroids, and ethanol (Sieghart, 1992). 
Chapter 1 12 
Q) 
O 
C 
o 
T3 
C 
O 
O 
CJ 
Log [GABA] 
Figure 1.2 Theoretical dose-response curves for the effect of 
benzodiazepine ligands on GABA-induced chloride conductance. C 
is the control curve. A is in the presence of a full agonist, B is in 
the presence of a partial agonist and D is in the presence of an 
inverse agonist. 
1.2.6 Summary 
Benzodiazepine ligands exert their pharmacological effects through allosteric 
modulation of the G A B A A receptor protein. This is achieved by modulating the frequency 
of CI - channel opening in the G A B A A receptor. Benzodiazepine receptor agonists act as 
positive modulators and facilitate GABAergic transmission by increasing the frequency of 
channel opening. Inverse agonists depress GABA function by decreasing the probability 
of CI - channel opening and so act as negative modulators. Antagonists have no intrinsic 
activity and do not alter GABA function when they bind to the benzodiazepine receptor. 
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1.2.7 G A B A A receptor subtypes 
The G A B A A complex is probably one of the best studied neurotransmitter 
receptors. As a result, the structure and function of this receptor is sufficiently advanced 
to explain how some benzodiazepine ligands modulate G A B A A receptor function. 
Although it was initially thought that the G A B A A receptor was a single molecular 
species (Haring et al., 1985), it is now accepted that G A B A A receptors constitute a 
heterogeneous population. The first evidence suggesting G A B A A receptor multiplicity 
came from biochemical studies. First, polyacryamide gel electrophoresis (PAGE) 
revealed two major protein bands: a 53 kDa band (the a subunit) and a 57 kDa band (the 
P subunit). These were thought to combine to form a pentameric complex of total 
molecular weight of between 220 and 355 kDa. Second, selective photoaffinity labelling 
studies showed the a subunit was irreversibly labelled by [3H] flunitrazepam, and the p 
subunit was labelled by [3H] muscimol (Sigel, Stephens, Mamlaki and Barnard, 1983). 
Improvements in the resolution of gel electrophoresis techniques then revealed that these 
subunits consisted of several different proteins (Fuchs and Seighart, 1989). 
Molecular biological cloning techniques have since allowed the identification of 
15 different receptor subunits. These subunits have been categorized into 5 groups 
according to amino acid sequence homology (a, p, y, 5, and p subunits). Each subunit is 
encoded on separate genes that can be differentially spliced to produce multiple isoforms. 
In the rodent brain, six a subunits have currently been identified ( a l - a6), four p 
subunits ( p i - p4), three y subunits ( y l - y3), a 5 subunit and two p subunits located in 
the retina (Luddens and Wisden, 1991; Olsen and Tobin, 1990). This diversity is 
increased further by RNA editing which leads to the formation of phenotypic variants 
(Whiting, McKernan, and Iversen, 1990). For example, the y subunit can exist in either a 
long or short form depending on the presence or absence of an eight amino acid insert 
(Wafford et al., 1991). The designation of p subunits as G A B A A subunits has been 
challenged recently by Darlison and Albrecht (1995). These authors argue that p subunits, 
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originally found in the human retina (Cutting et al., 1991), do not assemble with a and (3 
subunits to form G A B A A chloride channels, but instead form part of the GABAc 
receptor. 
Assembly of varying combinations of these 15 different subunits probably results 
in the creation of functionally diverse G A B A A receptor subtypes. It is likely that several 
different subpopulations exist which differ pharmacologically and in their distribution in 
the brain. There is evidence that benzodiazepine pharmacology is determined by 
substitution of different subunits in the G A B A A receptor complex (Luddens, Korpi and 
Seeburg, 1995). Therefore, an examination of the function of G A B A A receptor subunits 
may be important for understanding the behavioural effects of benzodiazepine ligands. 
For example, G A B A A receptor heterogeneity may provide a pharmacological explanation 
for the wide range of effects which result from modulation of GABAergic transmission • 
by benzodiazepines, including anxiolytic, anticonvulsant, muscle relaxant and 
hyperphagic activity. 
In summary, the G A B A A receptor complex is formed from the assembly of five 
subunits. These subunits can be selected from an array of 15 different types that have 
been grouped into 5 classes (a,(3,y,5 andp). This means that it is possible to form many 
different G A B A A receptors, depending on the subunit composition. Benzodiazepine 
receptors coupled to different G A B A A receptor subtypes located in different brain areas 
could explain the diversity of benzodiazepine effects on behaviour. 
Subunit functions 
The identification of multiple receptor subunits does not allow the composition of 
functional receptors to be identified. To establish which subunits are assembled in the 
native receptor, and what the specific functional contribution of each subunit might be, 
recombinant G A B A A receptors have been artificially expressed in Xenopus oocyte cells. 
Using an expression system like Xenopus means that the properties of the receptors can 
be studied in isolation from other receptors which are normally expressed in the neuronal 
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membrane. A combination of a and p subunits expressed in Xenopus has been found to 
successfully mimic GABA - induced chloride ion flux. However, receptors composed 
only of a and p subunits are not pharmacologically identical to the native G A B A A 
receptor, because benzodiazepine potentiation is not observed (Levitan, Blair, Dione and 
Barnard, 1988). This result implies that other subunits are required for benzodiazepine 
activity. 
The y subunit, isolated by Pritchett and co-workers (1989), has been shown to be 
necessary for benzodiazepine function. Most studies have reported expression of the y2 
subunit because it was the first to be cloned. However, limited studies with the yl 
subunit (Ymer et al., 1990) suggest that it produces unusual responses. When the yl 
subunit is combined with a l or a5, and pi subunits in oocytes, a reduced potentiation is 
observed following flunitrazepam administration. In addition, the response to inverse 
agonists such as DMCM is either reduced, or unexpectedly potentiated (von Blankenfeld 
et al., 1990). Consequently, it has been suggested that this receptor subunit combination 
may not occur in vivo (Ymer et al., 1990). The novel y3-subunit, recently isolated by 
Herb and colleagues (1991), also appears to confer benzodiazepine responsivity and has 
been shown to functionally replace the y2 subunit (Knoflach et al., 1991). 
Experiments in which receptors have been artificially produced in vitro, have 
shown that G A B A A receptor subunits differ in function. The y subunit is required to elicit 
a benzodiazepine response, but the a subunit appears to determine benzodiazepine 
pharmacology. For example, the type of a subunit affects both the efficacy and affinity of 
benzodiazepine binding (Sigel, Baur, Trube, Mohler and Malherbe, 1990; von 
Blankenfeld, 1990). Substitution of a 5 subunit for a y subunit in recombinant receptors 
results in a loss of benzodiazepine sensitivity (Shivers et al., 1989). This suggests that 
receptors containing a 5 subunit may constitute G A B A A receptors that are not modulated 
by benzodiazepines. 
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Multiple benzodiazepine receptor subtypes? 
Early benzodiazepine binding studies identified compounds with differential 
binding characteristics. A distinction was drawn between Type I and Type I I 
benzodiazepine receptors (Klepner et al., 1979). Some receptors displayed a greater 
affinity for benzodiazepines such as CL 218 872 and p-carbolines. These are the Type I 
receptors. They are distributed ubiquitously in the brain but are particularly abundant in 
the cerebellum. Type I I receptors have a high affinity for benzodiazepines but a reduced 
affinity for other compounds. These receptors are more selectively located in the 
hippocampus, striatum and spinal cord. 
The molecular basis for this potential receptor heterogeneity has been examined 
by expression of recombinant receptors in cell lines. Receptors composed from the a l , 
pi and y2 subunits have high affinity for CL 218 872 (Pritchett et al., 1989). The 
distribution of a l subunits is also high in the cerebellum (Luddens et al., 1990), 
suggesting that this subunit confers Type I receptor pharmacology. Evidence indicates 
that several a subunits may be responsible for Type n receptor pharmacology. Receptors 
expressing the a2 and a3 subunits show lower affinity for benzodiazepine Type I 
selective ligands (Pritchett, Luddens and Seeburg, 1989; Pritchett and Seeburg 1990). 
Substitution of the a5 subunit results in Type Il-like pharmacology but with a reduced 
affinity for the benzodiazepine ligand Zolpidem (Pritchett and Seeburg, 1990). 
The inverse agonist Ro 15-4513 has been shown to bind to cerebellar granule 
sites that are not labelled by [3H] flunitrazepam. These sites, first described by Turner, 
Sapp and Olsen (1991) have been termed diazepam insensitive (DI) sites, because 
diazepam fails to displace a significant proportion of bound [3H] Ro 15-4513 at these 
receptors. Several other inverse agonists including CGS 8216 bind to DI sites. However, 
D I sites do not uniquely bind inverse agonists since they also bind the partial agonist ZK 
91216. The properties of DI sites are probably due to the inclusion of the a6 subunit. 
Luddens et al. (1990) found that DI like properties were exhibited by human embryonic 
kidney cells transfected with a6, p2, and y2 subunit cDNAs (but not other subunits). 
Further evidence to support this conclusion is that the distribution of the a6 subunit 
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conveniently corresponds to the distribution of DI sites, because it is expressed almost 
exclusively in the cerebellum (Luddens et al., 1990). The insensitivity of the a6 subunit 
to diazepam is probably conferred by the presence of a single amino acid residue. 
Substitution of an arginine amino acid residue for a histidine in an a6 variant leads to 
diazepam sensitivity (Wieland, Luddens and Seeburg, 1992). Conversely, replacing a 
histidine residue with an arginine in the a l subunit confers diazepam insensitivity 
(Kleingor, Wieland, Korpi, Seeburg and Kettenman, 1993). The a4 subunit probably 
also confers insensitivity to diazepam (Wisden et al., 1991). 
Rather than two classes of benzodiazepine receptors, division into four classes 
may provide a better description of the data: Type I receptors (aipy2). Type I I receptors 
(a2/3Py2), Type I I I receptors (a5Py2) which have a low affinity for Zolpidem, and Type 
IV receptors (a6py2) which have low affinity for benzodiazepine agonists but high 
affinity for Ro 15-4513. 
Heterogeneity of benzodiazepine receptors could explain the selective profile of 
benzodiazepine partial agonists. Partial agonists could differ in their affinity for specific 
receptor subtype populations located in different brain areas. This would mean that 
targeting one receptor population would lead to a highly selective behavioural outcome. 
However, because there are no selective antagonists for benzodiazepine receptor subtypes 
at present, this theory is difficult to test. In addition, the situation is made slightly more 
complicated by the fact that recent studies have shown that subunit composition may not 
only affect the affinity, but also the intrinsic activity of a compound (Puia, Vicini, 
Seeburg and Costa, 1991; Wafford, Whiting and Kemp, 1993). What this probably 
means is that for any receptor subtype it is necessary to consider the intrinsic efficacy of a 
ligand as well as its affinity. This suggests that compounds with a selective efficacy could 
be developed which affect G A B A neurotransmission at some but not all receptor 
subpopulations. The first potential subtype selective antagonist for G A B A A receptors has 
recently been reported. Furosemide has been shown to antagonize G A B A evoked 
currents in cerebellar granule cells comprising the a6 subunit but not the a l subunit 
(Korpi, Kuner, Seeburg and Luddens, 1995). Additionally, U-90042, a novel hypnotic 
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with specificity for receptors containing the a6 subunit has also been recently described 
(Tang, Smith, Carter, Im and Vonvoigtlander, 1995). These compounds and those like it 
wil l be important for investigating the functional significance of different receptor 
subunits. 
Which combinations occur in vivo? 
The actual composition of G A B A A receptors in vivo, and the rules for subunit 
assembly are not precisely known. This is because although recombinant receptors can be 
artificially expressed in Xenopus and other systems, it does not necessarily follow that 
these receptor combinations will also occur in vivo. Some indication as to the most 
plausible subunit combinations in vivo has been gathered from studies examining the 
pattern of gene expression using in situ hybridization. This technique allows a map to be 
drawn of messenger RNA (mRNA) encoding in the brain. It is assumed that the levels of 
mRNA reflect levels of protein (receptor expression) in that area. The distribution of 
mRNA in the CNS varies for different subunits. Some subunits such as the a l and p2 
subunits are often co-localized (Wisden, Laurie, Monyer and Seeburg, 1992). Other 
evidence suggests that p subunit is only expressed in the retina (Cutting et al., 1991). 
Other investigators have made use of antibodies to label specific subunits to 
identify subunit combinations. These antibodies precipitate varying amounts of receptor 
which can be detected by immunoprecipitation and immunoaffinity chromatography. 
Most receptors precipitated contain a single a subunit type (Duggan and Stephenson, 
1990). Antibodies recognising all p subunits are able to precipitate 100% of purified 
benzodiazepine receptors, whereas antibodies raised to the Y2 subunit precipitate only 
75% of receptors (Stephenson, Duggan and Pollard, 1990). For the 8 receptor, specific 
antibodies precipitate only about 20-30% of purified benzodiazepine receptors (Benke, 
Mertens, Trzeciak, Gillessen and Mohler 1991). This suggests that most G A B A A 
receptors associated with benzodiazepine binding sites contain a, p and y subunits. 
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Evidence from both mRNA studies and antibody labelling suggests the existence 
of several likely combinations of G A B A A receptor subunits in vivo (McKernan and 
Whiting, 1996). First, a combination of aip2y2 subunits, which probably corresponds 
to the Type I benzodiazepine receptor. Second, an a2p2/3y2 subunit combination which 
may be equivalent to the Type I I benzodiazepine receptor. Another likely combination of 
subunits is a6pxy2 which may correspond to the diazepam insensitive site, and is located 
preferentially on cerebellar granule cells. Other likely combinations include the a2pxyl, 
a5p3yx and a4p5. Therefore, although the exact stoichiometry and subunit composition 
of naturally occurring G A B A A receptors remains to be determined, some receptor 
combinations are probably more plausible than others. Further work is required to isolate 
specific subunit combinations from the brain. 
1.2.8 Summary 
The specific combination of G A B A A receptor subunits may determine the 
resultant pharmacology of benzodiazepine receptor ligands. Theoretically, since it is 
possible that many different populations of G A B A A receptors exist in vivo, stimulation 
of a particular population could result in selective behavioural effects. The availability of 
ligands for these different receptor populations would mean that behaviour could be 
affected more precisely. For example, it might be possible to elicit the hyperphagic effects 
of benzodiazepine receptor agonists without inducing anxiolytic or sedative activity. 
, It has been shown that the y subunit is necessary for benzodiazepine receptor 
activation and that substitution of different y subunit results in unusual responses to 
inverse agonists. Additionally, the type of a subunit is important for determining the 
binding of benzodiazepine ligands. The a l subunit confers Type I receptor 
pharmacology, whereas a2 and a3 subunit inclusion leads to Type I I receptor 
responses. Substitution of the a5 subunit also results in reduced affinity for the 
benzodiazepine ligand Zolpidem. The a6 subunit confers insensitivity to diazepam and a 
selective affinity for the inverse agonist Ro 15-4513. 
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Four possible benzodiazepine receptor subtypes are shown in Fig 1.3. The 
t 
availability of more selective drugs, specific for particular receptor subunit combinations, 
would allow behaviour to be affected much more discretely. 
B e n z o d i a z e p i n e r e c e p t o r s u b t y p e s 
Diazepam insensitivd 
Type IV 
a6p2y2 
Diazepam sensitive 
Zolpidem sensitive Zolpidem insensitive 
CI 218.872 high 
Type I 
aip2y2 
CI 218.872 low 
Type II 
a2/3P2Y2 
Type II! 
cx5p272 
Figure 1.3 Diagram to show putative benzodiazepine receptor 
subtypes. Benzodiazepine receptor subtypes are represented by 
different combinations of G A B A A receptor subunits and are 
differentiated in terms of ligand specificity. Adapted from Luddens 
et al. (1995). 
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1.2.9 Endogenous ligands 
The presence of specific binding sites for benzodiazepines in the CNS suggested 
to many researchers the possibility that endogenous ligand could be found. The search 
for a naturally occurring ligand was encouraged by fact that the behavioural effects of the 
opioid antagonist naloxone had been explained by its blockade of endogenous opioid 
compounds (Hughes et al., 1975). 
The first potential endogenous modulator of the benzodiazepine receptor complex 
to be identified was the P-carboline p-CCE. This compound was obtained from human 
urine but was later found to be an artifact of the extraction procedure (Braestrup and 
Nielson, 1980). Another possible candidate was purified from brain extracts by Guidotti 
and colleagues (Guidotti, Toffano and Costa, 1978). This compound was named 
diazepam-binding inhibitor (DBI) because it displaced 3[H]-Diazepam from specific 
binding sites (Guidotti et al., 1983). DBI has been shown to possess inverse agonist like 
properties (Bormann, Ferrero, Guidotti and Costa, 1985). It has proconflict effects 
(Corda, Baker, Mendelson, Guidotti and Costa, 1983) and acts as an anxiogenic 
(Guidotti et al., 1983). Cleavage of DBI produces several peptide products that also 
inhibit diazepam binding. One product of cleavage is the neuropeptide 
octadecaneuropeptide (ODN). It has been proposed that DBI is a precursor of ODN and 
other smaller peptides which bind to benzodiazepine receptors (Ferrero, Guidotti, Conti-
Tronconi and Costa, 1984). DBI immunoreactivity has been detected in the brain 
(Ferrero, Costa, Conti-Tronconi and Guidotti, 1986) and it is possible that ODN, derived 
from DBI, acts as a negative modulator in vivo. Naturally occurring positive allosteric 
modulators of benzodiazepine receptors have also been located in the brain. These 
compounds have been called endozepines and have been purified from both rat and 
human brain (Rothstein et al., 1992a,b). 
The presence of an endogenous ligand has also been inferred indirectly from 
experiments that have demonstrated behavioural effects of the specific benzodiazepine 
antagonist flumazenil. It is assumed that flumazenil has no intrinsic efficacy and so can 
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only affect behaviour by blocking the action of an endogenous ligand. Flumazenil has 
been shown to provoke panic attacks in some studies (Nutt, Glue, Lawson and Wilson, 
1990). However, it is controversial whether this effect reflects an intrinsic pharmacologic 
action of the drug, or is due to blockade of an endogenous ligand. It is true to say that 
although research aimed at elucidating an endogenous benzodiazepine ligand has yielded 
several candidates, there is no general consensus on the presence and activity of such 
compounds. 
1.2.10 Interim summary 
Over the past 25 years a range of ligands from full agonist to full inverse agonist 
have been developed which bind with high affinity to benzodiazepine receptors in the 
CNS. These ligands are useful tools which can be used to further our understanding of 
the neural and behavioural basis of ingestive behaviour. 
It has been shown that benzodiazepine receptors are associated with the G A B A A 
receptor complex and that benzodiazepines ligands modulate G A B A function by altering 
the frequency of G A B A A receptor CI- channel opening. Recent developments in the field 
of molecular biology have revealed unexpected heterogeneity in the composition of the 
GABAA/benzodiazepine receptor complex. This multiplicity is due to the differential 
assembly of at least 15 receptor subunits. Combining different subunits is proposed to 
result in the formation of different receptor subtypes possessing unique physiological 
properties and pharmacological profiles. This raises the possibility that the diverse effects 
of benzodiazepines on behaviour are due to stimulation of specific receptor subtypes in 
different brain areas. Functional analysis of G A B A A receptor subtypes of known subunit 
composition could aid the development of subtype-selective drugs with which to probe 
behaviour more precisely. These pharmacological studies provide a basis for 
understanding how benzodiazepines may bring about the changes ingestive behaviour 
which are reviewed in the next section. 
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1.3 Benzodiazepines and food intake 
The aim of this section is to review the literature concerning the specific effects of 
benzodiazepines on ingestive behaviour. The relationship between the appetite stimulating 
effects of benzodiazepine receptor agonists and their anxiolytic effects will first be 
discussed. The effect of benzodiazepine ligands on food intake will then be reviewed. 
Finally, experiments that have examined the behavioural mechanisms involved in 
benzodiazepine effects on ingestion will be addressed. 
The first report to appear documenting the effects of benzodiazepines on food 
intake was the finding by Randall and colleagues (1960) that the benzodiazepine agonist 
chlordiazepoxide (CDP) increased food consumption in rats and dogs. This result was 
largely ignored at the time. However, since this original observation, 
benzodiazepine-induced hyperphagia has been reported for a whole range of agonists 
(Cooper, 1989). Moreover, the effect has also been reported across many different 
species, including the cat (Fratta, Mereu, Gessa, Pagletti and Gessa 1976; Mereu, Fratta, 
Chessa and Gessa, 1976), rabbit (Mansbach, Stanley, and Barret 1984), primate (Foltin, 
Ellis and Schuster, 1985), wolf (Kreeger, Levine, Seal, Callahan and Beckel, 1991), and 
pigeon (Cooper and Posados-Andrews, 1979). This suggests that the hyperphagic effect 
is not species-specific and does not depend upon a particular type of feeding strategy or 
diet. 
1.3.1 Benzodiazepine-induced hyperphagia and anxiety 
It has been argued that the .hyperphagic effects of benzodiazepines can be 
explained by appealing to the anxiolytic action of these drugs (Poschel, 1971). This 
hypothesis suggests that benzodiazepine agonists increase food intake via a decrease in 
the anxiety associated with exposure to a novel test situation. Appealing though this 
explanation may be, it cannot account for all the data. For example, benzodiazepine 
receptor agonists have been shown to stimulate food intake in animals that have been fed 
to satiety and are fully familiarized with the test procedure (Cooper, Barber, Gilbert and 
Moores, 1985). In addition, Cooper has demonstrated that when a food-deprived animal 
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is given a choice between a novel and familiar food, CDP (5-10 mg/kg) increases the 
consumption of the familiar food, but not that of the novel food (Cooper and Crummy, 
1978). This evidence suggests that instead of overcoming any neophobia towards the 
novel food, CDP may affect appetite directly. Such an interpretation is complicated 
however, by the results of an additional study in which increasing the dose of CDP to 15 
mg/kg led to an increase in the consumption of the novel food (Cooper and McClelland, 
1980). This result was explained in terms of a dual effect of CDP on both food 
neophobia and appetite. Increased intake of the familiar food at low doses was assumed 
to reflect a specific appetite-enhancing effect of this compound, while increased choice of 
the novel food at higher doses was thought to be due to an anti-neophobic action. 
This hypothesis was examined further by testing for differences in the 
development of tolerance to the two effects (Cooper, Burnett and Brown, 1981). 
Tolerance has been shown to develop to the antianxiety action of benzodiazepines (File, 
1980) but not to the hyperphagic effects of these compounds (Cooper and Francis, 
1979a). Following acute injection of CDP, choice of the novel food was increased, 
whereas following chronic treatment, choice of the familiar food was enhanced. Novelty 
was assumed to be a critical factor in determining the effects of CDP since no tolerance 
was observed in a group of animals that had been previously familiarized with all the test 
foods. The explanation for these data was that tolerance developed rapidly to the anti-
neophobic effects of CDP, leaving the appetite-enhancing effects of the drug intact. In 
the above experiment, an anti-neophobic action of CDP was detected, but this effect 
could nevertheless be dissociated from the additional hyperphagic effects of this 
compound (Cooper et al., 1981). Therefore, the increase in food intake caused by 
benzodiazepines is probably due to a specific effect on appetite because the effect cannot 
be fully explained by the action these drugs also have on anxiety induced by a novel test 
situation. 
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1.3.2 Benzodiazepine ligands and food intake 
The following section deals with the effect of benzodiazepine receptor agonists, 
partial agonists, antagonists and inverse agonists on ingestive behaviour. Comparison 
across different classes of benzodiazepines ligands is important for demonstrating 
pharmacological specificity, because if a behavioural effect is mediated by benzodiazepine 
receptors then agonists, antagonists and inverse agonists should elicit predictable effects 
on behaviour. 
Benzodiazepine receptor agonists 
When administered peripherally, benzodiazepine agonists have been shown to 
reliably produce hyperphagia in rats and numerous other species (Cooper, 1980a, 1989). 
Non-benzodiazepines such as zopiclone which exhibit agonist properties at 
benzodiazepine receptors also induce increases in food intake (Cooper and Moores, 
1985a). The increase in food intake can be blocked by administration of selective 
benzodiazepine receptor antagonists (Cooper and Moores, 1985b; Cooper et al., 1985), 
and the effect is stereospecific (Cooper and Yerbury, 1986a). Therefore, the hyperphagic 
effect of these compounds is probably due to a specific action at benzodiazepine 
receptors. 
Benzodiazepine receptors are located in the central nervous system and at 
peripheral sites. The benzodiazepine receptor agonist clonazepam shows selectivity for 
central type benzodiazepine receptors, whereas Ro 5-4864 binds preferentially to 
peripheral type receptors. It has been shown that clonazepam, but not Ro 5-4864, 
stimulates an increase in the food consumption in rats (Cooper and Gilbert, 1985). This 
result implies that stimulation of central rather than peripheral type receptors accounts for 
the hyperphagic effects of benzodiazepine agonists. 
The only benzodiazepine receptor agonist which apparently failed to enhance 
ingestive behaviour reliably was the novel sedative-hypnotic, Zolpidem. Zolpidem is a 
ful l agonist which displays some anxiolytic activity, but also has pronounced sedative 
effects at low doses (Depoortere et al., 1986; Sanger and Zivkovic, 1988). Cooper and 
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others have provided data to suggest that when administered alone Zolpidem has no effect 
on eating and drinking responses (Sanger and Zivkovic, 1988; Yerbury and Cooper, 
1989) . It was suggested that the unusual profile of Zolpidem could be explained by its 
selectivity for benzodiazepine Type I receptor subtypes. According to this line of 
argument. Type I receptors are involved in regulating anxiolytic and sedative behaviour, 
but not ingestional responses. This result is of potential interest since it may provide 
evidence for mapping of subtype selective behaviours. More recently though. Stanhope 
and colleagues have shown that under certain circumstances a hyperphagic effect of 
Zolpidem can be demonstrated (Stanhope, Roe, Dawson, Draper, and Jackson, 1993). 
The reason for this discrepancy may be that the experimental protocol used by Stanhope 
and associates minimised the sedative effects of the drug and so allowed an unmasking of 
its effects on food intake. In summary, a comprehensive range of benzodiazepine 
receptor full agonists have been tested in ingestive behaviour experiments and all have 
been shown to increase food intake under certain circumstances. 
Benzodiazepine receptor partial agonists 
Partial agonists are low efficacy compounds that display anxiolytic and 
anticonvulsant activity, but do not produce either ataxia or sedation (Haefely et al., 
1990) . A number of benzodiazepine receptor partial agonists such as bretazenil (Ro 16-
6028) and the p-carboline ZK 91296 have been shown to increase in food intake in rats 
(Cooper, Yerbury and Desa, 1987; Yerbury and Cooper, 1987). However, not all partial 
agonists reliably induce increases in ingestive behaviour. Cooper and colleagues found 
that the pyrazoloquinolines COS 9896 and COS 9895 did not stimulate an increase in 
food consumption in non-deprived animals (Cooper and Gilbert, 1985; Cooper and 
Yerbury, 1986a). Several other authors have also failed to observe an effect of COS 
9896 and CGS 9895 on food intake in hungry rats (Sanger, Joly and Zivkovic, 1985). 
This is despite the fact that these drugs were able to antagonize the effect of 
benzodiazepine receptor full agonists (Cooper and Yerbury, 1986). The lack of effect of 
CGS 9896 and CGS 9895 on ingestive behaviour may be due to the low efficacy of 
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these compounds. Alternatively, it could be that COS 9896 and COS 9895 are subtype 
selective agonists which bind with reduced affinity to a population of benzodiazepine 
receptors specific for ingestional responses (Cooper et al., 1987). This conclusion is not 
supported by recent data gathered by Chen, Davis and Loew (1995). These authors 
found that in both deprived and non-deprived animals, COS 9896 did induce an increase 
in intake of a palatable diet. Therefore, although it appears that in most cases 
benzodiazepine partial agonists increase ingestive behaviour, for compounds with very 
weak agonistic properties, such as COS 9896 and COS 9895, the degree of hyperphagia 
observed depends upon the specific test conditions. 
Benzodiazepine receptor antagonists 
In feeding tests, the benzodiazepine flumazenil and the p-carboline ZK 93426 
behave as benzodiazepine receptor antagonists. When administered alone these 
compounds do not significantly affect feeding behaviour (Cooper and Gilbert, 1985; 
Estall and Cooper, 1986). However, flumazenil has been shown to block the increase in 
intake induced by clonazepam (Cooper and Gilbert, 1985). 
Benzodiazepine receptor inverse agonists 
If benzodiazepine receptor agonists increase food intake then it is predicted that 
inverse agonists should cause anorexia. This has been confirmed in many studies. The 
inverse agonists FG 7142, DMCM, and the weak inverse agonist CGS 8216 all produce 
dose-dependent decreases in the consumption of a palatable diet in non-deprived male rats 
(Cooper et al., 1985). The effect of FG 7142 can be reversed by administration of the 
antagonist ZK 93426 (Cooper, 1986b). In addition, midazolam, clonazepam and 
triazolam have all been found to block the reduction in intake produced by FG 7142 
(Cooper, 1985a; Cooper et al., 1985). This suggests that the anorectic effect of inverse 
agonists is mediated by central benzodiazepine receptors. 
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As shown in Fig 1.5 control over eating behaviour can be exerted bidirectionally through 
drug action at benzodiazepine receptors. Agonists enhance food consumption, whereas 
inverse agonists reduce intake. 
Bi-directional control of appetite 
Agonist 
Inverse agonist 
Benzodiazepine 
Receptor 
Hyperphagia 
Anorexia 
Figure 1.5 Diagram to show bidirectional control of food intake 
at the level of the benzodiazepine receptor. Agonists increase food 
intake and inverse agonists decrease food intake. 
1.3.3 Benzodiazepine-induced hyperphagia and GAB A function 
Despite evidence of a close association between GABA and benzodiazepines there 
has been some debate concerning the relevance of this relationship, for the effects of 
benzodiazepine ligands on food intake. I f benzodiazepine receptor agonists exert their 
effects on ingestive behaviour via facilitation of GABAergic transmission then it is 
predicted first, that GABA agonists should increase food intake, and second, that GABA 
antagonists should block benzodiazepine-induced hyperphagia. This hypothesis has been 
tested with mixed results. The GABA agonist muscimol has been shown to increase 
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food intake in rats in some cases (Grandison and Guidotti, 1977), but not others (Sanger, 
1984). Studies using GAB A antagonists have provided similarly ambiguous findings. 
Birk and Noble (1982) found that the increase in ingestive behaviour induced by 
diazepam could be attenuated by pretreatment with both picrotoxin and bicuculline. 
However, this result has not been replicated by other authors (Sanger, 1984; Shepherd 
and Broadhurst, 1982). The lack of effect of muscimol on feeding behaviour observed 
by Sanger (1984) may have been due to the systemic route of administration used, 
because muscimol is reported to have poor penetration into the brain due to rapid 
metabolism (Snodgrass, 1978). One difference between G A B A agonists and 
benzodiazepine agonists which might explain these results is that G A B A agonists 
produce a global effect at G A B A A receptors throughout the central nervous system, 
whereas benzodiazepine agonists require the presence of endogenous G A B A for their 
effects. 
However, more difficult to explain without abandoning the hypothesis that 
GABAergic transmission mediates the hyperphagic effect of benzodiazepine ligands, is 
the finding that G A B A antagonists did not block the hyperphagic effect of CDP. An 
important point in this respect may be that not all G A B A A receptors are coupled to 
benzodiazepine receptors. It could be that an action of G A B A mimetics at sites not linked 
benzodiazepine receptors effectively masks any effect at the benzodiazepine G A B A A 
receptor complex. Alternatively, because G A B A antagonists block other behavioural 
effects of benzodiazepines such as their anti-conflict effects (Scheel-Kruger and Peterson, 
1982) and sedative effects (Billingsley and Kubena, 1978), it could be that GABA 
mediates some but not all of the behavioural effects of these drugs. Because of problems 
in interpreting the results of the effect of GABA antagonists on feeding behaviour 
induced by benzodiazepine receptor agonists, a role for GABA in mediating the 
hyperphagic effect of these drugs has not been unequivocally demonstrated. However, 
the wealth of pharmacological and biochemical data suggesting an association between 
GABA and the behavioural effects of benzodiazepines means that GABA facilitation is 
the most likely mechanism of action. 
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1.3.4 Summary 
Evidence suggests that benzodiazepine receptor ligands exert a specific effect on 
ingestive behaviour that is distinct from the additional action of these drugs on anxiety 
processes. It has been shown that benzodiazepine-induced changes in food intake are 
mediated by benzodiazepine receptors located in the central nervous system. It is possible 
to exert bidirectional control over feeding behaviour, depending on the nature of the 
benzodiazepine receptor ligand: agonists cause hyperphagia, inverse agonists have an 
anorectic action, and antagonists block the effects of these compounds. The effects of 
these drugs on ingestive behaviour are probably mediated via modulation of GABAergic 
transmission mediated by G A B A A receptors. 
1.3.5 Behavioural processes 
The control of food intake involves the integration of many complex signals 
which may be metabolic, hormonal or neural in nature. Because of this, many 
opportunities exist for pharmacological intervention in the system. Therefore, although it 
is consequently often quite easy to demonstrate a drug-induced effect on appetite, the 
interpretation of such an effect may not be straightforward. For example, a drug could 
affect food intake in any of three major ways. First, it could affect satiety processes. A 
drug could influence the post-ingestive consequences of feeding such that the inhibition 
of hunger brought on by the food itself is either increased or decreased. Second, it could 
alter the sensory perception of the food (taste, smell and texture), or its palatability. 
Finally, the drug might not have a direct effect on the controls of ingestive behaviour at 
all but instead induce non-specific effects. For example, an animal may have a motoric or 
sensory deficit and not be able to contact the food properly or even detect its presence. 
Alternatively, the drug may induce sickness. Much of the behavioural pharmacology of 
appetite has been engaged in determining the specificity of drug-induced changes in 
ingestion. Some progress has been made in analyzing the behavioural mechanisms 
responsible for the effects of benzodiazepine ligands on food intake. The results of an 
extensive period of research into the behavioural mechanisms responsible for 
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benzodiazepine-induced changes in food intake are reviewed below. Early theory tended 
to emphasize the importance of hunger and satiety as important factors, whereas later 
theory has focused on the role of taste factors or palatability. 
1.3.6 Hunger and satiety 
It has been known since 1974 that diazepam will increase operant responding for 
food pellets in non-deprived rats (Wise and Dawson, 1974). One explanation for this 
effect is that the effects of benzodiazepines on feeding behaviour are similar to those 
produced by food deprivation. However, some authors have detected differences 
between the effects of food deprivation and hunger. This suggests that benzodiazepine 
receptor agonists do not produce their effects on food intake by mimicking hunger (Hunt, 
Poulos and Cappell, 1988; Shepherd and Broadhurst, 1982). Recent experiments using 
an incentive learning paradigm lend support to this conclusion (Balleine, Ball and 
Dickenson, 1994). Balleine and colleagues (1994) found that instead of producing a state 
analogous to hunger, midazolam influenced the incentive value ascribed to the food. 
Consumption of a non-nutritive saccharin solution was only enhanced in animals that had 
previously been given the opportunity to learn about the incentive value of the food under 
the midazolam condition. These authors argued that incentive value is determined by the 
hedonic response to the food, and that benzodiazepines increase incentive value through 
an increase in the perceived palatability of the stimulus. It would be expected that inverse 
agonists would reduce the incentive value of the instrumental outcome because of a 
decrease in palatability. This hypothesis has yet to be confirmed, but evidence from 
intra-cranial self stimulation (ICSS) suggests that a result to the contrary would be 
extremely surprising. Pellow and Herberg (1984) found that FG 7142 produced a dose 
related decrease in responding for rewarding stimuli that was effectively blocked by 
CDP. 
An early explanation of benzodiazepine-induced increases in food intake placed 
emphasis on the potential anti-satiety effects of these drugs (Margules and Stein, 1967). 
The results of more recent experiments involving manipulation of within-meal satiety 
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factors do not provide evidence to support this interpretation. Midazolam has been shown 
to increase food consumption in animals that have been pre-fed to satiety, suggesting that 
it is probably not suppressing satiety signals (Cooper et al., 1985). This led investigators 
to examine the possibility that instead of mimicking hunger or inhibiting satiety, 
benzodiazepines may increase food intake by affecting palatability. 
1.3.7 Paiatability 
If the usefulness of a scientific concept is defined by its ability to stimulate 
research then the concept of palatability has proved to be extremely useful indeed. 
Despite this, difficulties with the definition and misunderstanding of the term have led to 
many calls that it should be abandoned as an explanatory construct in the field of 
ingestive behaviour research. A full discussion of palatability is beyond the scope of this 
thesis. Nevertheless, given the pervasiveness of the term within the literature it is 
necessary to define what is meant by the term palatability in this thesis. Traditionally, 
palatability has been taken to refer to invariant properties of tastants which lead to them 
being either accepted or rejected by consumers. As Grill and Berridge (1985) have 
pointed out though, this definition constitutes a stimulus measure and has clear 
limitations. A tastant which is consumed readily by animals, such as sucrose, is often 
described as a 'palatable' stimulus. The problem with this definition is that the response 
to sucrose may not always be predictable. For example, a sucrose solution accepted by 
an animal on one occasion may be rejected on another. Acceptance of the sucrose may 
depend not only on some perceptual quality of sfimulus itself, but also on the 
physiological state of the animal (e.g. sated versus non-sated). Conditioned associations 
may also have an influence, such as the previous pairing of the stimulus with illness 
(Garcia and Koelling, 1966). As an alternative to a stimulus measure. Grill and Berridge 
(1985) have suggested that palatability might be more properly defined as the outcome of 
the integration of taste signals with internal state and associative signals. A mathematical 
model of ingestive behaviour proposed by Davis and Levine (1977) suggests that 
palatability factors exert excitatory control over feeding while internal-state factors (e.g. 
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post-ingestive feedback) have an inhibitory effect. Despite this, the use of the term 
'palatable' as a modifier for a taste stimulus may be justified in certain cases since the 
palatability of some tastes is relatively stable under a broad range of conditions. 
The use of the terms palatable and palatability in this thesis reflect their usage in 
the literature. The terms will sometimes be used to describe a taste stimulus (as in 
'palatable' mash) but will also be referred to in a more strictly defined sense to describe 
the integrative process occurring in the central nervous system elicited by taste stimuli. 
Various attempts have been made to provide an operational definition of 
palatability. This has mainly involved the development of tests which measure the 
behavioural response to taste stimuli. Such tests include the taste preference test and sham 
feeding paradigm. There has been considerable debate about which of these paradigms 
constitutes the best measure of palatability. Each test has obvious drawbacks and 
limitations. This means that a single test is unlikely to provide privileged information 
concerning palatability. Therefore, the most useful exercise is probably to draw 
conclusions from the effects of a drug manipulation across a range of these paradigms, 
rather than merely relying on one. Gathering evidence from several experimental sources 
is the most reasonable way of asserting that a drug is preferentially affecting palatability. 
Benzodiazepine ligands provide a good example of a drugs which have been examined in 
many tests thought to provide a measure of palatability. 
Palatable mash consumption 
It has been argued that studies in which animals are offered a highly palatable diet 
enable conclusions to be drawn concerning the effect of a drug manipulation on hedonic 
factors involved in the control of eating behaviour (Blundell, 1987). Often the test food 
is a palatable sweet wet mash which is consumed in large quantities by non-deprived rats. 
Benzodiazepine receptor agonists dramatically increase the consumption of this diet 
(Cooper and Gilbert, 1985). These results provide evidence that benzodiazepine receptor 
agonists may increase food intake by modulating hedonic responses to foodstuffs. 
Predictably, benzodiazepine receptor inverse agonists reduce intake of palatable 
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food. It has been reliably demonstrated that FG7142 (a 6-carboline) and CGS 8216 (a 
pyrazoloquinoline) and Ro 15-4513 (an imidazobenzodiazepine) all produce dose-
dependent and significant decreases in palatable food intake (Cooper et al., 1985; 
Cooper, Bowyer and van der Hoek, 1989). 
Sham feeding 
The sham feeding paradigm provides a means of studying the effect of 
oropharyngeal factors on the consumption of palatable food. In this preparation, the aim 
is to eliminate postingestional factors by allowing ingested material to drain out of the 
stomach via a chronically implanted gastric fistula. Such fistulated animals display a 
pronounced satiety deficit, and it has been proposed therefore that the technique provides 
a measure of palatability (Weingarten and Watson, 1982). Midazolam and clonazepam 
have been shown to produce significant increases in the sham feeding of a palatable 
sucrose solution compared with a vehicle control condition (Cooper, van der Hoek and 
Kirkham, 1988). This suggests that the increase in consumption caused by 
benzodiazepine receptor agonists is not due to an effect on the rate of gastric emptying, 
because it is still observable when food material is prevented from accumulating in the 
gut. Postabsorbative factors are also less likely to be able to account for benzodiazepine-
hyperphagia, although it has been argued that the sham feeding preparation may not 
totally eliminate absorption (Sclafani and Nissenbaum, 1985). Despite this, data from 
sham feeding experiments seems to suggest that benzodiazepines have an effect on 
oropharyngeal factors controlling intake rather than postingestional effects (Cooper et al., 
1988). 
The inverse agonists CGS 8216, Ro 15-3503 and FG 7124 all produce dose-
related decreases in real and sham feeding of a palatable sucrose solution (Kirkham and 
Cooper, 1987; Cooper et al., 1988). CGS 8216 was found to cause a 50% reduction in 
sucrose consumption. The suppression of sham feeding caused by CGS 8216 was also 
antagonized by flumazenil suggesting the effect is mediated by central benzodiazepine 
receptors (Kirkham and Cooper, 1987). CGS 8216 has been shown to increase plasma 
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corticosterone levels, an effect that is also observed in response to stress (Pellow and 
File, 1985). Therefore, it is possible that CGS 8216 decreased intake because it induced a 
stress-like state. However, several pieces of evidence argue against this interpretation. 
First, sham drinking of water was unaffected by CGS 8216. This indicates that the 
decrease in sucrose consumption was not due to a non-specific deficit because of stress. 
Second, the effect of CGS 8216 on palatable food consumption was not abolished by 
adrenalectomy. This suggests that the effects of this drug on ingestive behaviour are not 
related to increased plasma corticosterone levels (Cooper and Kirkham, 1987). Third, the 
decrease in the rate of ingestion caused by this inverse agonist is similar to the effects 
observed when decreasing sucrose concentration in the sham feeding rat. Therefore, the 
effect of CGS 8216 and other inverse agonists on ingestive behaviour are probably better 
explained by a diminution in palatability. 
Taste preference 
It is possible that benzodiazepine-induced hyperphagia is a general effect, and that 
following administration of benzodiazepine receptor agonists the consumption of all 
ingestive material is enhanced indiscriminantly. Alternatively, benzodiazepine ligands 
may act on feeding responses related to the evaluation of taste stimuli. The taste 
preference paradigm allows this hypothesis to be tested directly. Instead of having access 
to a single bottle, animals are given a choice between two bottles. I f benzodiazepine 
receptor agonists produce a non-specific increase in ingestive behaviour then an increase 
in the consumption of both solutions should be observed in this test. I f the effect is 
specific for taste related behaviour then consumption of one solution should be enhanced 
selectively. Maickel and Maloney (1974) exposed water-deprived rats to water, or 
solutions of 0.2% saccharin or 0.5% tartartic acid. These authors noted that although 
benzodiazepine receptor agonists had a general hyperdipsic effect, this effect was more 
pronounced when animals had access to the sweet saccharin solution. One explanation 
for this result is that the agonists were enhancing sweet taste preference, an effect distinct 
from the general hyperdipsia also observed. This hypothesis was only explicitly tested 
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much later in 1988, by Cooper and Yerbury who used a two-bottle intake test in which 
rats were given a choice between a preferred (0.05%) saccharin solution and water. In 
this experiment, clonazepam increased the consumption of the saccharin solution without 
causing a concomitant increase in the consumption of water. Using the same preference 
test, this result has since been extended to include a range of benzodiazepine receptor full 
agonists such as CD? (Parker, 1991), the p-carboline abecarnil (Cooper and Greenwood, 
1992) , and partial agonists including bretazenil and Ro 17-1812 (Cooper and Green, 
1993) . These data indicate that benzodiazepine receptor agonists specifically affect 
ingestive behaviour since the results cannot be accounted for by arguing that there was 
general increase in arousal. In addition, saccharin is a non-nutritive stimulus and so this 
supports the conclusion that benzodiazepines do not significantly affect the postingestive 
consequences of feeding. 
The prediction that inverse agonists produce the opposite effect to agonists and 
block sweet taste preferences has been tested in several studies. The inverse agonists FG 
7142, CGS 8216, Ro 15-4513 all reduce saccharin intake in a two-choice test without 
affecting water consumption (Cooper, 1986a; Cooper et al., 1989; Kirkham and Cooper, 
1986). This result contrasts with the effects of other well-known anorectic agents such as 
amphetamine which display a general hypodipsic effect and reduce consumption of both 
water and saccharin (Maickel and Webb, 1972). 
To examine whether the effect of benzodiazepine ligands on hedonic responses to 
food extends to salty tastes, salt preference tests have been used. Isotonic saline is readily 
ingested by rats and benzodiazepine agonists have been shown to cause an increase in the 
consumption of a palatable 0.9% NaCl solution (Estall and Cooper, 1987; Turkish and 
Cooper, 1984). Abecarnil has also been shown to increase intake of a 0.9% NaCl 
solution, without affecting water consumption in a two-choice test (Cooper and 
Greenwood, 1992). The same result has been obtained using the partial agonists 
bretazenil and Ro 17-1812 (Cooper and Barber, 1993). Therefore, it appears that 
modulation of preferences by benzodiazepines is not limited only to sweet tastes. 
The effect of inverse agonists on salt preference has been examined with 
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somewhat surprising results. Cooper and Barber (1993) did not observe any reduction in 
the preference for a 0.9% saline solution in a two-botde test following administration of 
Ro 15-4513. In addition, this compound did not increase the relative aversion to a 
stronger 1.8% NaCl solution. This result implies that unlike sweet tastes there is no 
bidirectional control of preference for salt. However, Ro 15-4513 may have an atypical 
pharmacological action and so it will be necessary to examine the effects of other inverse 
agonists before any firm conclusions can be drawn. Alternatively, the mechanisms 
underlying salt and sweet preference may be different and so caution must be exercised in 
equating the two. 
It could be argued that benzodiazepine agonists increase intake in the taste 
preference test by having an anti-aversive effect rather than acting directly on palatability. 
However, this explanation is not supported by data from experiments investigating 
quinine aversion. Adding quinine to fluids and foods causes them to have an aversive 
taste. Margules and Stein (1967) observed that oxazepam can overcome this aversion. 
Cooper and Green (1993) employed a two-bottle intake test in which rats were given a 
choice between water and 0.005% quinine HCl. In this case the animals display a 
preference for water. Following treatment with bretazenil and Ro 17-1812, consumption 
of water was unaffected, whereas an increase in the ingestion of quinine was observed. 
This evidence suggests that it is unlikely that benzodiazepine agonists merely enhance the 
choice of a more preferred fluid, because water intake was not affected in the test. It 
could still be argued that this result is due to an anti-aversive effect. However, this 
conclusion is not supported by the effect of benzodiazepine receptor inverse agonists on 
quinine aversion. In a two-bottle test, FG 7142 did not elicit an increase in the aversion to 
quinine, although a decrease in preference for saccharin was observed in the same study 
(Cooper, 1986a). This evidence implies that inverse agonists attenuate the positive 
reactions to sapid stimuli without affecting aversive reactions. In summary, the most 
parsimonious explanation of these taste preference data is to suggest that benzodiazepine 
ligands increase the palatability of flavoured solutions. 
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Taste reactivity 
The taste reactivity test (Grill and Norgren, 1978a,b) is a method that enables the 
dissociation of the ingestion of fluids from the hedonic or aversive responses to those 
stimuli. In this paradigm, sapid solutions are infused directly into the oral cavity of rats. 
The orofacial responses and body movements elicited are then recorded. These responses 
are species-specific, reliably emitted, and are referred to as fixed action patterns (FAPs). 
The pattern of responding indicates whether the animal is reacting to the infused solution 
in a positive, ingestive manner, or with aversive reactions. It has been proposed that this 
test provides a relatively pure measure of palatability. Using a taste reactivity paradigm 
Berridge and Treit (1986) found that CDP increased the number of ingestive FAPs 
elicited in response to solutions of 0.03M sucrose, 0.0IM HCl and 10 -3M QHCl, but 
had little or no effect on aversive or neutral FAPs. This evidence suggests that CDP 
enhances the positive palatability of ingested fluids, and has been replicated in several 
studies (Berridge, 1988; Treit and Berridge, 1990; Treit, Berridge and Schultz, 1987). 
Midazolam has also been shown to affect taste reactivity responses in rats which do not 
have an intra-oral cannula but instead are allowed to sample taste stimuli voluntarily. In 
this modification of the taste reactivity test, midazolam has been shown to increase the 
number of ingestive responses to a 3% sucrose solution (Gray and Cooper, 1995). These 
data are consistent with those reported for oral-cannulated animals. 
The effect of inverse agonists in the taste reactivity paradigm has not been so 
meficulously investigated. Treit et al. (1987) found that the enhancement of positive 
palatability produced by CDP could be antagonised by flumazenil and the weak inverse 
agonist CGS 8216. However, CGS 8216 did not have any intrinsic inhibitory activity, 
even at doses found to produce reliable effects on sham feeding (10 mg/kg). This result 
may have been due to a floor effect, and further studies will be essential to characterize 
the effect of inverse agonists in the taste reactivity paradigm. It might be predicted that 
inverse agonists would only affect positive palatability and so would attenuate positive 
ingestive reactions while not affecting aversive reactions, but this hypothesis remains to 
be tested. 
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1.3.8 Summary 
There is much evidence to suggest that the changes in food intake elicited by 
administration of benzodiazepine ligands is due to a specific effect of these drugs on 
palatability. In support of this view, midazolam has been shown to increase sucrose sham 
feeding and ingestive taste reactivity responses. Several benzodiazepine receptor agonists 
have also been shown to enhance the consumption of a preferred saccharin solution, 
without affecting water intake, in a two-bottle choice test. In addition to the tests 
described above such as sham feeding and taste reactivity, it has been suggested that 
analysis both of the time course and detailed structure of the components of ingestive 
behaviour may provide information concerning the behavioural mechanisms responsible 
for changes in intake. Studies in this area could provide important new information to 
elucidate further the mechanisms involved in the effects of benzodiazepine ligands on 
ingestive behaviour. The next section is concerned with reviewing the techniques 
available for analyzing the detailed structure of ingestive behaviour. 
1.3.9 Temporal analysis of feeding behaviour 
Feeding behaviour varies along two dimensions: the contextual and the temporal 
(Blundell, 1987). Context refers to the impact of environmental conditions on feeding 
behaviour. The temporal dimension reflects the pattern of feeding over time. Much 
research activity has been focused on analysis of the temporal pattern of feeding 
behaviour. The reason for this may have something to do with the relative ease of 
recording the occurrence of feeding events with the use of automatic recording 
equipment. For example, the availability of reasonably priced computers to log large 
numbers of data points has been a key factor in the development of this area (Clifton, 
1987). It has been argued that examination of temporal patterns of feeding and drinking 
allows conclusions to be drawn concerning the behavioural mechanisms responsible for 
any changes in food intake. Blundell (1987) has suggested that analysis of the sequence 
of ingestive behaviours may be particularly useful for distinguishing between 
pharmacological manipulations which mimic naturally occurring physiological processes 
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as opposed to those which induce pathological or non-specific effects. Merely measuring 
intake would not yield enough information to allow such a distinction to be made. 
Several problems may be encountered in attempting to describe the pattern of 
feeding behaviour over time. The first involves defining the most appropriate unit of 
classification to use. An important point in this respect is that the components of feeding 
behaviour are not distributed randomly over time. Thus, an animal engaged in feeding or 
drinking wil l chew or lick in runs of rapidly repeated stereotyped actions. These 
sequences of behaviours, which are often referred to as bouts, are then separated by 
pauses in which non-ingestive behaviour is displayed. Additionally, over longer periods 
bouts of ingestive behaviour also occur in clusters or meals. It may be reasonable to 
assert therefore, that feeding behaviour is organised into naturally occurring descriptive 
units. This acknowledgement means that discrete episodes of feeding (bouts and meals), 
can be treated as variables that may reflect specific changes in the control of ingestive 
behaviour. The study of bouts of behaviour has proved to be fruitful area of research, 
especially in the field of ethology (McFarland, 1970; Slater, 1974). 
Having accepted the usefulness of analyzing ingestive behaviour in terms of bouts 
and meals, a second problem presents itself. This problem is concerned with choosing an 
appropriate bout or meal criterion (Clifton, 1987; Machlis, 1977). Bout structure is 
determined by the length of the intervals between ingestive acts rather than the acts 
themselves. Traditionally, bouts of behaviour have been defined by choosing an interval 
(xt) to separate one bout from another. An interval less than X t is classified as a within-
bout interval, and an interval equal to or greater than X t is classified as a between-bout 
interval. The setting of this criterion has often been done arbitrarily by merely observing 
the behaviour. Recently, to provide a more objective definition, bout criterions have been 
derived from log survivorship functions. A log survivorship analysis first involves back 
cumulation of interval frequency (starting with the longest not the shortest interval). This 
cumulative frequency is then plotted on a log scale against interval length. Events that are 
randomly distributed over time follow a negative exponential distribution. When plotted 
on a log survivor plot, this kind of distribution appears as a straight line. However, 
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intervals between feeding events do not conform to this simple model. It is not surprising 
therefore that a single negative exponential does not provide a good fi t for ingestive 
behaviour data. Instead, a broken stick appearance describes the data quite well. The 
curve descends steeply at first and then subsequently declines more gradually. The sum 
of two negative exponential distributions generates a better fit for this data. This supports 
the assumption that it is possible to divide the intervals that separate feeding events into 
two categories generated by different processes: those which have a high probability of a 
further event following (within-bout interval) and those which have a low probability of 
another event occurring (between-bout intervals). It has been suggested that the simplest 
way of defining a bout would be to use a criterion just to the right of the most obvious 
break point in the log survivorship function (Slater, 1974). Errors of classification will 
always be made, since the distributions are overlapping and so classification into two 
mutually exclusive categories is impossible. However, log survivor plots generated in 
feeding experiments generally have sharp discontinuities making misclassification less 
likely. Choosing an error that is too short will have most impact on the data, and so the 
best strategy is to select a criterion that is slightly longer than the optimal to reduce this 
possibility. Once a suitable criterion has been defined, feeding data can be analyzed 
according to bout or meal size and frequency among other parameters. This technique has 
been applied to the study of long term changes in meal patterns over 24h in rats and to 
analyzing the structure of single meals, both of which are described below. 
Meal pattern analysis 
Analysis of meal patterns usually involves the monitoring of feeding in free 
feeding animals over a 24h period. Frequently, animals are tested in a specially adapted 
home cage that enables the time of removal of a food pellet from the hopper to be 
recorded (Clifton, 1987). This method has the advantage of allowing animals to be 
observed in a more normal feeding situation because deprivation or access to palatable 
food is not required to induce animals to feed. 
The effect of bretazenil on meal patterning has been examined by Clifton and 
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Cooper (1996). Bretazenil increased the size of the first meal following drug treatment. 
However, no increase in food intake was observed over the 24h period. Therefore, the 
effect of the drug was short lived. One factor to allow for when interpreting these results 
is that bretazenil is a short acting drug and so may have ceased to be effective after 2h. 
Nevertheless, the results do imply that bretazenil does not induce long term changes in 
eating patterns since the size of further meals was not significantly different from 
controls. Importantly, these data confirm that benzodiazepine hyperphagia can be 
demonstrated in a situation where the animals are fully habituated to a quiet unchanging ' 
environment. 
Microstructural analysis 
Examination of the pattern of feeding over long periods, can often provide 
information concerning the mechanisms responsible for drug-induced changes in intake. 
However, sometimes it may be more revealing to focus on behaviour within a meal. 
Characterizadon of the individual components of ingestive behaviour is called 
microstructural analysis. This kind of analysis may be especially pertinent for the study 
of the effects of benzodiazepines ligands on ingestive behaviour. Meal pattern data 
suggests that benzodiazepine-induced hyperphagia may be rapid in onset and fairly short 
lived. Assuming this is the case, it might be expected that quantification of feeding 
behaviour at a fine grained level would be more appropriate than 24h analysis of feeding 
and drinking patterns. 
Microstructural analysis has been applied to eating and drinking behaviour alike. 
Such analysis involves dividing feeding behaviour within a meal into bouts as described 
above. Examination of the effects of benzodiazepine receptor ligands on solid food intake 
has shown that midazolam increases intake via a lengthening the individual bouts of 
ingestion in rats consuming a palatable mash (Cooper and Yerbury, 1986b). Midazolam 
did not affect the frequency of bouts. Similar analysis conducted for the inverse agonist 
FG 7142 showed that this compound reduced the duration of bouts, but did not affect the 
number of bouts. 
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Microstructural analysis has been more frequently applied to the study of licking 
behaviour. This is probably a direct result of the availability of lickometers to record 
accurately the occurrence of individual licks. The effects of manipulating palatability on 
bout structure has been thoroughly examined (Davis and Perez, 1993; Davis and Smith, 
1990; Davis and Smith, 1992). Davis and Smith (1992) found that for a range of 
carbohydrates, bout size increased monotonically with increasing concentration. 
Consequently, it has been suggested that bout duration may be sensitive to changes in 
palatability. 
A microstructural approach may also be sensitive to non-specific motor effects on 
licking behaviour. Licking in rats is highly stereotyped in nature, consisting of fast 
rhythmic tongue protrusions. Stellar and Hill (1952) showed that rats lick at a reasonably 
constant rate of about 6-7 licks per second. This is the intrabout lick rat which is 
calculated by counting the number of intervals between licks in a bout and then dividing 
by the time spent drinking. Any disruption of this rate would suggest that a 
pharmacological treatment might be affecting sensorimotor coordination, as distinct from 
a specific effect on the controls of ingestion. Thus, Davis and Smith (1992) showed that 
intrabout lick rate is reduced by moving the drinking spout progressively further away 
from an animal, but not by altering the solution concentration. These data suggest that 
microstructural analysis provides a useful model for studying the effects of 
benzodiazepines on ingestive behaviour. 
Rate analysis 
It is important to distinguish between two types of rate measure referred to in the 
literature. The first type of measure is the rate of consumption within a bout, or local rate 
of eating which has been referred to previously. The second is the change in the rate of 
licking over test session (overall lick rate). The model for the control of ingestive 
behaviour proposed by Davis and Levine (1977) makes specific predictions concerning 
the effects of excitatory orosensory input and post-ingestive negative feedback on the rate 
of ingestion. These predictions have been confirmed experimentally in a number of 
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studies (Davis and Levine, 1977; Davis, Kung and Rosenak, 1995; Davis and Smith, 
1990). This suggests that analysis of overall lick rate provides important information 
concerning the relative contribution of these variables to the control of food intake. For 
example, it is found that initial lick rate increases with increasing carbohydrate 
concentration (Davis, 1973; Davis and Smith 1988), but decreases as a result of quinine 
administration (Davis and Levine, 1977). Therefore, the initial lick rate has been taken as 
a measure of palatability. The rate of clearance of ingested substances from the stomach 
can be manipulated by adding mannitol to the test meal. Mannitol is absorbed from the 
intestine very slowly and is found to have a selective effect on the decline in the rate of 
licking within a test period. The decrease in the rate of licking has thus been taken to be a 
measure of post-ingestive negative feedback (Davis, Collins and Levine, 1975; Davis and 
Levine, 1977). An advantage of examining the change in the rate of ingestion over a 
meal is that it enables the interaction between orosensory stimulation and post-ingestive 
negative feedback to be studied rather than studying these factors in isolation. 
Satiety sequence 
Changes in feeding behaviour over time can also be analyzed in terms of the 
transition from feeding to non-feeding components. It has been noted that i f animals are 
deprived overnight and then allowed to feed to satiety the next day they exhibit a 
characteristic sequence of behaviours. Initially, feeding predominates but then this gives 
way to other behaviours which occur in a reproducible sequence as follows: Feeding -
activity - grooming - sleep/resting (Antin et al., 1975). If a drug is having a specific effect 
on satiety then it should induce a shift in behaviour on the temporal plane. If on the other 
hand, a drug is having a non-specific effect on behaviour then this would be reflected in a 
disruption of component parts of the sequence rather then a temporal shift. Clifton and 
Cooper (1996) have recently examined the effect of bretazenil on the satiety sequence. 
Despite a high baseline intake of palatable mash in this experiment, bretazenil was found 
to increase consumption in a 30 min test. A decrease in the time spent engaged in active 
behaviours and grooming was also observed, and there was a significant increase in 
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resting. Bretazenil appeared to speed the transition from feeding to activity and grooming, 
but also enhanced resting. Bretazenil did not significantly extend feeding behaviour in the 
temporal plane, but counter-intuitively displayed a profile similar to anorectic drugs such 
as the indirect 5-HT agonist fenfluramine. One interpretation of the results is to say that 
bretazenil did not increase food intake by suppressing satiety but merely increased 
consumption only in the early part of the test. This conclusion is consistent with other 
data suggesting that the action of benzodiazepines on food intake is related to the initial 
hedonic evaluation of ingested materials. The results also indicate that enhanced 
progression from feeding to resting in the satiety sequence may not be a reliable indicator 
of an effect on satiety mechanisms. 
1.3.10 Summary 
Detailed examination of the components of feeding in short term tests (analysis of 
bout structure) and over 24h periods (meal pattern analysis) can provide information 
concerning the behavioural mechanisms responsible for changes in food intake. Analysis 
of the change in the rate of ingestion within a meal can also allow the contribution of 
factors such as satiety and palatability in determining meal size to be assessed. No data 
have been published to date concerning the effect of benzodiazepine ligands on the rate 
and microstructure of licking behaviour. Therefore, studies of this kind may be important 
in determining the behavioural mechanisms responsible for benzodiazepine-induced 
changes in intake. 
1.4 Neural substrates 
Since the hyperphagic effects of benzodiazepine receptor agonists were first 
reported in the 1960s, progress has been made in defining the behavioural mechanisms of 
action for the effect these drugs on ingestion. Concurrent with progress in understanding 
the behavioural mechanisms involved in benzodiazepine-induced changes in food intake, 
there has also been an increase in understanding the pharmacology and molecular biology 
of benzodiazepine receptors. Consequently, there is now a comprehensive profile of 
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compounds from full agonists through to partial agonists, antagonists, partial inverse 
agonists and full inverse agonists with which it is possible to exert bidirectional control at 
the receptor level. 
Despite such behavioural and pharmacological advances, little evidence has been 
gathered to date concerning the neural substrate for the effect benzodiazepine ligands on 
ingestive behaviour. The focus for the few studies that have been carried out has been on 
brainstem structures. Given the fairly sparse distribution of benzodiazepine receptors in 
this area may seem somewhat surprising. Nevertheless, there is evidence to suggest that 
brainstem sites, although traditionally neglected in the study of ingestive behaviour, may 
have an important role to play in the control of feeding. Berridge (1988) has shown that 
the increase in positive ingestive responses occurring following administration of CDP 
can still be observed in a decerebrate rat preparation. In this preparation a transection is 
made at the level of the midbrain effectively isolating communication of hindbrain 
structures with forebrain areas. This result is important because it indicates that the neural 
circuitry necessary for the effects of benzodiazepine receptor agonists in the taste 
reactivity test may be located within the lower brainstem. Since taste is an important 
determinant of ingestive behaviour it is possible that benzodiazepine receptor agonists 
might increase food intake by acting on neural systems involved in the processing of taste 
information. Following this argument, if benzodiazepine-induced hyperphagia is due to a 
change in the taste properties of ingested materials, then brainstem mechanisms might be 
expected to be involved not only in the effects of benzodiazepines in the taste reactivity 
paradigm but also in intake tests. 
1.5 Interactions with opioids 
It has been suggested that benzodiazepine and opioid effects on behaviour may be 
interdependent. In support of this hypothesis, opiate antagonists have been shown to 
block the effects of benzodiazepines in a range of behavioural tests. For example, 
naloxone has been shown to block the anti-conflict effects of diazepam in the Geller-
Seifter test (Soubrie, Joubert and Thiebot, 1980). In addition, some biochemical evidence 
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also suggests that the effect of benzodiazepines may be related to endogenous opioid 
acfion. Duka and her colleagues have demonstrated that benzodiazepines modulate 
enkephalin release (Duka, Wuster and Herz, 1979). 
The possibility that the effects of benzodiazepines on ingestive behaviour are 
mediated in some way by opioids has also been investigated (Cooper, 1983a; Reid, 
1985). Examination of the effects of both opioids and benzodiazepine ligands on food 
intake reveals some striking similarities. For example, morphine has been shown to 
cause a significant increase in food consumption when administered systemically 
(Kavaliers and Hirst, 1985; Sanger and McCarthy, 1980). Various other opioid agonists 
cause reliable increases in feeding comparable to benzodiazepine-induced stimulation of 
ingesfion (Cooper, Moores, Jackson and Barber, 1985; Gosnell, Levine and Moriey, 
1983, 1986; Moriey, Levine, Kneip, and Grace, 1982). Opioid agonists, like 
benzodiazepine receptor agonists, increase the preference for saccharin in water deprived 
rats (Calcagnetti and Reid, 1983). In addition, several authors have shown that morphine 
also enhances positive taste reactions in a manner similar to benzodiazepine agonists 
(Doyle, Berridge and Gosnell, 1993; Rideout and Parker, 1996). Conversely, opioid 
antagonists, which block the action of endogenous opioids, have been shown to inhibit 
food intake (Cooper, 1980; Holtzman, 1974, 1975; Margules, Moisset, Lewis, Shibuya 
and Pert, 1978), attenuate sweet taste preference (Cooper, 1983; Le Magnen, Marfaing-
Jallat and Devos, 1980), and reduce sucrose sham feeding (Kirkham and Cooper, 1988a; 
Rockwood and Reid, 1982). The effect of the opioid antagonist naloxone on sham 
feeding sucrose is reversed by increasing sucrose concentration (Kirkham and Cooper, 
1988b). This suggests that opioids, like benzodiazepines, may be involved in palatability 
(for review see Cooper and Kirkham, 1993). 
It has been suggested that hedonic evaluation of foodstuffs may be mediated by 
benzodiazepine receptors which then leads to the release of endogenous opioid peptides 
(Cooper, 1983a). This hypothesis predicts that opioid antagonists should block 
benzodiazepine-induced effects on ingestion. Opioid antagonists have been shown to 
block benzodiazepine-induced hyperphagia (Birk and Noble, 1981; Britton, Britton, 
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Dalton and Vale, 1983; Jackson and Sewell, 1985; Naruse, Asami and Koizumi, 1989; 
Stapleton, Lind, Merriman and Reid, 1979). However, opiate antagonists can also 
reduce food intake in the absence of any other treatment (Apfelbaum and Mandenoff, 
1981; Cooper and Turkish, 1989). In some of the above experiments, the effect of 
naloxone when administered alone was not thoroughly examined and so this makes it 
difficult to interpret the results of any potential interaction. An attenuation of 
benzodiazepine-induced increases in food intake by naloxone may have been the result of 
an additive action of both these drugs. Further work is required to investigate the role of 
the opioid system in benzodiazepine-induced effects on feeding. 
1.3.13 Summary 
No systematic attempt has been made to date to investigate the neural substrate for 
benzodiazepine-induced changes in feeding behaviour. Evidence from the taste reactivity 
paradigm suggests that benzodiazepines may affect the early processing of taste stimuli. 
Berridge found that increases in ingestive responding in the taste reactivity test, which is 
characteristic of benzodiazepine agonists, could still be observed in a decerebrate rat 
preparation. I f the effects of benzodiazepine ligands on food intake are mediated by the 
same receptor populations responsible for the enhancement of hedonic responding, then 
examination of brainstem sites may prove to be fruitful in this area. 
It has been reported that the effects of benzodiazepines can be blocked by 
administration of opiate antagonists. This suggests a role for endogenous opioids in 
benzodiazepine-induced effects on ingestive behaviour. The similarity between the effects 
of benzodiazepine agonists and opioid agonists on food intake supports this hypothesis, 
but the precise nature of any interaction remains to be thoroughly investigated. 
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1.6 Aims 
The main aims of this thesis are. first, to investigate the neural substrate for 
benzodiazepine-induced changes in food intake, and second, to further examine the 
behavioural processes responsible for the effect of benzodiazepine ligands on ingestive 
behaviour. This work forms the basis of a longer term goal which is to explain how the 
molecular effects of benzodiazepines translate into neuronal activity within particular 
brain areas to bring about specific changes in ingestive behaviour. This kind of 
investigation could help to increase understanding generally of the mechanisms involved 
in the control of ingestion. 
The experiments reported in Chapters 2 and 3 used microinjection techniques to 
examine the neural basis of benzodiazepine-induced hyperphagia. There is some evidence 
to suggest that brainstem structures may be involved in the effects of benzodiazepine 
ligands on food intake (see section 1.4). The aim of the experiments in Chapter 2 was to 
determine whether hindbrain structures play an important role in the hyperphagic effect of 
benzodiazepines. In Experiment 1, midazolam was injected directly into the IVth 
ventricle, and its effect on palatable food intake was measured. In Experiment 2, the 
selective benzodiazepine antagonist flumazenil was used to establish specific 
benzodiazepine receptor-mediation of an enhanced feeding effect. 
These inidal experiments were followed up in Chapter 3 with injecfions of 
midazolam into an area proximal to the IVth ventricle. The parabrachial nucleus (PBN) of 
the pons was identified as a possible candidate for mediation of the effects observed 
following injection into the IVth ventricle. The effect of injection of midazolam into the 
PBN on consumption of a palatable mash was investigated (Experiment 3). Experiment 4 
then checked if the response to midazolam is mediated by specific benzodiazepine 
receptors by pre-treating the animals with flumazenil. The aim of Experiment 5 was to 
determine whether the effect of midazolam injected directly into the PBN increased the 
consumption of palatable food whether solid or liquid. Non-deprived rats were trained to 
consume a palatable 3% sucrose solution and the potential hyperphagic effect of intra-
PBN midazolam was investigated (Experiment 5). The behavioural specificity of the 
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effects of intra-PBN midazolam was also examined by investigating the effect of 
injections of midazolam on locomotor activity (Experiment 6). 
It has been suggested that analysis of the rate and microstructure of ingestion may 
provide information concerning the behavioural mechanisms responsible for changes in 
intake. However, this kind of analysis has been limited to the study of carbohydrate 
intake. The aim of the experiments reported in Chapter 4 was to extend these 
observations to the consumption of fats as well as carbohydrates. A microstructural 
approach was adopted to compare the licking responses to a carbohydrate (sucrose) and a 
lipid emulsion (Intra-lipid) in both a 20-min test (Experiment 7) and a brief contact test 
(Experiment 8). The rationale was that this would provide a starting point for 
interpretation of the effects of drugs on the consumption of both lipid and carbohydrates. 
There have been no reports of the effects of benzodiazepine ligands on the 
microstructure of licking for either carbohydrates or fats. Chapter 5 investigated the effect 
of midazolam on licking responses for sucrose and Intra-lipid. The aim of Experiment 9 
was to examine in detail the effect of midazolam on the temporal and microstructural 
characteristics of licking for Intra-lipid in a 20-min test. Licking for sucrose was also 
measured under the same conditions. In Experiment 10, the aim was to focus on potential 
oropharyngeal determinants of ingestion in more detail by limiting access to the liquids to 
an initial 60s period. 
In Chapter 6 the effect of the benzodiazepine receptor inverse agonist Ro 15-4513 
on the microstructure of sucrose and lipid drinking was analyzed using a brief contact 
test. The aim of Experiment 11 was to test the hypothesis of bidirectional control at the 
level of the benzodiazepine receptor. 
The experiments reported in Chapter 7 were carried out to investigate further the 
suggestion that endogenous opioids are involved in benzodiazepine-induced effects on 
ingestive behaviour. First, a microstructural analysis of the effect of the opioid agonist 
morphine and the antagonist naloxone on lipid consumption was performed (Experiments 
12 and 13). The aim of these experiments was to examine whether the effects of 
benzodiazepines and opioids on microstructural components of licking behaviour are 
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similar. In Chapter 8, a microstructural analysis of the effect of naloxone on midazolam 
induced increases in intake was carried out using a brief contact test (Experiment 14). 
Previous reports of an interaction between benzodiazepines and opioids in the control of 
food intake had yielded inconsistent results. The aim of Experiment 14 was to improve 
on previous designs and use a dose of naloxone shown to have no intrinsic effect on 
intake. 
The general aim of this set of experiments was to provide new information 
concerning the potential neural and behavioural mechanisms involved in the effects of 
benzodiazepine ligands on ingesdve behaviour. 
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The effects of direct administration of midazolam into the 
IVth ventricle on ingestive behaviour 
2.1 Introduction 
Following systemic administration, benzodiazepine receptor agonists such as 
chlordiazepoxide (CDP) and midazolam reliably produce hyperphagia in numerous 
species including the rat (Cooper, 1980a, 1989). For example, benzodiazepine receptor 
agonists have been shown to stimulate a substantial increase in food consumption in non-
deprived rats trained to eat a palatable diet (Cooper et al., 1985). The hyperphagic effect 
can be blocked by a specific benzodiazepine receptor antagonist such as flumazenil 
(Cooper et al., 1985; Cooper and Moores 1985b). 
It is unlikely that the increase in food intake brought about by benzodiazepine 
agonists is due to an inhibition of satiety. Instead, it has been proposed that 
benzodiazepine-induced hyperphagia is due to an increase in the palatability or hedonic 
value of ingested materials (Berridge and Pecina, 1995). In support of this view, 
midazolam has been shown to increase sucrose sham feeding (Cooper, et al., 1988), and 
several benzodiazepine agonists have been shown to selectively enhance the consumption 
of a preferred saccharin solution, without affecting water intake, in a two-bottle choice 
test (Cooper and Green, 1993; Cooper and Yerbury, 1988; Roache and Zabik, 1986). 
Furthermore, CDP has also been shown to enhance positive ingestive responses in the 
taste reactivity paradigm (Berridge and Treit, 1986; Treit et al., 1987). 
Despite much progress in analyzing the behavioural mechanisms underlying the 
effects of benzodiazepines on ingestion, little is known about the neural substrate for 
benzodiazepine-induced hyperphagia. An important result relevant to possible central 
sites of action of benzodiazepine agonists, is that CDP retains its effect to enhance 
positive taste reactions in the chronic decerebrate rat (Berridge, 1988). These data appear 
to indicate that the lower brain-stem may contain the site(s) of action for the effects of 
CDP in the taste reactivity paradigm. In an extension of this work, Berridge and Pecina 
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(1995) have shown recently that direct administration of the benzodiazepine receptor 
agonist diazepam into the FVth ventricle in the hindbrain of rats was sufficient to enhance 
the positive hedonic reactions elicited by a 7% sucrose solution. The conclusion from 
these data is that structures close to the IVth ventricle may be involved in mediating the 
effects of benzodiazepine receptor agonists in the taste reactivity test. Since the influence 
of postingestive factors are eliminated in the taste reactivity test, the increase in ingestive 
responding brought about by benzodiazepine agonists is probably due to an effect on the 
processing of taste stimuli. 
The proposal that the hyperphagic effect of benzodiazepine agonists might be due 
to the influence these drugs have on taste processing is supported by the effectiveness of 
these compounds in the sham feeding, and taste preference tests. Benzodiazepine-induced 
increases in food consumption may also depend on brainstem taste systems. The present 
experiments were designed to investigate the possibility that hindbrain structures may be 
important for the hyperphagic effects of benzodiazepine agonists. In Experiment 1, the 
water soluble benzodiazepine receptor agonist midazolam was injected directly into the 
IVth ventricle of .the hindbrain, and its effect on food intake was determined. It was 
predicted that i f brainstem structures are important for the hyperphagic effects of 
benzodiazepine agonists then injection of midazolam into the IVth ventricle should mimic 
the effects of systemic administration. Blockade of the effect by the selective 
benzodiazepine receptor antagonist flumazenil was used as a test of the specific 
benzodiazepine receptor mediation of the enhanced feeding effect (Experiment 2). 
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2.2 Method 
2.2.1 Animals 
Twenty three non-deprived adult male hooded rats (General strain bred in the 
School of Psychology, University of Birmingham) weighing 300-500 g were used. Rats 
were housed individually in plasdc cages in a room with a constant temperature of 22± 2 
°C, and were maintained on a 12h light:dark cycle (lights on at 8.00). Standard laboratory 
food pellets (Pilsbury 4IB, Heygate and Sons, U.K.) and water were available at all 
times, except during testing. Behavioural testing was conducted in the light phase. 
2.2.2 Drugs 
The benzodiazepine receptor agonist midazolam maleate (Roche, Basel, 
Switzerland) was prepared for injection by dissolving in isotonic saline. Midazolam was 
used preferentially to other agonists because it is soluble in water. The doses used, were 
3 and 30 ]igl]i\ of midazolam which had been determined to be effective in previous pilot 
experiments. The vehicle used in control injections was isotonic saline. 
The selective benzodiazepine antagonist flumazenil (Ro 15-1788) (Roche, Basel, 
Switzerland) was prepared for injection by ultrasonic dispersion in distilled water to 
which Tween 80 (BDH Chemicals Ltd, Poole, England) had been added. The dose used 
in these experiments was 20 mg/kg or vehicle (distilled water to which Tween 80 had 
been added). This dose was used because it had been shown in previous experiments to 
be effective in blocking the hyperphagia induced by systemic midazolam (Cooper et al., 
1985; Cooper and Moores, 1985b). 
2.2.3 Surgerv 
For implantation of stainless-steel guide cannulae, rats were anesthetized and 
placed in a stereotaxic frame. The anesthetic used was pentobarbital at a dose of 60 mg/kg 
i.p. A single stainless steel guide cannulae (21 gauge, 16 mm length) was implanted 
1 mm dorsal to the IVth ventricle (coordinates L 0, A-P, -10.5 V -6). Bregma was 
used as a reference point and the coordinates were taken from the atlas of Paxinos and 
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Watson (1982). The cannulae were fixed to the skull using three screws and dental 
acrylic. Stylets were placed in the guide cannulae to prevent occlusion, and the rats were 
allowed seven days to recover before behavioural testing occurred. Postoperative care 
involved weighing the rats daily and applying an antibiotic wound powder to the 
headmount if necessary. 
2.2.4 Injection procedure 
Centra] microinjection of midazolam was performed using an injection cannula 
connected by a polyethylene tube to a micrometer-driven 10 fxl Hamilton syringe. The 
injection needles protruded 1 mm beyond the tip of the guide cannula, and accuracy of 
injections was ensured by observing the progress of an air bubble in the tubing. The 
volume infused was 3 | i l , injected over a period of 1-min. Each rat was then placed 
immediately in the test cage and food intake over a 30-min test period was measured. In 
the case of pretreatment with flumazenil, the antagonist was administered via the i.p. 
route 15-min prior to central injection of midazolam. The volume injected was 1 ml/kg. 
Two days prior to testing each rat received a sham injection of isotonic saline to 
familiarize it with the microinjection procedure. 
2.2.5 Test meal 
The sweetened mash meal was made up daily according to the following formula: 
100 ml sweetened condensed milk, 400 ml ground maintenance diet (Special Diet 
Services Ltd., Essex, UK), and 200 ml distilled water. The constituents were mixed to 
produce a soft mash. This recipe has been previously shown to be readily consumed by 
rats (Cooper et al., 1985). 
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2.2.6 Procedure 
Following recovery from surgery, the rats were adapted to eating the palatable 
sweetened mash. Familiarization continued until a steady baseline intake of mash was 
observed which was achieved after a period of approximately 10 days. Each rat was ' 
given 30-min access to 50 g portions of the diet placed in a clear plastic dish inside an 
individual stainless steel test cage. The consumption of the sweetened mash was 
measured to the nearest 0.1 g with corrections made for any spillage. During testing, rats 
did not have access to water or maintenance diet. All testing was carried out during the 
light cycle to insure relatively low baseline levels of consumption. 
2.2.7 Histologv 
At the end of each experiment rats were deeply anaesthetized with pentobarbital 
and a small quantity of methylene blue dye was injected through the cannula. Each rat 
was then perfused transcardially with isotonic saline followed by a 10% formalin 
solution. After decapitation, the excised brains were fixed in a 10% formalin solution for 
one week. The fixed brains were then frozen and sectioned sagitally on a freezing 
microtome and the correct placement of the cannulae was verified histologically. The 
histological work was conducted blind with respect to the behavioural results. 
2.2.8 Statistical design and analysis 
A repeated-measures design was used throughout in which each rat served as its 
own control and 24h elapsed between successive injections. A 24h wash-out period was 
considered sufficient since midazolam is a short acting drug with a half life of 27 + 1 min 
when injected peripherally in rats. The data were analyzed using a one-way analysis of 
variance (ANOVA) for repeated-measures. Post hoc comparisons between means were 
carried out using Dunnett's t-test or a Newman-Keuls multiple comparisons test. 
Statistical tests were performed using Statview SE-i-graphics (Abacus Concepts Inc., 
Berkeley, CA, 1987) and a result was considered statistically significant if p < 0.05. 
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2.3 Results 
Experiment 1: The effect oflVth ventricular midazolam on ingestion of sweet mash. 
Of the fifteen rats used in Experiment 1, three rats did not undergo behavioural 
testing due to problems following surgery. Histological analysis revealed that all cannulae 
were correctly targeted in the remaining animals and therefore all of the remaining 12 rats 
were included in the data analysis (Figure 2.1). Midazolam produced a dose-dependent 
increase in food consumption (P 2,12 = 5.61, p < 0.01). The baseline intake of 13.8 g 
was increased to 18 g after 30-min (Figure 2.2). Individual comparisons with a 
Dunnett's t-test revealed that a significant increase occurred at the 30 [ig/|il dose (p < 
0.01). Midazolam had an effect early in the test session and a significant increase in 
intake was evident after 10-min (F 2,22 = 7.25, p < 0.01). The difference between 
treatment groups did not reach significance at 20-min (F 2,22 = 0-23, n.s.), but was 
evident at the end of the 30-min session. A summary of the results is shown in Table 
2.1. 
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Figure 2.1 The distribution of injection sites in the FVth ventricle 
for rats used in Experiment 1. Sections are redrawn from Paxinos 
and Watson (1982). Each shows the location of the injection 
cannula tip for 1 rat. Section numbers refer to mm from bregma. 
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Figure 2.2 The effect of direct injection of midazolam (3 and 
30^g/)j.l) into the IVth ventricle on intake of sweet wet mash after 
30-min + S.E.M. n = 12. Asterisk indicates significantly different 
from vehicle condition ** p < 0.01 (Dunnett's t-test). 
Table 2.1 The effects of IVth ventricular midazolam on the intake 
of sweet wet mash. 
Treatment 
10-min 
Mash consumed (g) 
20-min 30-min 
Vehicle 5.9 10.6 13.8 
± 0 . 8 ± 1.1 ± 1.3 
midazolam 7.0 11.7 14.3 
3 l^g/^ ll ± 0 . 7 ± 1.1 ± 1.3 
midazolam 9 6** 11.7 18.00** 
30 i^g/^ l ± 0 . 6 + 1.3 ± 0 . 8 
Results are shown mean intake (g) + S.E.M. n = 12. Levels of 
significance **p<0.01 (Dunnett's t-test). 
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Experiment 2: The effect of flumazenil on hyperphagia induced by IVth ventricular 
midazolam 
Of the eight rats used in Experiment 2, one rat did not undergo behavioural testing 
due to problems following surgery. Histological analysis revealed that all cannulae were 
targeted correctly in the remaining seven animals (Figure 2.3). A one-way repeated-
measures ANOVA revealed a significant effect of drug treatment (F 3_ ig = 7.66, p < 
0.01). A Newman-Keuls multiple comparison test showed that the dose of 30 of 
midazolam significantly increased consumption of the mash compared with the control 
condition (p < 0.01). The baseline intake of 11.7 g was increased by 50% to 16.8 g 
(Figure 2.4). This increase was almost completely blocked by pretreatment with 
flumazenil (20 mg/kg). When administered alone, flumazenil had no significant effect on 
the ingestion of sweet wet mash. The effect of midazolam (30 \igl\i\) was observed 
within the first 10-min of the test. A significant increase in food intake was already 
evident after 10-min (F 3, 18 = 9.93, p < 0.001). This early increase was also effectively 
blocked by pretreatment with flumazenil. The hyperphagic effect of midazolam was 
maintained after 20-min (F 3, ig = 8.06 p < 0.01). The results are shown in Table 2.2. 
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Figure 2.3 The distribution of injection sites in the IVth ventricle 
for rats used in Experiment 2. Sections are redrawn from Paxinos 
and Watson (1982). Each shows the location of the injection 
cannula tip for 1 rat. Section numbers refer to mm from 
bregma. 
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Figure 2.4 The effect of flumazenil (20 mg/kg) on hyperphagia 
induced by injection of midazolam (30 |ig/nl) into the IVth 
ventricle after 30-min -i- S.E.M. n = 7. Asterisk indicates 
significantly different from vehicle condition ** p < 0.01 + 
indicates significantly different from vehicle/midazolam 
condition p < 0.05. 
Table 2.2 The effect of flumazenil on hyperphagia induced by 
IVth ventricular midazolam 
Treatment 
10-min 
Mash consumed(g) 
20-min 30-min 
Vehicle 7.4 10.8 11.7 
Vehicle ± 1.4 ± 1.1 ± 1.2 
Humazenil 7.6 12.8 14.1 
Vehicle ± 1.1 ± 1.7 ± 1.8 
Vehicle 12.4** 15.3** 16.7 ** 
Midazolam ± 1.0 *± 1.5 ± 1.6 
Flumazenil 8.6+ 11.4+ 13.1 + 
Midazolam ± 1.2 ± 1.1 ± 1.0 
Results are shown mean intake (g) + S.E.M. n = 7 rats per 
condition. Levels of significance: ** p < 0.01, different from 
veh/veh condition. + p < 0.05, different from veh/mdz condition 
(Newman-Keuls multiple comparisons test) 
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2.4 Discussion 
The results of Experiments 1 and 2 show that direct injection of a benzodiazepine 
receptor agonist into the IVth ventricle is sufficient to induce a significant hyperphagic 
response in non-deprived adult male rats. The increase in food intake observed by this 
route of administration is comparable to that obtained following systemic administration 
of benzodiazepine receptor agonists (Cooper et al., 1985). Antagonism of the 
hyperphagic effect by flumazenil is an indication that the effect is mediated by specific 
benzodiazepine receptors. These results argue for central mediation of benzodiazepine-
induced hyperphagia, and point to lower brainstem structures as possible locations of the 
site of action of the drug. 
Berridge (1988) has shown that the effects of benzodiazepine receptor agonists in 
the taste reactivity test remain intact in midbrain-transected rats. More recently, Berridge 
and Pecina (1995) have shown that direct administration of diazepam into the IVth 
ventricle of the rat enhances hedonic reactions to a 7% sucrose solution. The present data 
are consistent with these results in showing that the lower brainstem may be important for 
the effects of benzodiazepines on ingestive responses. 
The precise location of the brainstem receptors remains uncertain but the 
parabrachial nucleus (PBN) in the pons may be a possible candidate for mediation. Data 
from an autoradiographic binding study has highlighted a population of benzodiazepine 
receptors in or near the PBN (Higgs, Gilbert, Barnes, and Cooper, 1993). Hence, 
benzodiazepine receptors in this area may be involved in the effects of benzodiazepines 
on ingestive behaviour. There are several reasons for asserting that the PBN may be an 
important central site of action for the effects of benzodiazepines on food intake. First, 
the neuroanatomy of the gustatory system has been carefully mapped, and it is well 
established that the PBN contains the second central relay for the taste pathway (Norgren, 
1976; Norgren and Leonard, 1973; Norgren and Pfaffmann, 1975). It has been 
established that the PBN makes extensive connections to many areas of the brain which 
are involved in the control of ingestive behaviour, such as the hypothalamus (Krukoff, 
Harris and Jhamandas, 1993; Norgren 1976; Saper and Loewy, 1980) and amygdala 
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(Norgren 1976), and this prompts the notion that the PBN itself may contribute to the 
execution of such behaviours. It is possible that benzodiazepine receptor agonist 
modulation of feeding may occur even earlier on the taste pathway in the nucleus of the 
solitary tract (NTS), which is the first relay in the gustatory pathway (Norgren, 1978). 
This hypothesis remains to be tested, but a role for the NTS seems less likely given that 
the autoradiographic binding study failed to reveal any benzodiazepine receptors in this 
nucleus (Higgs et al., 1993). 
Presently, it is not possible to rule out the possibility that structures rostral to the 
IVth ventricle are also involved in benzodiazepine-induced hyperphagia. Direct injection 
of benzodiazepine receptor agonists into the forebrain would help to address this issue, 
but the present results do serve to draw attention to brainstem participation in the control 
of ingestive behaviour, particularly in relation to benzodiazepine effects. Evidence for this 
focus is provided by Berridge and Pecina (1995) who have compared the relative efficacy 
of IVth and lateral ventricle microinjections of diazepam in increasing ingestive 
responding in the taste reactivity paradigm. The dose threshold required for lateral 
ventricular administration to enhance hedonic responses, was significantly greater than 
for IVth ventricular injections. These data suggest that the continued investigation of 
brainstem mechanisms of ingestion would prove to be of great value. 
An important question arising from the present studies is whether the effects of 
benzodiazepines in the taste reactivity test are mediated by the same receptor populations 
underlying benzodiazepine-induced hyperphagia. It is possible that the increase in 
hedonic reactions following benzodiazepine administration may be dissociable from the 
effect of these drugs on food consumption. This dissociation could occur either in terms 
of distinguishable sites of action, or in terms of specific receptor subtypes within a 
specific location, or both. Alternatively, it may be that the hyperphagic effect depends 
upon and is secondary to the enhancement of hedonic reactions to taste stimuli. This 
would suggest that whenever an increase in hedonic reactions is achieved (e.g. by 
benzodiazepine treatment) an increase in food consumption would follow. This idea is 
consistent with the possibility that benzodiazepines enhance food palatability. Integrating 
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the results of the present study with the data of Berridge and Pecina (1995) provides 
some support for this view since IVth ventricular administration of a benzodiazepine 
agonist has been shown to be increase both hedonic reactions to taste stimuli and food 
consumption. This conclusion is reinforced by the observation that the increase in 
consumption of the palatable mash caused by midazolam was observed after just 10-min 
of the test session had elapsed. This suggests that the hyperphagic effect was probably 
not caused by a reduction in satiety occurring at the end of the feeding period. 
In summary, the present studies indicate that the neural substrate for 
benzodiazepine-induced hyperphagia may be located in the brainstem although precisely 
which structures are involved remains to be elucidated. 
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The effects of direct administration of midazolam into the 
parabrachial nucleus on ingestive behaviour 
3.1 Introduction 
In the previous chapter it was shown that a reliable hyperphagia could be elicited 
following microinjection of midazolam into the FVth ventricle of non-deprived rats. It was 
then shown this effect is receptor specific because it was completely abolished by the 
selective benzodiazepine receptor antagonist flumazenil. It was proposed that at least one 
of the populations of receptors responsible for the effects of benzodiazepines on food 
intake may be located in the brainstem, in the proximity of the IVth ventricle. The aim of 
the experiments in this chapter was to further assess the contribution of brainstem 
structures to benzodiazepine-induced increases in food intake. 
The major target for Experiments 3, 4, 5, and 6 was the parabrachial nucleus 
(PBN) of the pons. One reason why the PBN was selected as a potential site of action is 
because this nucleus contains the second relay for the taste projection system (Norgren 
and Leonard, 1973; Norgren and Pfaffman 1975). Taste is an important determinant of 
food intake (Pfaffmann, 1982), and so the PBN is well-placed to mediate the effects of 
benzodiazepines on ingestive behaviour. Another reason to suggest the involvement of 
the PBN in benzodiazepine-induced hyperphagia is that an autoradiographic binding 
study has revealed a population of benzodiazepine receptors in the region of the PBN 
(Higgs et al., 1993). Additionally, it is well established that the PBN makes extensive 
connections to many other areas of the brain involved in the control of ingestive 
behaviour, such as the hypothalamus (Krukoff et al., 1993; Norgren, 1976; Saper and 
Loewy, 1980) and amygdala (Norgren 1976). 
The aim of Experiment 3 was to establish whether an injection of midazolam into 
the PBN can elicit a hyperphagic response. Experiment 4 was designed to check if the 
response to midazolam is mediated by specific benzodiazepine receptors. The PBN can 
be subdivided up into a number of distinct regions (Krukoff et al., 1993; Saper and 
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Loewy 1980). In the experiments reported in this chapter, guide cannulae were targeted 
either to medial or lateral areas of the PBN to examine whether a functional dissociation 
between these two areas could be demonstrated. 
Systemic administration of benzodiazepine receptor agonists enhances the 
consumption of both liquid and solid foods (Cooper and Greenwood 1992; Cooper et al., 
1987). The aim of Experiment 5 was to determine whether the effects of midazolam 
injected directly into the PBN mimics the effects of systemically administered 
benzodiazepine receptor agonists in increasing the consumption of both solid and liquid 
foods. Non-deprived rats were trained to consume a 3% sucrose solution and the 
potential hyperphagic effect of intra-PBN midazolam was investigated. 
Besides their effects on food intake, benzodiazepine receptor agonists have 
anxiolytic, sedative, and muscle relaxant properties. It has been suggested that the wide 
ranging effects of these drugs may be due to stimulation of receptor subpopulations 
specific for one type of behaviour, located in different brain areas. The aim of Experiment 
6 was to examine the possibility that benzodiazepine receptors in the PBN constitute a 
subpopulation of receptors specific for ingestional responses. An activity monitor was 
used to measure locomotion following administration of intra-PBN midazolam. As a 
control experiment, the intake of a sweetened wet mash was also measured in the same 
rats but on a separate occasion, to ensure that any result obtained was not a false positive 
due to failure of the drug to reach the receptors. 
Virtually all previous work on the PBN and ingestive responses has involved 
lesion techniques which have obvious drawbacks and limitations (Spector, 1995). The 
aim of these studies was to employ a pharmacological approach with the specific purpose 
of determining i f the PBN is a principle site of action for benzodiazepine-induced 
hyperphagia. 
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3.2 Method 
3.2.1 Animals 
Thirty eight non-deprived adult male hooded rats (General strain bred in the 
School of Psychology, University of Birmingham) weighing 300-400 g at the beginning 
of experimentation were used. Rats were housed individually in plastic cages in a room 
with a constant temperature of 22± 2 °C, and were maintained on a 12h light:dark cycle 
(lights on at 8.00). Standard laboratory food pellets (Pilsbury 4IB, Heygate and Sons, 
U.K.) and water were available at all times, except during testing. Behavioural testing 
was conducted in the light phase. 
3.2.2 Drugs 
The water soluble benzodiazepine receptor agonist midazolam maleate (Roche, 
Basel, Switzerland) was prepared for injection by dissolving in isotonic saline. The doses 
used, were 3, 10 and 30 |a.g/|il of midazolam. This dose range was chosen because in 
Chapter 2 it was shown that 3 and 30 | ig/ | i l of midazolam increased intake of mash 
following injection into the IVth ventricle of rats. The vehicle used in control injections 
was isotonic saline. The selective benzodiazepine receptor antagonist flumazenil (Ro 15-
1788) (Roche, Basel, Switzerland) was prepared for injection by ultrasonic dispersion in 
distilled water to which Tween 80 (BDH Chemicals Ltd, Poole, England) had been 
added. The dose used, was 20 mg/kg which has been shown previously to block the 
hyperphagic effect of benzodiazepine agonists (Cooper and Moores, 1985b). 
3.2.3 Surgerv . 
For implantation of stainless steel guide cannulae, rats were anesthetized with 
medetomidine, 250 |ig/kg (Domitor) and ketamine, 60 mg/kg (Vetelar) combination 
anesthetic. Effects of the medetomidine were reversed using atipmazole (Antisedan) at a 
dose of 1 mg/kg. The analgesic buprenorphine (Temgesic) was also administered prior to 
recovery at a dose of 0.03 mg/kg. Guide cannulae were targeted bilaterally to either the 
medial or lateral parabrachial nucleus (coordinates for medial parabrachial: L -i-1.4 A-P 
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-9.4 V -5.8, coordinates for lateral parabrachial: L +2.2 A-P -9.4 V -6.2). The cannulae 
tips were implanted 2 mm dorsal to the intended injection site. Bregma was used as a 
reference point and the coordinates were taken from the atlas of Paxinos and Watson 
(1982). Dental acrylic and three screws were used to fix the cannulae to the skull. Stylets 
were placed in the cannulae to prevent occlusion, and the rats were allowed seven days to 
recover before behavioural testing occurred. Postoperative care involved weighing the 
rats daily and applying an antibiotic wound powder to the headmount if necessary. 
3.2.4 Injection procedure 
Central microinjection of midazolam was performed bilaterally using injection 
cannulae connected by a polyethylene tube to a micrometer-driven 10 |Lil Hamilton 
syringe. The injection needles protruded 2 mm beyond the tip of the guide cannula and 
accuracy of injections was ensured by observing the progress of an air bubble in the 
tubing. The volume infused was 0.5 | i l each side, injected over a period of 30s. Each rat 
was then placed immediately in the test cage and food intake over a 30-min test period 
was measured. Flumazenil was administered via the i.p. route 15-min prior to central 
injection of midazolam. The volume injected was 1 ml/kg. Two days prior to testing each 
rat received a sham injection of isotonic saline to familiarize it with the microinjection 
procedure. 
3.2.5 Food intake measurement 
Mash intake Rats were first adapted to eating a sweetened wet mash for a 
period of approximately 10 days. The meal was made up daily according to the following 
formula: 100 ml sweetened condensed milk, 400 ml ground maintenance diet (Special 
Diet Services Ltd., Essex, U.K.) and 200 ml distilled water. It has been shown that this 
mash is readily consumed by non-deprived rats (Cooper et al., 1985). Each rat was given 
30-min access to 50 g portions of the diet placed in a clear plastic dish inside an 
individual stainless steel test cage. The consumption of the mash was measured to the 
nearest 0.1 g with corrections made for any spillage. 
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Sucrose intake Familiarisation with a 3% sucrose solution occurred over a 
period of approximately seven days. Rats were transferred from their home cages to 
testing cages in which they had access to a single drinking spout attached to a 50 ml 
graduated cylinder. Sucrose intake was recorded volumetrically to the nearest ml after the 
20-min test period. 
3.2.6 Locomotor activity 
A photo-cell activity monitor was used to measure locomotor activity. This 
consisted of a black plastic cylindrical container 30 cm in height. An outer circle of 
diameter 42 cm enclosed an inner circle of diameter 18 cm. The arrangement created a 
12 cm wide corridor which allowed the rats to move in a circular path. Three 
photobeams, positioned near to the floor, monitored the activity of the rat. When a beam 
was interrupted this registered as one count. Each rat was familiarised with the test 
procedure over a period of five days. Individual rats were exposed to a 20-min session in 
the photocell activity monitor. 
3.2.7 Histologv 
At the end of each experiment rats were deeply anaesthetized with pentobarbital 
and a small quantity of methylene blue dye was injected through the cannula. Each rat 
was then perfused transcardially with isotonic saline followed by a 10% formalin 
solution. After decapitation, the excised brains were fixed in a 10% formalin solution for 
one week. The fixed brains were then frozen and sectioned sagitally on a freezing 
microtome and the correct placement of the cannulae was verified visually. The 
histological work was conducted blind with respect to the behavioural results. Rats with 
cannulae placements further than 1 mm from the intended injection site were judged to be 
non-PBN placements and so were analyzed separately from PBN placements. This 
criterion was chosen based on previous studies showing that an injection volume of 
0.5 \L\ diffuses to spread over a 1 mm area (Myers, 1966). 
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3.2.8 Statistical analysis 
Al l data were analyzed using a one-way analysis of variance (ANOVA) for 
repeated-measures. Comparisons between means were carried out using Dunnett's t-test 
or a Newman-Keuls multiple comparisons test. Statistical tests were performed using 
Statview SE+graphics (Abacus Concepts Inc., Berkeley, CA, 1987) and a result was 
considered statistically significant if p < 0.05. 
3.3 Results 
Experiment 3: The effect of direct injection of midazolam into the PBN on intake of a 
palatable mash 
Of the twelve animals used in Experiment 3, one did not undergo behavioural 
testing due to problems following surgery. Histological analysis of the remaining eleven 
animals showed that not all the placements were targeted at the PBN and so the data for 
those rats where the cannulae were located more than 1 mm outside the PBN (n = 5) were 
analyzed separately from the PBN placements (n = 6) (Figure 3.1). In Experiment 3, no 
difference was observed between the responses of rats receiving lateral as opposed to 
medial injections of midazolam into the PBN, and so their data were pooled. The results 
are summarized in Table 3.1. 
PBN placements. A one-factor repeated-measures ANOVA revealed a 
significant effect of the drug after 30-min (F 3,15 = 9.78, p < 0.001). Midazolam (3-30 
| ig/ | i l in 0.5 fxl) significantly increased consumption of the mash relative to the control 
condition. The baseline intake of 8.6 g was almost doubled to 15.5 g (Figure 3.2a). Post 
hoc tests indicated that the 10 |Xg / | i l and 30iig/\i\ conditions differed significantly from 
the vehicle condition (p < 0.01). 
Non-PBN placements. A one-factor repeated-measures ANOVA revealed 
that injections which were not within 1 mm of the PBN had no significant effects on 
intake (F 3_i2 = 0.17, n.s.). The baseline intake of 13.3 g was not affected by 
administration of midazolam into areas around the PBN (Figure 3.2b). 
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Figure 3.1 The distribution of injection sites in the parabrachial 
nucleus for rats used in Experiment 3. Sites are shown bilaterally. 
Sections are redrawn from Paxinos and Watson (1982). Section 
numbers refer to mm from bregma. 
Table 3.1 The effect of intra-parabrachial midazolam on the intake of 
sweet wet mash. 
Treatment Mash consumed (g) 
PBN Non-PBN 
Vehicle 8.6 13.3 
+ 1.1 + 2.4 
3 )ig/|il midazolam 10.3 12.3 
± 1.5 ±1.4 
10 |ig/ |il midazolam 14.2 * 14.2 
± 1.5 ± 2 . 5 
30 |ig/fxl midazolam 15.6 ** 13.3 
+ 1.3 + 0.9 
Results are shown mean intake (g) ± S.E.M. PBN (n = 6) non-
PBN (n = 5). Intake recorded over 30-min. Levels of significance: 
* p < 0.05 ** p < 0.01 (Dunnett's t-test) 
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Figure 3.3 Intake of a sweet wet mash (g) after 30-min as a 
function of increasing dose of midazolam (3-30 |Xg/nl) for a) PBN 
(n = 6) and b) Non-PBN placements (n = 5) + S.E.M. Asterisk 
indicates significantly different from vehicle condition * p < 0.05 
** p < 0.01 (Dunnett's t-test). 
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Experiment 4: The effect of pretreatment with flumazenil on hyperphagia induced by 
injection of midazolam into the PBN 
Following histological examination it was found that of the ten animals used in 
Experiment 4, in four cases the guide cannulae were located further than 1 mm away 
from the intended area and so the data for these rats were analyzed separately from the 
PBN placements (n = 4) (Figure 3.3). The histology for two rats showed extensive tissue 
damage such that it was impossible to determine the placement site, and so the data for 
these rats were discarded. No difference was observed in the results for rats receiving 
lateral as opposed to medial injections of midazolam into the PBN, and so the data were 
pooled for analysis. A summary of the results is shown in Table 3.2. 
PBN placements. A one-factor repeated-measures ANOVA revealed a 
significant effect of treatment after 10-min (F 3,9 = 8.16, p < 0.01). Intra-PBN injection 
of midazolam dose-dependently enhanced mash consumption relative to the control saline 
injection. Pairwise comparison with a Newman-Keuls multiple comparison test revealed 
that the 30 | ig/ | i l dose significantly increased ingestion of the mash after 10-min 
(p < 0.01) (Figure 3.4a). Flumazenil (20 mg/kg) administered alone had no significant 
effect on mash intake after 10-min. However, flumazenil did significantly attenuate the 
increase in ingestion caused by midazolam as indicated by the significant pretreatment x 
drug interaction (F i j = 10.96, p < 0.05). No significant effect of drug treatment was 
observed in the PBN placements after 30-min. This was despite the fact that the baseline 
intake of 12.8 g was nearly doubled following administration of midazolam alone to 
21.8 g. 
Non-PBN placements. Analysis of the data from rats with guide cannulae 
more than 1 mm away from the PBN did not reveal a significant effect of drug treatment 
after 10-min (F 3,9 = 0.57, n.s.). The baseline intake of 9 g was not significantly affected 
(Figure 3.4b). There was still no drug effect evident after 30-min (F 3.9 = 1.1, n.s.). 
Chapter 3 75 
\ 5 
Figure 3.3 The distribution of injection sites in the parabrachial 
nucleus for rats used in Experiment 4. Sites are shown bilaterally. 
Sections are redrawn from Paxinos and Watson (1982). Section 
numbers refer to mm from bregma. 
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Figure 3.4 Effect of flumazenil (20 mg/kg) on hyperphagia 
induced by intra-PBN midazolam (30 p-g/nl) for a) PBN (n = 4) and 
b) Non-PBN placements (n = 4) after 10-min + S.E.M. Asterisk 
indicates significantly different from vehicle condition ** p < 0.01 
+ significantly different from vehicle/midazolam condition p < 0.05. 
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Table 3.2 The effect of flumazenil on hyperphagia induced 
by intra-parabrachial midazolam. 
Treatment Mash consumed (g) 
PBN Non-PBN 
Vehicle 7.7 8.9 
Vehicle ± 1 . 1 ± 2 . 0 
Flumazenil 8.4 10.8 
Vehicle ± 1 . 4 ± 1 . 3 
Vehicle 15.1 ** 7.6 
Midazolam ± 1 . 5 ± 2.0 
Humazenil 8.2 + 9.5 
Midazolam ± 1 . 6 ± 0.7 
Results are shown mean intake (g) ± S.E.M. PBN (n = 4) Non-
PBN (n = 4). Intake recorded over 10-min. Levels of significance: 
** p < 0.01, different from VehA^eh condition. + p < 0.05, 
different from Veh/Midazolam condition (Newman-Keuls multiple 
comparisons test). 
Experiment 5: The effect of direct injection of midazolam into the PBN on intake of a 3% 
sucrose solution 
Of the eight rats used in Experiment 5, two did not undergo behavioural testing 
due to problems following surgery. Histological analysis showed that in the remaining 
six rats, not all the placements were correctly targeted. Five rats had cannulae that were 
correctly targeted. In one rat the cannulae missed the target area by more than 1 mm and 
so the data from this rat was discarded. Although cannulae were targeted at both the 
lateral and medial PBN, no difference was observed between the results for these groups 
and so the data were pooled. The results are summarized in Table 3.3. 
PBN placements. A one-factor repeated-measures ANOVA revealed a 
significant effect of drug in the PBN group (F 3,12 = 12.81, p < 0.001). Midazolam (3-
30 |J.g/|J-l in 0.5 |xl) increased consumption of the 3% sucrose solution relative to the 
control condition (Figure 3.5). The high baseline intake of 21.4 ml was increased to 
25.6 ml after 20-min (Figure 3.6). Post hoc tests indicated that the 10 \ig/\i\ (p < 0.05) 
and the 30 |J.g/|a-l (p < 0.01) condition differed significantly from the vehicle condition. 
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Figure 3.5 The distribution of injection sites in the parabrachial 
nucleus for rats used in Experiment 5. Sites are shown bilaterally. 
Sections are redrawn from Paxinos and Watson (1982). Section 
numbers refer to mm from bregma. 
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Figure 3.6 Intake of a 3% sucrose solution (ml) after 20-min as 
a function of increasing dose of midazolam (3-30 i^g/jxl) (n = 5) + 
S.E.M. Asterisk indicates significantly different from 
vehicle condition * p < 0.05 ** p < 0.01 (Dunnett's t-test). 
Table 3.3 The effect of intra-parabrachial midazolam on the intake 
of a 3% sucrose solution. 
Treatment Sucrose consumed (ml) 
Vehicle 
3 M-g/fil midazolam 
10 |Xg/|il midazolam 
30 Hg/jil midazolam 
21.4 
± 0 . 6 
22 
± 2 . 3 
23.4 * 
± 0 . 9 
25.6 ** 
+ 0.9 
Results are shown mean intake (ml) ±_ S.E.M. n = 5. Intake 
recorded over 20-min. Levels of significance: * p < 0.05 ** p < 
0.01 (Dunnett's t-test). 
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Experiment 6: The effect of direct injection of midazolam into the PBN on locomotor 
activity 
Locomotor activity 
Of the eight rats used in Experiment 6, the data from one rat had to be discarded 
from the analysis due to a fault in the equipment. In six cases the cannulae were correctly 
targeted (Figure 3.7). There was one case where the guide cannula missed the intended 
target by more than 1 mm and so this rat was not included in the statistical analysis. 
PBN placements. Results are shown in Figure 3.8a. A one-factor repeated-
measures ANOVA revealed no significant effect of treatment after 20-min (F 3_i5 = 2.19, 
n.s.). The mean count for the vehicle treated group was 224.6 in 20-min and this was not 
significantly affected by drug administration. 
Mash intake 
A paired t-test revealed that there was a significant effect of the drug (p < 0.05). 
Midazolam (30 fxg/|il in 0.5 )il) significantly increased consumption of the mash after 
30-min. The baseline intake of 7.6 g was substantially increased to 12.1 g (Figure 3.8b). 
A summary of the results is shown in Table 3.4. 
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Figure 3.7 The distribution of injection sites in the parabrachial 
nucleus for rats used in Experiment 6. Sites are shown bilaterally. 
Sections are redrawn from Paxinos and Watson (1982). Section 
numbers refer to mm from bregma. 
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Figure 3 .8 Effect of intra-PBN midazolam on a) locomotor 
activity and b) Intake of a sweet wet mash (n = 6) + S.E.M. 
Asterisk indicates significantly different from vehicle 
condition * p < 0.05. 
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Table 3.4 The effect of intra-parabrachial midazolam on 
locomotor activity 
Treatment Counts in 20-min 
Vehicle 221.8 
±21 .5 
3 fJ-g/|il midazolam 198.4 
±33 .2 
10 |Xg/p.l midazolam 260.4 
±23 .6 
30 | ig / | i l midazolam 212 
±30 .6 
Results are shown mean counts in 20-min + S.E.M. n = 6. 
3.4 Discussion 
In the present experiments, direct administration of midazolam (10 and 30 |ig/|il) 
into the PBN caused a significant increase in the consumption of a palatable diet in non-
deprived rats. This increase in intake was blocked by adminstration of the selective 
benzodiazepine receptor antagonist flumazenil. Injection of midazolam directly into the 
PBN (3-30 |ig/)il) also significantly increased the consumption of a 3% sucrose solution, 
despite the fact that the rats were consuming at high baseline levels. These data are in 
close agreement with the effects of peripherally-administered benzodiazepines on 
ingestive behaviour (Cooper et al., 1985). Injection of midazolam (3-30 |ig/)il) into the 
PBN did not affect locomotor activity, although in the same rats, the highest dose of 
30 |Xg/|J.l significantly increased the consumption of a palatable mash. 
In the previous chapter, it was shown that injection of midazolam into the IVth 
ventricle induced a significant increase in food consumption. This increase was attenuated 
by pretreatment with flumazenil. This suggests that the effects of midazolam when 
injected into the PBN were due to an action at benzodiazepine receptors. The blockade of 
the effects of midazolam by flumazenil also argues against the effects of midazolam being 
due to any artifact of pH, osmolarity or hydraulic pressure. The data from Experiments 3 
and 4 suggest that this effect may have been due to rapid diffusion of the drug from the 
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IVth ventricle to benzodiazepine receptors in the PBN. An action at benzodiazepine 
receptors in the PBN, rather than diffusion to other brain areas provides the most likely 
explanation of the data for several reasons. First, analysis of data from rats where the 
guide cannulae were more than 1 mm away from the PBN revealed that in these cases 
there was no increase in consumption following direct administration of midazolam. This 
is wholly consistent with the finding that benzodiazepine receptors are present in the PBN 
but not in adjacent areas (Higgs et al., 1993). Second, the injection volume used was 0.5 
| i l which has been reported to spread 1 mm from the injection site (Myers, 1966). This 
means that diffusion from the PBN injection site to the IVth ventricle is unlikely to be 
able to account for the results. Nevertheless, it might be predicted that the behaviourally-
effective dose for PBN injection compared with IVth ventricle injection should be lower 
if receptors in the PBN were responsible for the IVth ventricle effect. We found no 
difference in the doses effective in increasing food intake for both the previously reported 
IVth ventricle experiments and the current experiments. However, the volumes injected 
in both cases were different. The volume injected into the IVth ventricle was 3 
compared with a volume of 0.5 \i\ which was injected into the PBN. I f the results 
obtained when injecting into the PBN were due to a ventricular site of action, then it 
might be expected that when injecting a much larger volume into the IVth ventricle (3 ^1), 
a lower dose would be effective. Since this was not so, the IVth ventricle results might 
be better explained by diffusion from the ventricle to receptors in the PBN. Taken 
together, this evidence indicates that the hyperphagic effect depends upon benzodiazepine 
receptors located in the PBN. 
No difference was found in the current experiments between injections into the 
medial versus the lateral regions of the PBN. Therefore, the data from both sets of rats 
were combined. The reason for the failure to distinguish between medial compared with 
lateral injection sites, despite the differential connections of these two areas, may have 
been due to spread of the injection volume through the entire PBN. Future experiments 
investigating the contribution of sub-regions within the PBN would involve injecting 
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smaller volumes of drug to allow more accurate distinctions between the functioning of 
different regions to be made. 
It should be noted that in Experiment 1, the average intake (g) in the vehicle 
condition for the non-PBN group was higher than for the PBN group. A difference in 
the baseline measure was therefore observed, and it could be argued that any real effect 
on feeding was consequently being masked in the non-PBN group. However, this 
argument can be counteracted by the observation that the rats were not consuming at 
ceiling levels, and that the difference in baseline intake was not observed for the non-
PBN rats in Experiment 2. This suggests that the discrepancy was due to an absolute 
difference in the baseline consumption between the two groups of rats, and that a 
possible drug effect was not being obscured. 
In Experiment 5, injection of midazolam into the PBN increased consumption of 
a palatable sucrose solution. This result suggests that the effect of intra-PBN midazolam 
on ingestive behaviour applies not only to solid foods but can also be extended to liquid 
foods. This suggests that the effects of Intra-PBN midazolam on ingestive behaviour are 
similar to the effects of peripheral administration. 
In small doses benzodiazepine receptor agonists cause hyperlocomotion and in 
large doses produce sedation (File, 1981). The hyperlocomotion and sedative effects of 
these drugs following systemic administration were completely absent over the range of 
doses used in the present experiments. The absence of any effect on locomotion cannot 
be accounted for in terms of a general lack of drug effect in since in the same rats, a 
significant increase in mash intake was observed. The results of Experiment 6 indicate 
that benzodiazepine receptors in the PBN may be specific for ingestional behaviour. 
Benzodiazepine receptors are associated with the G A B A A receptor complex. This 
is supported by evidence that they co-immunoprecipitate (Schoch et al., 1985). The 
existence of specific benzodiazepine receptor subtypes is supported by the observation 
that the G A B A A receptor complex comprises subunits which have multiple isoforms (see 
Chapter 1 for discussion). Varying the combination of G A B A A receptor subunits has 
been shown to determine the resultant pharmacology of benzodiazepine receptor ligands 
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(Luddens et al., 1995). It is possible that different populations of G A B A A receptors exist 
in vivo, and that stimulation of a particular population results in selective behavioural 
effects. The benzodiazepine receptor population identified in the PBN may constitute a 
subpopulation specific for the effects of these compounds on ingestive behaviour. The 
development of subtype specific ligands would help to resolve this issue. 
The effect of lesioning the PBN on the behavioural response to taste stimuli has 
been widely studied by several investigators. The results of these studies have shown that 
an intact PBN is important for the execution of a variety of taste-guided behaviours. For 
example, PBN lesioned rats are unable to form conditioned taste aversions (CTAs) 
(Reilly, Grigson and Norgren, 1993), have blunted responses to taste stimuli, and do not 
reliably express a depletion-induced sodium appetite (for review see Spector, 1995). 
Since the PBN is contains third order gustatory neurons this is perhaps not surprising. 
However, PBN lesions do not simply render rats ageusic or unable to detect taste stimuli. 
Despite blunted responses to unconditioned tastants, PBN lesioned rats can discriminate 
between taste stimuli and show concentration dependent responses (Flynn et al., 
1991a,b; Spector, Grill and Norgren, 1993). It is unlikely that the decreased 
responsiveness to taste stimuli in PBN lesioned rats results from a reduction in the 
perceived intensity of the stimulus. Spector and colleagues have shown that PBN 
lesioned rats which fail to learn a CTA can nevertheless use taste stimuli as signals for 
other reinforcing events. For example, such rats perform competently in a taste-signalled 
shock avoidance task (Spector, Scalera, Grill and Norgren, 1995). This suggests that 
PBN lesions may result in an impairment of the affective response to taste stimuli rather 
than a purely sensory deficit. Therefore, the PBN may be involved in mediating the 
affective response to taste stimuli. Integrating the data gathered from lesion studies with 
the present results suggests that the increase in food intake caused by midazolam injected 
into the PBN results from an increase in hedonic responding mediated by receptors in this 
area. This conclusion is consistent with evidence from systemic injections of 
benzodiazepine agonists which suggest that these drugs increase ingestive behaviour by 
increasing palatability (Berridge and Pecina, 1995). Further experiments examining the 
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effect of intra-PBN midazolam in sham feeding and taste preference tests are required.to 
examine this hypothesis. 
The PBN may not be the only important structure for the effects of 
benzodiazepines on ingestive behaviour and it is possible that benzodiazepine receptor 
agonist modulation of feeding may occur even earlier on the taste pathway in the nucleus 
of the solitary tract (NTS) which is the first relay in the gustatory pathway (Norgren, 
1978). This possibility remains to be tested, but a role for the NTS seems less likely 
given that an autoradiographic binding study failed to reveal any benzodiazepine receptors 
in this nucleus (Higgs et al., 1993). In addition, other brain sites such as the amygdala 
and hypothalamus which are known to be involved in the control of ingestive behaviour 
may also be important for the effects of benzodiazepines on food intake. This possibility 
could be examined by performing a cannula-mapping study. 
In conclusion, the studies reported in this chapter indicate that the neural substrate 
for benzodiazepine-induced hyperphagia may be located in the brainstem, specifically in 
the PBN. Stimulation of receptors located in the PBN may affect ingestive behaviour 
without affecting locomotor behaviour. 
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Analysis of lick rate and microstructure of licking for sucrose 
and Intra-lipid 
4.1 Introduction 
A large body of evidence suggests that under real-feeding conditions, 
carbohydrate intake is determined by at least two important variables which have been 
modelled using principles from control theory by Davis and Levine (1977). The first 
variable is orosensory information, which stimulates ingestion via a positive feedback 
mechanism. The second is postingestive information which counteracts this stimulation, 
and reduces intake via a negative feedback signal. The model makes very specific 
predictions about the way in which manipulation of these two control variables should 
affect the rate of ingestion. One prediction is that the initial rate of ingestion of a solution 
should reflect the hedonic evaluation, or palatability of that stimulus. This hypothesis is 
well supported by data from experiments that have examined the effect of manipulating 
the concentration of carbohydrate solutions. Increasing carbohydrate concentration is 
assumed to increase orosensory stimulation and so alter the hedonic response to the 
solution being ingested. Many studies have shown that initial lick rate increases as a 
function of increasing carbohydrate concentration (Davis, 1973; Davis and Levine, 1977; 
Davis and Smith, 1988). This confirms the prediction that initial lick rate reflects changes 
in the underlying assessment of palatability. A second prediction is that the rate of decline 
of licking over time should reflect the development of a negative feedback signal arising 
from the postingestional consequences of feeding (Davis, et al., 1975; Davis and Levine, 
1977). This prediction has been tested by adding mannitol to a carbohydrate test meal. 
Mannitol is absorbed from the intestine very slowly and has the effect of slowing the rate 
of clearance of ingested substances from the stomach. The effect of mannitol on the rate 
of ingestion is consistent with that predicted by the model. Mannitol does not decrease the 
initial rate of licking, but enhances the decline in the rate of licking within a test session 
(Davis and Levine, 1977). The model has proved to be successful because it can account 
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for a variety of experimental results, and because it allows investigators to separate out 
the effects of palatability and postingestional feedback in determining meal size. 
In an extension of this work, Davis and Smith (1992) have suggested that 
microstructural analysis of the licking behaviour of rats may also provide information 
concerning the role of orosensory and postingestive factors in influencing ingestive 
behaviour. Microstructural analysis involves describing in detail the pattern of individual 
components of feeding behaviour (e.g. licks). The duration of bouts of licking has been 
shown to increase as a function of increasing concentration (Davis and Smith, 1992; 
Smith et al., 1992). This contrasts with the relationship between intake and concentration 
which varies non-monotonically according to an inverted U-shaped function, probably 
reflecting increased negative feedback associated with accumulation of ingested material 
in the gastrointestinal (GI) tract (Davis and Levine, 1977; Spector and Smith, 1984). 
Thus, it has been suggested that the duration of bouts may reflect changes in orosensory 
input which are uncontaminated by postingestive influences. Microstructural analysis 
may also provide information concerning non-specific motor effects on licking 
behaviour. Stellar and Hill (1952) showed that rats lick at a reasonably constant rate of 
about 6-7 licks per second. Any disruption of this rate might suggest that a treatment is 
affecting sensorimotor coordination, as distinct from an effect on the controls of 
ingestion. Thus, Davis and Smith (1992) showed that the intrabout lick rate is affected by 
moving the drinking spout progressively further away from an animal, but not by altering 
the solution concentration. 
The Davis and Levine model could provide useful information concerning the 
mechanisms responsible for drug- or lesion-induced changes in ingestive behaviour. For 
example, i f a drug were reducing food intake by decreasing palatability then it would be 
expected to decrease the initial rate of licking and reduce mean bout duration. Such 
information could not be gathered from merely measuring intake. However, one potential 
problem with the model is that experimental evaluation of it has been limited so far to the 
effect of manipulating the concentration of carbohydrates. I f the model is to provide an 
adequate description of ingestive behaviour, then it must also account for the ingestion of 
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other macronutrients such as fats. Additionally, such information is crucial if 
unambiguous interpretations of lesions or pharmacological manipulations are to be made 
when these are linked to macronutrient variables. The aim of the present experiments was 
to investigate whether the predictions made by the Davis and Levine model also apply 
when the test fluid is a fat emulsion. The emulsion used, was Intra-lipid (Pharmacia Ltd, 
Milton Keynes, U.K.). This is a commercially-prepared lipid emulsion consisting of 
fractionated soya bean oil, fractionated egg phospholipids and glycerol (200 kcal per 100 
ml). It is well suited for use in lickometer studies because it emulsifies well, is not 
viscous, and is readily consumed by rats. 
The aim of Experiment 7 was to examine in detail the temporal and 
microstructural characteristics of licking for Intra-lipid in a 20-min test. Licking for 
sucrose was also measured under the same conditions. Rats were given 20-min access to 
various concentrations of either Intra-lipid (1%, 3% and 10%) or sucrose (1%, 3%, 10% 
and 30%). In Experiment 8, the aim was to minimize longer-term negative feedback from 
the GI tract by limiting access to the test fluids to an initial 60s period of licking. Several 
concentrations of sucrose or Intra-lipid were presented within the test session in a random 
order, and the licking behaviour analyzed. A short interval (10s) intervened between 
subsequent presentations because it had been shown previously that such rapid evaluation 
does not yield significantly different results from those obtained using longer inter-trial 
intervals (Smith, Davis and O' Keefe, 1992). This brief contact method has the advantage 
that licking responses to a range of concentrations can be evaluated rapidly within a single 
session. 
4.2 Method 
4.2.1 Animals 
Forty naive non-deprived adult male hooded Lister rats (Charles River, U.K.) 
weighing 300-350 g at the beginning of training were used. They were housed in pairs in 
plastic cages in a room with a constant room temperature of 21+2 °C, and were 
maintained under a 12h light:dark cycle (lights on at 08.00). Rats were allowed ad lib 
Chapter 4 91 
access to food pellets, (SDS RMI (E), Essex, U.K.) and water, except during testing. All 
testing was carried out in the light phase between 09.00 and 13.00h. 
4.2.2 Test meal 
Rats had access to various concentrations of sucrose (granulated cane sugar) or 
Intra-Iipid emulsions which were made up freshly each day. The Intra-lipid emulsions 
were made up by diluting a 20% commercial preparation with tap water and the sucrose 
solution was made up to volume each day using tap water. 
4.2.3 Apparatus 
Testing was carried out using an MS80 multistation lick analysis system (Dilog 
Instruments, Tallahassee, FL). Rats were placed in a perspex chamber which was 
approximately 16 cm wide, 30 cm long and 20 cm tall. A perspex lid with four small 
holes in the top secured the chamber. The floor was made of stainless steel rods which 
were spaced 1 cm apart. An opening in the centre of the front wall of the chamber 
allowed rats access to a drinking spout which was located 85 mm from the floor of the 
chamber. This portal could be covered by a motorized shutter so that drinking from the 
spout was carefully controlled. The drinking spout was located 3 mm behind the wall so 
that to lick from the spout the rat was required to protrude its tongue through a small slot. 
This was to ensure that only licks were recorded and not contact made by the paws or 
snout, etc. The time of each lick to the nearest millisecond was recorded for later data 
analysis. Every time the rat contacted the drinking tube this completed a computer-
monitored electronic circuit and was counted as a lick. Bottles containing the fluids were 
mounted in a line on a metal platform that could be moved backwards and forward by a 
reversible motor. This allowed any bottle to be stationed in front of the drinking slot for a 
given presentation. The opening of the shutter and positioning of the bottles was 
computer-controlled. The number of presentations, duration of each presentation, and the 
duration of the interpresentation interval were all determined by the experimenter. 
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4.2.4 Procedure 
Experiment: 7: Microstructural analysis of drinking for sucrose and Intra-Lipid over a 
20-min session 
Training Twenty rats were divided into two groups (n = 10 per group), and 
were well familiarized with the test apparatus and procedure. Each group had access to 
one training fluid which was either a 30% concentration sucrose solution (granulated cane 
sugar) or a 10% concentration Intra-lipid emulsion. The presentation time was 20-min. 
Presentation began with the shutter opening to allow access to the drinking spout, but the 
20-min test session did not start until the rat had started licking. Testing began once the 
amount ingested within a session showed no significant increase over three consecutive 
days. This was achieved after a period of approximately 10 days. 
Testing In the test phase rats were given access to four different 
concentrations of sucrose (1, 3, 10 and 30%), or three different concentrations of Intra-
lipid (1,3 and 10%). The test fluids were offered in ascending order of concentration 
with the same concentration being offered on two consecutive days. This allowed the rats 
to adapt to a new concentration to avoid novelty effects. Only data from the second day 
were analyzed. The rats were tested for 20-min on each concentration. The total amount 
ingested after this period was recorded by successive weighings of the bottles. 
Experiment 8: Microstructural analysis of drinking for sucrose and Intra-Lipid in a brief 
contact test 
Training Twenty rats were divided into two groups (n = 10) and were well 
familiarized with the test apparatus and procedure. This involved placing each rat in the 
test chamber were they had access either to a 3% concentration sucrose solution or a 3% 
concentration Intra-lipid emulsion. Each rat received four or three presentations of 60s 
with an interpresentation interval (IPI) of 10s. For each presentation the bottle contained 
either 3% sucrose or 3% Intra-lipid. This procedure continued until the rats were 
Chapter 4 93 
consuming steady baseline levels across presentations and across days (approximately 10 
days). 
Testing The test phase was identical to the training phase in that rats had 
four presentations of 60s with an IPI of 10s. However, in the test phase, instead of only 
having access to one concentration of fluid, the rats had access to all concentrations of 
either sucrose (1, 3, 10 and 30 %) or Intra-lipid (1, 3 and 10%). Each concentration was 
presented for a total duration of 60s. The order of presentation was randomised. Testing 
occurred on two consecutive days and only data from the second test day were analyzed. 
The order of presentation of fluid concentrations was counterbalanced across rats and 
across days. 
4.2.5 Data analysis 
The data collection programme recorded the time of each lick contact to the nearest 
millisecond. These lick time data were then analyzed using Dilog software (Ross 
Henderson, Dilog Instruments Tallahassee, Florida), followed by further processing 
using a Microsoft Exel spreadsheet programme. The change in lick rate across the test 
session was determined by calculating the number of licks in successive time bins for 
individual rats and then averaging across rats. In Experiment 7, an exponential decay 
function of the form y = Ae (-Bt) was fitted by a least squares method to the rate of licking 
data using the Sigma Plot graphics programme (Jandel Corp. Rafael, CA, 1986). This 
function was chosen because it provides a good description of the decline in the rate of 
licking which occurs, and is of theoretical importance (Davis and Levine, 1977). The 
results are expressed as the value of the intercept (A) and the rate constant of the decay 
function (B). A Spearman correlation coefficient was then calculated for the actual values 
and those predicted by the fit, to give a measure of how well the fit described the data. In 
Experiment 8, the main effect of concentration on the rate of licking in 60s was analyzed 
using a one-way repeated-measures ANOVA. 
Microstructural analysis of the rats licking behaviour was also performed. Licking 
in rats is a highly stereotyped activity that occurs in sustained periods of licking or 
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'bouts' which are separated by pauses or inter-bout intervals (ILIs). The lick data were 
first grouped into bouts by specifying an upper ELI of 400 ms. This definition of a bout 
was used because it had been established in previous studies that an interval of 400 ms 
was just longer than the break point in a log survivor plot of ILIs (Morris, 1993). The 
data analysis programme gave the number of bouts and the duration of each bout within a 
presentation. The mean bout duration was calculated by summing over the presentation 
and taking an average value for each rat. Another parameter examined was the intrabout 
lick rate. This was calculated as the number of licks in a bout minus one, divided by the 
total duration of the bout. The latency to engage in drinking (time from shutter opening to 
first lick) was also examined. All data were analyzed using a one-way repeated-measures 
analysis of variance (ANOVA). Post hoc comparisons were made using a Dunnett's t-
test. Statistical tests were performed using Statview SE+graphics (Abacus Concepts Inc., 
Berkeley, CA, 1987) and a result was considered statistically significant if p < 0.05. 
4.3 Results 
Experiment 7: Microstructural analysis of drinking for sucrose and Intra-Lipid over a 
20-min session. 
Intake 
Figure 4.1 shows the intake of both sucrose and Intra-lipid as a function of 
concentration. In both cases, the volume consumed varied significantly with 
concentration: sucrose (F 3 , 2 1 = 13.69, p < 0.001); Intra-lipid (F 2, is = 5.72, p < 0.01). 
The relationship between concentration and intake in both cases was non-monotonic. In 
the sucrose group, there was a marked increase in consumption when the concentration 
was increased from the 1% to the 3% concentration (p < 0.01). When the concentration 
was raised from the 10% to the 30% concentration, there was a decrease in consumption. 
Increasing Intra-lipid concentration from 1% to 3% stimulated a modest increase 
in the volume ingested, although this was not significant in a post hoc test. An increase in 
the concentration from 3% to 10% produced a significant reduction in intake (p < 0.05). 
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Figure 4.1. Intake of sucrose and Intra-lipid in a 20-min 
test as a function of concentration (%) + S.E.M. Asterisk 
indicates significantly different from 1% * p < 0.05 ** p < 0.01 
(Dunnett's t-test). 
Rate of licking 
The data for the rate of licking at 1-min intervals for both sucrose and Intra-lipid 
are presented in Figure 4.2 which shows the effect of 1 % and 30% sucrose and the effect 
of 1% and 10% Intra-lipid. An exponential decay function was fitted to the data and the 
parameters derived from the curve-fitting procedure are shown in Table 4.1. Increasing 
the concentration of either sucrose or Intra-lipid affected both the initial rate of licking and 
the rate constant. Increasing concentration resulted in an increase in the initial rate of 
licking (A). This was true for both sucrose and Intra-lipid. Increasing concentration of 
sucrose and Intra-lipid also increased the estimate of the slope function (B). 
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Figure 4.2 The effect of concentration on the rate of licking 
(licks per min) for a) sucrose and b) Intra-lipid. The lines are the 
least squares fit of the function y = Ae (-BO to the data. Open circles 
( O ) indicate the 1% condition, filled triangles ( • ) indicate the 
10% (Intra-lipid) or 30% (sucrose) condition. 
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Table 4.1 Parameter estimates and standard errors and for the least squares fit to the 
rate of licking of the function y = Ae (-Bt). 
Sucrose 
Concentration (%) A B r 
Estimate 92.1 0.04 0.74 
S.E. 8.82 0.01 
30 
Estimate 279.3 0.12 0.98 
S.E. 16.14 0.01 
Intra-Lipid 
Concentration (%) A B r 
1 
Estimate 201.8 0.09 0.9 
S.E. 13.6 0.01 
10 
Estimate 245.9 0.16 0.93 
S.E. 17.6 0.01 
Parameters A and B describe the intercept and rate constant respectively, r is the 
correlation coefficient for the actual and predicted values calculated using a Spearman 
correlation coefficient. 
Microstructural analysis. 
Number of licks Figure 4.3 shows the data for the total number of licks 
generated in the test period for sucrose and Intra-lipid. There were concentration-
dependent effects on licking for both sucrose (F 3,27 = 10.14, p < 0.001) and Intra-lipid 
drinking (F 2, is = 8.47, p < 0.01). In each case the relationship was non-monotonic. 
For sucrose drinking, there was a large increase in the number of licks when the sucrose 
concentration was raised from the 1% to 3% or 10% concentration. At 30% sucrose 
concentration, the total number of licks declined from the peak level. Similarly, there was 
a slight enhancement in licking for Intra-lipid when the concentration was raised from the 
1% to the 3% concentration, with an absolute decrease in the number of licks (compared 
with 1%) when the concentration reached 10%. These data parallel the intake data shown 
in Figure 4.1. 
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Figure 4.3. The number of licks for sucrose and Intra-lipid 
drinking in a 20-min test as a function of concentration (%) + 
S.E.M. Asterisk indicates significantly different from 1% 
* p < 0.05 ** p < 0.01 (Dunnett's t-test). 
Mean bout duration For both sucrose (F 3, 27 = 10.98, p < 0.001) and Intra-
lipid drinking (F 2,18 = 10.76, p < 0.001), an increase in concentration led to an increase 
in the mean bout duration, although for sucrose drinking this relationship was non-
monotonic because there was a decrease in mean bout duration at 30% sucrose (Figure 
4.4a). 
Bout number As shown in Figure 4.4b a trend was observed towards 
increasing bout number with increasing sucrose concentration but this did not reach 
significance (F 3, 27 = 2.42, n.s.). Manipulating Intra-lipid concentration significantly 
affected the number of bouts in the test session (F 2, is = 8.112 p < 0.01). Increasing 
Intra-lipid concentration led to a decrease in the number of bouts (Figure 4.4b). 
In summary, an increase in sucrose concentration increased the size of bouts but 
did not greatly affect the number of bouts; in contrast, increasing Intra-lipid concentration 
led to an increase in the size of bouts, but decreased their number. 
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Figure 4.4 a) Mean bout duration and b) number of bouts 
for sucrose and Intra-lipid drinking in a 20-min test as a function 
of concentration (%) -I- S.E.M. Asterisk indicates significantly 
different from 1% * p < 0.05 ** p < 0.01 (Dunnett's t-test). 
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Intrabout lick rate The rate of licking within bouts (intrabout lick rate) was 
significantly affected by manipulating the concentration of both sucrose (F 3, 27 = 8.23, p 
< 0.001) and Intra-lipid (F 2,18 = 5.14, p < 0.05). An increase in the concentration of 
sucrose led to a significant decrease in the intrabout lick rate (Figure 4.5a). In the case of 
Intra-lipid drinking, increasing the concentration increased the rate of licking although 
this effect was not concentration dependent. At the 10% concentration of Intra-lipid, the 
rate of licking within bouts was significantly greater than that at the 3% concentration 
(p < 0.01), but the 1% condition did not differ significantly from the 10% condition 
(Figure 4.5a). 
Latency The latency to start drinking was significantly affected by 
manipulating concentration for sucrose drinking (F 3, 27 = 3.62, p < 0.05) (Figure 
4.5b). Post hoc analysis showed that the 10% (p < 0.05) and 30% (p < 0.01) 
concentration of sucrose differed significantly from the 1 % concentration condition. As 
shown in Figure 4.5b, increasing Intra-lipid concentration did not affect the latency to 
engage in drinking (F 2 j 8 = 0.82, n.s.). However, there was a trend towards increasing 
latency with increasing Intra-lipid concentration, although this did not reach significance. 
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Figure 4.5 a) Intrabout lick rate and b) latency for sucrose and 
Intra-lipid drinking in a 20-min test as a function of concentration 
(%) + S.E.M. Asterisk indicates significantly different from 1% 
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Experiment 8: Microstructural analysis of drinking for sucrose and Intra-lipid in a brief 
contact test 
Rate of licking 
A one-way repeated-measures ANOVA revealed that for sucrose there was a 
significant effect of concentration on the rate of licking over 60s (F 3, 21 = 18.6, p < 
0.01). The effect of sucrose concentration on the rate of licking is shown in Figure 4.6a. 
An increase in the initial rate of licking was observed with increasing concentration of 
sucrose. There was then a gradual decline in the number of licks per second over the 60s 
for each concentration (Figure 4.6a). This decline was inversely proportional to 
concentration. For the 30% concentration of sucrose, the rate of licking was maintained at 
a relatively high level over the 60s session. At lower concentrations, the rate of licking 
declined rapidly leading to a separation of the concentration curves after 60s. 
The effects of Intra-lipid concentration on the rate of licking were similar to the 
patterns obtained for sucrose (Figure 4.6b). There was a significant effect of Intra-lipid 
concentration on the rate of licking (F 2, is = 20.02, p < 0.01). The highest concentration 
of Intra-lipid (10%) stimulated a higher initial rate of licking than 1% concentration. The 
rate of licking for Intra-lipid also declined over the test session. As can be seen in Figure 
4.6b the rate of decline was similar for each concentration of Intra-lipid. Therefore, the 
curves show a parallel decrease over the test session. 
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Microstructural analysis 
Number of licks An increase in fluid concentration led to a significant and 
monotonic increase in the total number of licks in the test session for both sucrose (F 3,27 
= 21.9, p < 0.001) and Intra-lipid drinking (F 2, is = 20.0, p < 0.001) (Figure 4.7). 
Mean bout duration Mean bout duration varied significantly as a function of 
fluid concentration. Increasing the concentration led to a monotonic increase in the mean 
bout duration for both sucrose ( F 3_ 27 = 5.5, p < 0.01) and Intra-lipid drinking ( F 2, is 
= 8.38, p < 0.01) (Figure 4.8a). 
Number of bouts There was a significant effect of concentration on bout 
number for sucrose drinking, although post hoc comparisons revealed that this effect was 
not concentration-dependent (F 3, 27 = 3.7, p < 0.05) (Figure 4.8b). Manipulating the 
concentration of Intra-lipid did not significantly affect the number of bouts in the 60s test 
period (F 2,18 = 2.01, n.s.) (Figure 4.8b). 
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Figure 4.7 The number of licks for sucrose and Intra-lipid 
drinking in a brief contact test as a function of concentration (%) + 
S.E.M. Asterisk indicates significantly different from 1% 
* p < 0.05 ** p < 0.01 (Dunnett's t-test). 
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Intrabout lick rate The rate of licking within bouts was not affected by 
manipulating fluid concentration. This was the case for both sucrose (F 3,27 = 0-6, n.s.) 
and Intra-lipid drinking (F 2,18 = 0-18, n.s.). An increase in the concentration of both 
sucrose and Intra-lipid did lead to a slight decrease in the intrabout lick rate, although this 
did not reach significance (Figure 4.9a). 
Latency There was no effect of manipulating concentration on the latency 
to engage in drinking for either the sucrose (F 3,27 = 2.8, n.s.) or Intra-lipid groups (F 
2,18 = 0-9, n.s.). As can been seen in Figure 4.9b, there was a trend towards an increase 
in latency with increasing concentration, but this was not significant. 
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4.4 Discussion 
In Experiments 7 and 8, a comparison was made between the licking responses 
for sucrose and Intra-lipid to determine if the model of ingestive behaviour proposed by 
Davis and Levine (1977) can account for the effects of manipulating the concentration of 
fats as well as carbohydrates. The results show that the effect of manipulating fluid 
concentration on the general pattern of licking responses was the same for both sucrose 
and Intra-lipid. The initial lick rate for sucrose and Intra-lipid in a 20-min test was found 
to increase as a function of increasing concentration. Additionally, in a brief exposure 
test, mean bout duration was found to vary monotonically with concentration. 
In Experiment 7, the rate of licking over a 20-min test session was examined for 
several concentrations of sucrose and Intra-lipid. The initial rate of licking for these 
nutrients was found to increase with increasing concentration. The monotonic 
relationship between the initial rate of licking and increasing concentration contrasted with 
the relationship between concentration and intake in the same test which varied non-
monotonically according to an inverted U-shaped function. The decrease in intake 
observed at higher concentrations of sucrose and Intra-lipid probably reflected the 
emergence of an inhibitory feedback signal due to the accumulation of fluid in the gut. 
These results support the notion that the rate of licking during the initial period of licking 
for both sucrose and Intra-lipid reflects the stimulating effectiveness of the solution 
uncontaminated by negative feedback and so provides a measure of palatability. 
Increasing concentration also increased the slope of the rate function for sucrose 
and Intra-lipid drinking. This is consistent with the hypothesis that the rate of decay of 
licking provides a measure of postingestive negative feedback and can be explained as 
follows: increasing concentration led to an increase in the initial rate of ingestion. 
Consequently, the rate of accumulation of fluid in the gut was also increased, thus 
leading to an increase in the strength of a postingestive negative feedback signal. It is 
interesting that although the intake of 1% sucrose and 1% Intra-lipid were quite similar, 
rate analysis revealed differences between the magnitude of the initial rate of licking and 
slope function. The initial rate of licking for 1% sucrose was lower than that for 1% 
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Intra-lipid. However, the overall intake was roughly the same after 20-min because the 
rate of decline of 1% Intra-lipid drinking was much greater than that for 1% sucrose 
drinking. Such a difference between sucrose and Intra-lipid drinking could not have been 
identified from simple measures of intake and would suggest that even at low 
concentrations Intra-lipid is highly palatable. 
Microstructural analysis showed that manipulating concentration also produced 
changes in bout structure. Davis and Smith (1992) found that in a 30-min intake test, the 
only parameter to vary monotonically with increasing sucrose concentration was the bout 
duration. These authors suggested that this measure, like the initial rate of ingestion, 
could provide information concerning changes in palatability. The effect of manipulating 
sucrose and Intra-lipid concentration over 20-min in Experiment 7 did not produce such 
clear-cut effects on bout structure. Mean bout duration did significantly increase with 
increasing concentration of Intra-lipid. For sucrose drinking however, mean bout 
duration increased when concentration was raised form 1% to 10%, but there was then a 
decrease in mean bout duration when concentration was raised to 30%. The non-
monotonic effect of sucrose concentration on mean bout duration may have been due to 
changes in mean bout duration over time. Early in the test session drinking may have 
been characterized by few bouts of long duration due to the influence of palatability 
factors. However, towards the end of the test session, when postingestive factors 
predominate, bouts may have been more frequent but shorter. This interpretation is 
supported by the findings of Morris (1993), who showed that for concentrated sucrose 
solutions, bout duration was not constant across a 20-min test session. Bout duration 
was longer at the beginning of the test, but much shorter during the latter part of the test, 
possibly due to the influence of postingestive factors (Morris, 1993). The conclusion to 
be drawn from this is that changes in mean bout duration may only reflect changes in 
palatability when the test session is kept short to avoid the influence of postingestive 
factors. This problem is addressed later in Experiment 8 where the test session was 
limited to 60s. 
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There were no significant effects of concentration on the number of bouts for 
sucrose drinking, although there was a trend towards increasing bout number with 
increasing concentration. For Intra-lipid drinking, there was a significant decrease in the 
number of bouts at 10% which probably occurred as a consequence of the increase in 
mean bout duration at this concentration. The lack of effect of concentration on bout 
number is consistent with previous reports (Davis and Smith, 1992) and suggests that 
changes in bout number do not provide information concerning changes in palatability. 
In Experiment 7, the rate of licking within bouts was affected by manipulating the 
concentration of sucrose and Intra-lipid. Increasing sucrose concentration led to a 
decrease in the intrabout lick rate. This result is similar to the findings of Davis and Smith 
(1992) who also found a decrease in the rate of licking for sucrose with increasing 
concentration. These authors suggested that this effect could not account for any 
variability in intake and may have been an artifact of the test situation. One possible 
explanation for the results obtained in Experiment 7 is that at higher concentrations the 
tongue remained in contact with the lick tube for longer. A prolonging of the lick cycle at 
higher concentrations may have been due to increased viscosity when concentration is 
increased, or may be related to the increase in the stimulating effectiveness of higher 
concentrations. In the case of Intra-lipid drinking, there was an increase in the rate of 
licking within bouts at 10% compared with 1%. This result is harder to explain, and it is 
clear that the interpretation of intrabout lick rate is more complicated than first suggested 
by Davis and Smith (1992). Further work is required to examine the effects of viscosity 
and palatability on the rate of licking within bouts. 
The latency to engage in drinking was affected by manipulating sucrose 
concentration but not by manipulating Intra-lipid concentration. There was a decrease in 
latency with increasing sucrose concentration. It has been suggested that latency may 
provide a measure of motor incapacitation. However, the effect of sucrose concentration 
on latency suggests that this measure may also reflect changes in other variables. It is 
possible that changes in latency reflect changes in the motivation to start drinking. Such 
an explanation would suggest that increasing sucrose concentration in Experiment 7 
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resulted in increased motivation drink, possibly because of the increased palatability of 
higher concentrations of sucrose. The lack of effect of manipulating Intra-lipid 
concentration on latency may suggest that increasing Intra-lipid concentration does not 
affect motivation in the same way as manipulating sucrose concentration. It is clear that 
interpreting changes in latency may be problematic because several factors may lead to 
differences in the time to engage in drinking. Therefore, the conclusion from this is that 
caution must be exercised in explaining these differences. 
Microstructural analysis of sucrose and Intra-lipid drinking over a 60s 
presentation period revealed great similarity in the pattern of licking for these nutrients. 
The results for sucrose and Intra-lipid were comparable for all the variables examined, 
suggesting that there are no significant differences in the way in which rats respond to 
Intra-lipid and sucrose over the initial 60s period of drinking. The results obtained for 
sucrose drinking in the present experiments are consistent with previously published data 
for a range of other carbohydrates (Davis, 1973; Davis et al., 1995; Davis and Smith, 
1992). 
The rate of licking curves for sucrose showed that over the 60s test there was a 
gradual decline in the change in the rate of licking which was inversely proportional to 
concentration. These data are consistent with the findings of Smith et al. (1992) who 
found that the rate of licking for various carbohydrates including sucrose in a 30s test 
declined steadily, with lower concentrations showing a greater rate of decline. In 
Experiment 8, the rate of licking for sucrose was similar to the rate of licking for Intra-
lipid. With Intra-lipid there was also a decline in the rate of licking over the test sessions 
which was affected by manipulating concentration. There was an effect of Intra-lipid 
concentration after the first second of licking with higher concentration stimulating much 
higher rates of licking than lower concentrations. These results suggest that the increase 
in the initial rate of licking observed in Experiment 7 can be detected even within the first 
minute of presentation. As suggested previously (Smith et al., 1992), the decline in the 
rate of licking for both sucrose and Intra-lipid is most probably not due to inhibitory 
postingestive feedback since the test session is too short for a large enough volume of 
Chapter 4 112 
fluid to have accumulated in the GI tract. Instead, the effect is better explained by the 
emergence of adaptation to chemical or mechanical stimulation (Smith et al., 1992). Since 
this adaptation is sensitive to varying concentration, further examination of this effect 
may be important in determining the mechanisms responsible for the differential 
stimulating effectiveness of palatable solutions. 
Analysis of the total number of licks in 60s showed that this measure varied 
monotonically with concentration for both sucrose and Intra-lipid. Increasing 
concentration significantly increased the total number of licks in the session. In the brief 
contact test, the influence of postingestive feedback is minimized and so the relationship 
between the number of licks and concentration probably reflects orosensory determinants 
of ingestion. 
Microstructural analysis revealed that for both sucrose and Intra-lipid the increase 
in the number of licks was due to an increase in the mean bout duration rather than an 
increase in the number of bouts. Mean bout duration increased significanfly with 
increasing concentration of sucrose and Intra-lipid. This contrasts with the relationship 
between sucrose concentration and mean bout duration in the 20-min presentation used in 
Experiment 7 which was non-monotonic. Davis and Smith (1992) have suggested that a 
monotonic relationship between mean bout duration and.carbohydrate concentration 
indicates that this measures reflects the hedonic potency of ingested fluids, and so 
provides a robust measure of palatability. The differential effect of sucrose concentration 
on mean bout duration obtained in Experiments 7 and 8 suggests that this measure may 
only provide information concerning the palatability in a brief contact test where the effect 
of postingestional negative.feedback has been minimized. 
The finding that mean bout duration increases with increasing Intra-lipid 
concentration in a brief contact test contrasts with more recent findings of Davis et al. 
(1995) who examined licking responses to the ingestion of corn oil. These authors found 
that in the first minute of licking for this fat, the mean bout duration did not vary as a 
function of increasing concentration. It was suggested that the lack of effect of corn oil 
concentration on mean bout duration may have been due to the fact that changes in this 
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parameter reflect gustatory, rather than somatosensory stimulation. It could be that the 
initial response to corn oil is determined by texture rather than taste. In support of this, 
human psychophysical studies have shown that texture is important in determining 
perceived fattiness (Mela, 1988). It has been suggested by Mindell, Smith and Greenberg 
(1990) that fat texture is processed by oral tactile mechanisms of the trigeminal system. 
This system, rather than the gustatory system may be responsible for the differential 
stimulating properties of fats. The discrepancy between the present results and those of 
Davis et ai. (1995) could be explained by the fact that corn oil and Intra-lipid have 
different viscosities and textures. Further work is required to examine the role of 
viscosity and texture in determining the ingestion of fats. Additionally, Intra-lipid and 
corn oil may differ in their ability to stimulate the gustatory system. Although there has 
been little examination of the role of flavour in fat consumption to date, it could be that 
flavour is also an important determinant of fat palatability. 
In summary, the results of the Experiment 8 showed that mean bout duration 
varied monotonically with both sucrose and Intra-lipid concentration. This suggests that 
mean bout duration is sensitive to the palatability associated with sucrose and Intra-lipid. 
However, the results of Davis et al. (1995) indicate that mean bout duration may not be 
sensitive to the changes in oropharyngeal stimulation provided by all fats. It remains to be 
fully determined whether the effect of manipulating concentration on bout duration is 
related specifically to gustatory as opposed to other somatosensory stimulation. 
Manipulating concentration did not have any effect on the rate of licking within 
bouts for either sucrose or Intra-lipid drinking in the brief contact test used in Experiment 
8. This differs from the finding in Experiment 7 where intrabout lick rate varied with 
increasing fluid concentration. Therefore, the effects of concentration on this measure 
may be dependent on the presentation time. The intrabout lick rate was affected by 
concentration in the 20-min test, but not in the brief contact test. This may have been due 
to an effect of habituation apparent during a 20-min test but absent during a 60s 
presentation. The conclusion from this is that caution must be exercised in interpreting 
any changes in the intrabout lick rate because this measure may not be so robust a 
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measure of motoric disruption as suggested by Davis and Smith (1992). 
The latency to engage in drinking was not significantly affected by manipulating 
concentrafion of sucrose or Intra-lipid. This contrasts with the effect of sucrose 
concentration on latency which was obtained in Experiment 7. This suggests that further 
work is required to examine the effect of factors such as concentration on latency before 
firm conclusions can be drawn concerning the processes which are important in 
determining changes in latency. 
In summary, these data confirm the usefulness of analyzing the rate of ingestion 
and microstructure of licking behaviour in providing information concerning the 
processes responsible for controlling intake of carbohydrates and extends these 
conclusions to the control of Intra-lipid intake. The initial lick rate increased with 
increasing concentration suggesting that this measure may provide information 
concerning the palatability of both sucrose and Intra-lipid. It was shown that for both 
sucrose and Intra-lipid drinking, the effect of concentration on the initial rate of licking 
occurred within the first few seconds of the test. Mean bout duration increased 
monotonically as a function of concentration in a 60s test, but there was no significant 
effect of concentration on bout number. This suggests that in a brief contact test, mean 
bout duration may provide a measure of palatability which applies to both sucrose and 
Intra-lipid. 
An important aim of the experiments reported in this chapter was to establish 
control patterns of ingestion for sucrose and Intra-lipid before going on to investigate the 
effects of pharmacological manipulations on licking behaviour. In Experiments 7 and 8, it 
was shown that manipulating fluid concentration had specific effects on the 
microstructure of licking for both sucrose and Intra-lipid. From this it was suggested that 
microstructural analysis can provide information concerning changes in palatability. In 
subsequent chapters, the effects of drug adminstration on licking patterns will be 
compared with the effects of manipulating concentration to help elucidate the factors 
responsible for the effects of benzodiazepine ligands on intake. 
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The effects of midazolam on the microstructure of licking for 
sucrose and Intra-lipid 
5.1 Introduction 
It has recendy been suggested that the increase in food intake brought about by 
administration of benzodiazepines is due to an effect on palatability (Berridge and Pecina, 
1995). Evidence to support this argument derives from the effects of benzodiazepine 
receptor agonists in tests which are thought to provide a measure of palatability. Such 
tests include the taste reactivity paradigm, the taste preference test and sham feeding 
preparation. In the taste reactivity test, benzodiazepine receptor agonists have been shown 
to increase ingestive reactions to sapid solutions (Berridge and Treit, 1986; Gray and 
Cooper, 1995; Treit and Berridge, 1990). This suggests that they might be enhancing the 
hedonic value of ingested substances. Additionally, benzodiazepine receptor agonists 
exert selective effects in taste preference tests (Cooper and Green, 1993; Cooper and 
Yerbury, 1988; Roache and Zabik, 1986), and increase sucrose sham feeding in the 
gastric fistulated rat (Cooper, et al., 1988). 
It has been appreciated for some time that analysis of the rate and microstructure 
of ingestive behaviour may provide information concerning the factors responsible for 
controlling food and fluid intake (Davis and Levine, 1977; Davis and Smith, 1992). 
However, these techniques have not been systematically applied to the study of the 
effects of benzodiazepines on ingestive responses. Cooper and Yerbury (1986b), 
examined changes in the microstructure of solid food consumption and found that 
midazolam enhanced intake by increasing the duration of bouts as opposed to their 
number. However, there has been no investigation of the effects of benzodiazepines on 
the microstructure on licking behaviour. Microstructural analysis of licking patterns is 
often preferred to analysis of solid food consumption because the use of automated 
lickometers to measure licking for fluids in rats provides a more accurate way of 
determining the timing of ingestive events. 
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Studies have shown that manipulation of orosensory and postingestive factors 
achieved by manipulating the concentration of ingested fluids produces quite specific 
effects on the rate and microstructure of licking for carbohydrates. The initial rate of 
licking and duration of bouts have been shown to vary monotonically with increasing 
concentration of carbohydrates (Davis, 1973; Davis and Levine, 1977; Davis and Smith, 
1992). Hence, it has been suggested that these parameters provide the means to measure 
palatability. It has been also been proposed that the rate of decline of licking provides an 
estimate of the increasing influence of inhibitory postingestive factors as ingestive 
behaviour proceeds (Davis, et al., 1975; Davis and Levine, 1977). The results of the 
previous chapter suggest that these measures also provide a measure of palatability and 
postingestive feedback associated with at least one source of fat, Intra-lipid. In 
Experiment 7, increasing the concentration of either sucrose or Intra-lipid increased the 
initial lick rate and led to a steeper rate of decline of licking. In a brief contact test 
(Experiment 8), mean bout duration increased with increasing concentration of both 
sucrose and Intra-lipid. Comparison of the effects.of benzodiazepines with the effects of 
manipulating concentration on licking patterns could provide new information concerning 
the behavioural mechanisms involved in benzodiazepine-induced hyperphagia. 
The aim of the present experiments was to use the licking microstructural 
approach to further investigate the behavioural mechanisms responsible for 
benzodiazepine-induced changes in ingestive behaviour. The effects of midazolam on the 
microstructure of licking were compared with the effects obtained when manipulating 
fluid concentration. 
An additional aim was to compare and contrast the effects of benzodiazepine 
receptor agonist administration on the consumption of carbohydrates versus fats. There 
are no previous reports of the effect of benzodiazepines on the consumption of specific 
macronutrients. Therefore, such information would be of great interest. I f 
benzodiazepine agonists increase ingestive behaviour through an enhancement of 
palatability, then this should operate as much on the hedonic evaluation of fats as on that 
of carbohydrates. 
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The data from two experiments are reported in this chapter. In Experiment 9, the 
effects of midazolam on the rate and microstructure of licking for both a 3% sucrose 
solution and a 1 % Intra-lipid emulsion in a 20-min test were examined. This experiment 
demonstrated that midazolam increased the rate of licking in the initial part of the test. To 
examine this effect in greater detail. Experiment 10 was designed to investigate the 
responses to a range of concentrations of sucrose and Intra-lipid in a brief contact test. 
The microstructural variables examined were the total number of licks, mean bout 
duration, number of bouts, intrabout lick rate and the latency to engage in drinking. 
5.2 Method 
5.2.1 Animals 
Forty naive non-deprived adult male hooded Lister rats (Charles River, U.K.) 
weighing 300-350 g at the beginning of training were used. They were housed in pairs in 
plastic cages in a room with a constant room temperature of 21+2 °C, and were 
maintained under a 12h light:dark cycle (lights on at 08.00). Rats were allowed ad lib 
access to food pellets, (SDS RMI (E), Essex, U.K.) and water, except during testing. 
Al l testing was carried out in the light phase between 09.00 and 13.00h. 
5.2.2 Drugs 
The benzodiazepine receptor agonist midazolam maleate (Roche, Basel, 
Switzerland) was prepared for injection by dissolving in distilled water. The doses used 
in these experiments were 0.3, 1 and 3 rflg/kg. It has been shown previously that 
midazolam elicits a hyperphagia when injected i.p. within this dose range (Cooper et al., 
1985). The vehicle used in control injections was distilled water. 
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5.2.3 Test meal 
Rats had access to various concentrations of sucrose solutions (granulated cane 
sugar) or Intra-lipid emulsions (Pharmacia Ltd, Milton Keynes, U.K.) which were made 
up freshly each day. The Intra-lipid emulsions we're made up by diluting a 20% 
commercial preparation with tap water, and the sucrose solutions were made up to 
volume each day using tap water. 
5.2.4 Apparatus 
Testing was carried out using the MS80 multistation lickometer described in detail 
in the Chapter 4 (Section 4.2.3). 
5.2.5 Procedure 
Experiment 9: Microstructural analysis of the effect of midazolam on drinking for a 3% 
sucrose solution and a 1% Intra-lipid solution over a 20-min session 
Training Twenty rats were divided into two groups (n = 10 per group), and 
were well familiarized with the test apparatus and procedure. Each group had access to 
one training fluid which was either a 3% sucrose solution or a 1% Intra-lipid emulsion. 
These concentrations were chosen to give low baseline levels of consumption. Training 
involved placing each animal in the lickometer chamber for a period of 20-min during 
which they had access to the appropriate training fluid. This procedure continued until 
steady baselines of consumption were observed across familiarization days 
(approximately 10 days). Two days prior to testing each animal received a sham injection 
of distilled water to familiarize it with the injection procedure. 
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Testing Midazolam was administered at doses of 0.3, 1 and 3 mg/kg 20-
min prior to testing. 20-min after injection the rats were placed in the lickometer chamber 
where they had access to either the 3% sucrose solution or the 1% Intra-lipid emulsion 
for 20-min. A within-subjects design was used in which each animal acted as its own 
control. The order of injections was counterbalanced and a period of 48h elapsed between 
each series of injections to avoid carry-over effects. 
Experiment 10: Microstructural analysis of the effect of midazolam on drinking for 
sucrose and Intra-lipid in a brief contact test 
Training Twenty rats were divided into two groups (n = 10 per group). 
Each group was well familiarized with the test apparatus and procedure. This involved 
placing each rat in the test chamber were they had access to a range of sucrose (1,3, 10 
and 30%) or Intra-lipid (1,3 and 10%) concentrations in a random order. Each 
concentration was presented for 60s and a 10s interval intervened between subsequent 
presentations. This procedure continued until steady baseline levels of licking were 
observed across days (approximately 10 days). Two days prior to testing each animal 
received a sham injection of distilled water to familiarize it with the injection procedure. 
Testing Following training, rats received i.p. injections of midazolam 
(0.3, 1 and 3 mg/kg) or vehicle. 20-min after injection the rats were placed in the 
lickometer chamber where they had access to all concentrations of either sucrose (1, 3, 10 
and 30%) or Intra-lipid (1, 3 and 10%). Each concentration was presented for a total 
duration of 60s. The order of presentation was randomised. A repeated-measures design 
was used in which each animal was tested at each dose. Injections were counterbalanced 
and 48h elapsed between treatments to avoid carry-over effects. 
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5.2.5 Data analysis 
The lick time data were analyzed as described in Chapter 4 (Section 4.2.5) using 
Dilog software written by Ross Henderson followed by further processing using a 
Microsoft Excel spreadsheet. The number of licks during successive minutes was 
calculated for each animai and then these minute-by-minute rates were averaged over all 
rats in each condition. In Experiment 9, an exponential decay function of the form y = Ae 
(-Bt) was fitted by a least squares method to the rate of licking data using the Sigma Plot 
graphics programme (Jandel Corp. Rafael, CA, 1986). In Experiment 10, the effect of 
midazolam on the rate of licking at each concentration of sucrose and Intra-lipid was 
analyzed using a one-way repeated-measures ANOVA. 
Various microstructural variables were also examined: the total number of licks, 
the mean bout duration, the number of bouts, the intrabout lick rate (licks per second 
within bouts), and latency to engage in drinking (time from shutter opening to first lick). 
In Experiment 9, the microstructural data were analyzed using a one-way 
repeated-measures analysis of variance (ANOVA). In Experiment 10, the microstructural 
data were analyzed using a two-way repeated-measures ANOVA, with drug dose and 
concentration of fluid as factors. Where there was no significant interaction between the 
two main factors, the main effect of drug collapsed across fluid concentration was 
considered. Post hoc comparisons to determine any significant differences between doses 
were made using a Dunnett's t-test. Statistical tests were performed using Super Anova 
and Statview SE-i-graphics (Abacus Concepts Inc., Berkeley, CA). A result was 
considered statistically significant if p < 0.05. 
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5.3 Results 
Experiment: 9: Microstructural analysis of the effect of midazolam on drinking for a 3% 
sucrose solution and a 1% Intra-lipid emulsion over a 20-min session 
Intake 
Figure 5.1 illustrates the effect of midazolam on intake (ml) of both sucrose and 
Intra-lipid in the 20-min test. A one-factor repeated-measures ANOVA revealed a 
significant effect of the drug in the sucrose group (F 3,27 = 3.17, p < 0.05). However, 
post hoc comparisons indicated that only the 3 mg/kg condition differed significantly 
from the vehicle condition (p < 0.05). For Intra-lipid drinking, midazolam did not 
significantly affect the volume consumed in the 20-min test (F 3, 27 = 0.4, n.s.). The 
baseline intake of 12 ml was not altered by drug administration. 
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Figure 5.1 Intake of sucrose and Intra-lipid in a 20-min test 
as a function of increasing dose of midazolam (0.3-3 mg/kg) -i-
S.E.M. Asterisk indicates significantly different from vehicle 
condition * p < 0.05 (Dunnett's t-test). 
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Rate of licking 
The effect of midazolam on the rate of licking for sucrose drinking at 1-min 
intervals is shown in Figure 5.2a. The rate of licking under the vehicle condition is 
compared with the rate of licking following administration of 3 mg/kg of midazolam. 
Figure 5.2b shows the rate of licking for Intra-lipid under the vehicle condition 
compared with the 3 mg/kg of midazolam condition. For both sucrose and Intra-lipid, an 
exponential decay function of the form y = Ae (-Bt) was fitted to the data. The parameters 
derived from the curve-fitting procedure are shown in Table 5.1. A Spearman correlation 
revealed that the function y= Ae (-Bt) provided a good description of the data. Midazolam 
affected both the initial rate of licking (A) and the rate constant (B). The 3 mg/kg dose of 
midazolam dramatically increased the initial rate of licking and increased the estimate of 
the slope function for both sucrose and Intra-lipid. 
Table 5.1 Parameter estimates and standard errors and for the least squares fit to the rate 
of licking of the function y = Ae (-Bt). 
Midazolam (mg/kg) 
Sucrose 
A B r 
0 
Estimate 
S.E. 
110.17 
6.29 
0.02 
0.005 
0.97 
3 
Estimate 
S.E. 
216.2 
21.0 
0.07 
0.01 
0.89 
Midazolam (mg/kg) 
Intra-lipid 
A B r 
0 
Estimate 
S.E. 
144.62 
21.1 
0.02 
0.008 
0.68 
3 
Estimate 
S.E. 
275.02 
15.7 
0.1 
0.009 
0.91 
Parameters A and B describe the intercept and rate constant respectively, r is the 
correlation coefficient for the actual and predicted values calculated using a Spearman 
correlation coefficient. 
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Figure 5.2 The effect of midazolam (3 mg/kg) on the rate 
of licking (licks per min) for a) sucrose and b) Intra-lipid. The 
lines are the least squares fit of the function y = Ae (-Bt) to the data. 
Open circles (O) indicate the vehicle condition, filled triangles (A) 
indicate the 3 mg/kg midazolam condition. 
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Number of licks 
The number of licks in the test session closely reflected the data for intake, so that 
for sucrose drinking, midazolam increased the overall number of licks during the test 
session (F 3,27 = 4.59, p < 0.01). Post hoc comparisons showed that only the 3 mg/kg 
dose produced a significant increase in the number of licks (p < 0.05). In the case of 
Intra-lipid drinking, there was no effect of the drug on the total number of licks in the 20-
min session (F 3^27 = 0.9, n.s.) (Figure 5.3). 
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Figure 5.3 Total number of licks for sucrose and Intra-lipid 
drinking in a 20-min test as a function of increasing dose of 
midazolam (0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly 
different from vehicle condition * p < 0.05 (Dunnett's t-test). 
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Microstructural analysis 
Mean bout duration Figure 5.4 indicates that for sucrose drinking, an increase 
in the dose of midazolam led to a slight increase in the mean bout duration, but this did 
not reach statistical significance (F 3,27 = 1 -26, n.s.). There was no effect of drug 
treatment on the mean bout duration for Intra-lipid drinking (F 3 27 = 0.3, n.s.) (Figure 
5.4). 
71 
3 
•0 
3 
0 
Si 
c 
n 
o 
5i 
3-
2-
0 
S u c r o s e Lipid 
Figure 5.4 Mean bout duration for sucrose and Intra-lipid 
drinking in a 20-min test as a function of increasing dose of 
midazolam (0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly 
different from vehicle condition * p < 0.05 (Dunnett's t-test). 
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Number of bouts Figure 5.5 shows that for sucrose drinking there was a 
significant effect of midazolam on the number of bouts elicited (F 3,27 = 3-07, p < 
0.05). Post hoc comparisons revealed that the 3 mg/kg dose of midazolam significantly 
increased bout number. No significant effects of midazolam on bout number were 
obtained for the Intra-lipid group, although there was a trend observed towards an 
increase in bout number with increasing dose of midazolam (F 3 27 = 1.2, n.s.) (Figure 
5.5). 
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Figure 5.5 Number of bouts for sucrose and Intra-lipid 
dr inking in a 20-min test as a funct ion of 
increasing dose of midazolam (0.3-3 mg/kg) -1- S.E.M. Asterisk 
indicates significantly different from vehicle condition * p < 0.05 
(Dunnett's t-test). 
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Intrabout lick rate The rate of licking within bouts (intrabout lick rate) for 
both the sucrose (F 3,27 = 9.98, p < 0.001) and Intra-lipid groups (F 3,27 = 44.5, p < 
0.001) was significantly affected by administration of midazolam. Increasing the dose of 
midazolam led to a dose-dependent decrease in the intrabout lick rate. Post hoc 
comparisons showed that this effect was significant at 1 mg/kg and 3 mg/kg of 
midazolam for both sucrose and Intra-lipid drinking (Figure 5.6). 
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Figure 5.6 Intrabout lick rate for sucrose and Intra-lipid 
drinking in a 20-min test as a function of increasing dose of 
midazolam (0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly 
different from vehicle condition * p < 0.05 ** p < 0.01 (Dunnett's 
t-test). 
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Latency Figure 5.7 shows the effect of midazolam on the latency to engage 
in drinking. Drug administration had no significant effect on this parameter for either 
sucrose (F 3,27 = 0.37, n.s.), or Intra-lipid drinking (F 3^27 = 0-91, n.s.). However, 
there was a tendency for latency to decrease with increasing dose of midazolam for both 
sucrose and Intra-lipid groups. 
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Figure 5.7 Latency for sucrose and Intra-lipid drinking 
in a 20-min test as a function of increasing dose of midazolam 
(0.3-3 mg/kg) + S.E.M. 
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Experiment 10: Microstructural analysis of the effect of midazolam on drinking for 
sucrose and Intra-lipid solutions in a brief contact test 
Rate of licking 
Midazolam had a significant effect on the rate of licking at the 1 % concentration of 
sucrose (F 3,27 = 8.29, p < 0.001). There were no significant effects of midazolam at 
either the 3% (F 3,27 = I -84, n.s.), 10% (F 3,27 = 1-85, n.s.) or 30% concentrations of 
sucrose (F 3, 27 = 1-53, n.s.). Figure 5.8a shows the effect of midazolam (0.3-3 mg/kg) 
on the rate of licking for the 1 % sucrose concentration. Midazolam increased the rate of 
licking after the first few seconds. At the 3 mg/kg dose of midazolam, there was a higher 
rate of licking compared with the control vehicle condition which was maintained 
throughout the test session 
The results for Intra-lipid drinking were similar for those obtained for sucrose 
drinking. There was a significant effect of midazolam on the rate of licking for Intra-lipid 
at the 1% concentration (F 2, is = 9.19, p < 0.001). However, there was no effect of 
midazolam on the rate of licking at either the 3% (F 2, is = 1-05, n.s.) or 10% 
concentrations of Intra-lipid (F 2,18 = 0.16, n.s.) The results for the 1% concentration of 
Intra-lipid are shown in Figure 5.8b. Midazolam stimulated an increase in the rate of 
licking for Intra-lipid after the first second of drinking, and led to a higher rate of licking 
compared with the vehicle condition for the rest of the test session. For both sucrose and 
Intra-iipid drinking there was a decline in the rate of licking across the test session which 
was evident for all conditions. This decline in the rate of licking was less marked 
following midazolam adminstration. 
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Figure 5.8 The average number of licks per second at Is 
intervals as a funcfion of increasing dose of midazolam (0.3-3 
m/kg) for a) 3% sucrose and b) 1% Intra-lipid in a brief contact 
test. Each dose is plotted separately. 
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Number of licks 
A two-way repeated-measures ANOVA revealed that for sucrose drinking there 
was a significant main effect for both drug dose (F 3,27 = 4.5, p < 0.01) and fluid 
concentration (F 3 27 = 135.23, p < 0.001) on the total number of licks. The main effect 
of drug on number of licks for sucrose is shown in Figure 5.9. Increasing the dose of 
midazolam led to a monotonic increase in the total number of licks. Table 5.2 shows that 
the total number of licks also increased monotonically as a function of increasing sucrose 
concentration. There was no significant drug-concentration interaction (F 9,81 = 1.7 
U . S . ) . 
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Figure 5.9 Total number of licks for sucrose drinking in a brief 
contact test as a function of increasing dose of midazolam (0.3-3 
mg/kg) + S.E.M. Asterisk indicates significantly different from 
vehicle condition ** p < 0.01 (Dunnett's t-test). 
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Midazolam significantly increased the number of licks for Intra-lipid drinking (F 
3,27 = 4.35, p < 0.01). There was also a main effect of concentration for Intra-lipid 
drinking (F 2,18 = 38.8, p < 0.001) and a drug-concentration interaction (F 6,54 = 3.5, 
p < 0.01). Figure 5.10 shows that this interaction probably arose because the effect of 
midazolam was more pronounced at 1% Intra-lipid. Midazolam did not increase the 
number of licks at 10% Intra-lipid perhaps due to ceiling effects. The effect of Intra-lipid 
concentration on the number of licks is shown in Table 5.2. Increasing Intra-lipid 
concentration led to an increase in the number of licks. 
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Figure 5.10 Total number of licks for Intra-lipid 
drinking in a brief contact test as a function of increasing dose of 
midazolam (0.3-3 mg/kg) -t- S.E.M. 
Table 5.2 Main effect of fluid concentration on total number of licks 
Total licks + S.E.M. 
Fluid 1% 3% 10% 30% 
Sucrose 57.8± 12.7 100.6+ 15.7 243.2± 18.5 320.7±8.0 
Intra-lipid 186.2± 18.4 270.5± 14.4 331.3±8.8 
n = 10 animals per group 
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Microstructural analysis 
Mean bout duration An increase in mean bout duration was observed as a 
function of increasing dose of midazolam (F 3,27 = 5.6, p < O.OI) (Figure 5.11). Mean 
bout duration was also an increasing function of sucrose concentration (F 3 27 = 10.32, 
p < 0.001) (Table 5.3). There was no main effect of drug on mean bout duration for 
Intra-lipid drinking, but Figure 5.11 shows that there was a trend towards an increase in 
mean bout duration with increasing dose of midazolam (F 3 ^7 = 1.9, n.s.). Mean bout 
duration increased with increasing concentration of Intra-lipid (F 2,18 = 13.16, p < 
0.001) (Table 5.3). There were no significant drug-concentration interactions for either 
sucrose (F 9,81 =0.6, n.s.) or Intra-lipid drinking (F 6,54 = 0.9, n.s.). 
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Figure 5.11 Mean bout duration for sucrose and Intra-lipid 
drinking in a brief contact test as a function of increasing dose of 
midazolam (0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly 
different from vehicle condition ** p < 0.01 (Dunnett's t-test). 
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Table 5.3 Main effect of fluid concentration on mean bout duration 
Mean bout duration (s) ± S.E.M. 
134 
Fluid 1% 3% 10% 30% 
Sucrose 1.5± 0.3 2.2± 0.3 4.2± 0.5 5.9± 0.8 
Intra-lipid 2.9± 0.3 5.4± 0.8 8.3± 1.2 
n = 10 animals per group 
Number of bouts For sucrose drinking, a two-way repeated-measures 
ANOVA did not reveal a main effect of drug (F 3,27 = 0.28, n.s.). The lack of effect of 
midazolam on the number of bouts for sucrose drinking is shown in Figure 5.12. 
However, there was a main effect of sucrose concentration on the number of bouts (F 
3,27 = 27, p < 0.001) (Table 5.4), but no interaction with drug dose (F 9,81 = 1.4, 
n.s.). An increase in sucrose concentration led to an increase in the number of bouts. 
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Figure 5.12 Number of bouts for sucrose drinking in a brief 
contact test as a function of increasing dose of midazolam (0.3-3 
mg/kg) -I- S.E.M. 
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In the case of Intra-lipid drinking, there was no main effect of either drug (F 3^ 27 
= 1.4, n.s.) or concentration (F 2,18 = 0-3, n.s.) on bout number. However, there was 
a significant interaction between these two factors (F 5,54 = 2.63, p < 0.05). Figure 5.13 
shows that this interaction arose because midazolam had differential effects at different 
concentrations of Intra-lipid. At the 1% concentration of Intra-lipid, increasing the dose 
of midazolam increased the number of bouts. At the 3% and 10% concentration 
conditions midazolam did not have any effect on bout number. 
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Figure 5.13 Number of bouts at different concentrations 
of Intra-lipid in a brief contact test as a function of increasing 
dose of midazolam (0.3-3 mg/kg)+ S.E.M. 
Table 5.4 Main effect of fluid concentration on number of bouts 
Number of bouts -f S.E.M. 
Fluid 1% 3% 10% 30% 
Sucrose 4.0± 0.4 6.3+ 0.5 10.2± 1.0 12.2±0.9 
Intra-lipid 9.9± 0.9 10.6±0.8 9.6± 0.8 
n = 10 animals per group 
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Intrabout lick rate There were significant main effects of drug dose on the 
intrabout lick rate for both sucrose (F 3,27 = 6.58, p < 0.001) and Intra-lipid (F 3,27 = 
24.4, p < 0.001) drinking, but no significant interactions: sucrose (F 9 gi = 1.2, n.s.); 
Intra-lipid (F 5 54 = 0.9, n.s.). As shown in Figure 5.14, midazolam dose-dependently 
decreased the intrabout lick rate for both sucrose and Intra-lipid drinking. For sucrose 
drinking there was no main effect of concentration on intrabout lick rate (F 3 27 = 0.6, 
U.S.) . For Intra-lipid drinking, increasing the concentration led to a decrease in the 
intrabout lick rate (F 2,18 = 6.2, p < 0.01) (Table 5.5.). 
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Figure 5.14 Intrabout lick rate for sucrose and Intra-lipid 
drinking in a brief contact test as a function of increasing dose of 
midazolam (0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly 
different from vehicle condition ** p < 0.01 (Dunnett's t-test). 
Table 5.5 Main effect of fluid concentration on intrabout lick rate 
Intrabout lick rate (1/s) ± S .E.M. 
Fluid 1% 3% 10% 30% 
Sucrose 6.4± 0.3 6.8± 0.2 6.1+ 0.1 6.6± 0.1 
Intra-lipid 6.5± 0.1 6.3± 0.1 6.3± 0.1 
n = 10 animals per group 
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Latency No significant effects of drug administration on latency were 
observed for either sucrose (F 3,27 = 0.14, n.s.) or Intra-lipid (F 3,27 = 0.28, n.s.) 
drinking (Figure 5.15). The effect on the latency to engage in drinking of increasing the 
concentration of sucrose and Intra-lipid is shown in Table 5.6. There were no main 
effects of concentration for either sucrose (F 3,27 = 1.4, n.s.) or Intra-lipid (F 2,18 = 
0.02, n.s.) or significant interactions. 
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Figure 5.15 Latency for sucrose and Intra-lipid drinking in a 
brief contact test as a function of increasing dose of midazolam 
(0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly different 
from vehicle condition ** p < 0.01 (Dunnett's t-test). 
Table 5.6 Main effect of fluid concentration on latency 
Latency (s) ± S.E.M. 
Fluid 1% 3% 10% 30% 
Sucrose ]2.2± 2.7 10.0± 1.9 6.1± 1.0 11.8± 3.2 
Intra-lipid 3.8± 1.1 4.2±1.4 3.8±2.0 
n = 10 animals per group 
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5.4 Discussion 
In this chapter a microstructural approach was employed to investigate the 
behavioural mechanisms responsible for the effects of the benzodiazepine agonist 
midazolam on ingestive behaviour. The effects of midazolam on the rate of licking and 
bout structure were compared with the effects of manipulating the concentration of 
sucrose and Intra-lipid. In a 20-min test session, (Experiment 9) midazolam affected the 
rate of licking in a manner similar to that observed when increasing concentration. In a 
brief contact test, (Experiment 10) midazolam increased mean bout duration, an effect 
which was also observed when increasing concentration. A second aim was to compare 
the effect of midazolam on the consumption of sucrose versus Intra-lipid. Despite 
differences in overall intake, the effects of this drug on the rate and microstructure of 
licking for Intra-lipid was quite similar to the effects observed for sucrose drinking. 
In Experiment 9, midazolam significantly increased the consumption of a 3% 
sucrose solution in a 20-min test. This result is consistent with previous findings which 
have demonstrated a hyperphagic effect of midazolam (Cooper et al., 1985) However, 
in Experiment 9, there was no significant effect of midazolam on intake of 1% Intra-lipid. 
This is the first report of the effect of a benzodiazepine agonist on fat consumption. The 
lack of effect of midazolam on Intra-lipid consumption cannot be explained by the fact 
that the rats were consuming at ceiling levels because the intake of Intra-lipid was 
approximately 15 ml, and rats have been shown to drink up to 25 ml of fluid in a 20-min 
test (Cooper and Green, 1993). From this, it might be concluded that midazolam-induced 
hyperphagia is limited to consumption of carbohydrate solutions. However, rate analysis 
showed that although midazolam did not increase intake of Intra-lipid, it did alter the 
pattern of ingestive responding for this fat in the early part of the test session, and this 
effect was similar to that observed for sucrose drinking. Midazolam increased the initial 
rate of licking for both sucrose and Intra-lipid drinking. There is evidence to suggest that 
the initial rate of licking is an appropriate measure of palatability. Davis and colleagues 
have shown that the initial lick rate increases as a function of increasing carbohydrate 
concentration (Davis and Levine, 1977; Davis and Smith, 1988). In Chapter 4, it was 
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shown that this measure also reflects changes in the palatability of Intra-lipid emulsions. 
The increase in the initial lick rate caused by midazolam suggests that it might be 
enhancing the palatability of both sucrose and Intra-lipid. It is possible that the effects of 
midazolam on palatability are responsible for the well-known hyperphagic effects of this 
drug. However, the data also suggest that changes in palatability may not always lead to 
an increase in intake, because despite similar effects of midazolam on the initial lick rate 
for sucrose and Intra-lipid, a hyperphagia was only observed for sucrose drinking. 
Possible reasons for this discrepancy wil l be discussed below. The results from 
Experiment 9 demonstrate the advantage of using rate analysis. The effect of midazolam 
on the pattern of ingestion for Intra-lipid would have been overlooked if intake had been 
the only measure. 
Midazolam also altered the rate of decline of licking across the test session. 
Increasing the dose of midazolam led to an increase in the rate constant for both sucrose 
and Intra-lipid drinking. This parameter probably reflects the emergence of an inhibitory 
negative feedback signal due to the accumulation of ingested material in the GI tract and 
consequent post-absorptive processes (Davis and Levine, 1977). For example, it has 
been shown that the more concentrated a sugar is, the steeper the slope of the rate 
function, due to more rapid accumulation in the stomach (Davis and Smith, 1988). The 
increase in the rate constant following midazolam adminstration may indicate that this 
drug affects the postingestive consequences of licking. However, the increase in the rate 
of decay of licking may also have occurred as a consequence of the increase in the initial 
rate of licking. A large increase in the initial rate would lead to faster accumulation of the 
fluid in the GI tract and so result in a greater rate of decline in licking. This may provide 
an explanation for the lack of effect of midazolam on Intra-lipid Intra-lipid intake, because 
the increase in the initial rate of licking may have lead to a very steep decline in the rate of 
licking thus opposing the initial stimulatory effect. This is supported by the fact that the 
slope estimate for Intra-lipid drinking was greater than that for sucrose drinking. 
From the microstructural analysis over the 20-min session it is not clear how the 
increase in lick rate caused by midazolam was achieved. For sucrose drinking, no 
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significant effect on mean bout duration was observed although there was a small trend 
towards an increase in mean bout duration with increasing dose of midazolam. 
Midazolam did significantly increase the number of bouts of sucrose drinking in the 20-
min session. For Intra-lipid drinking, there were no significant effects of midazolam on 
either mean bout duration or number of bouts. In the previous chapter it was shown that 
manipulating the concentration of sucrose and Intra-lipid did not have reliable effects on 
mean bout duration over a 20-min test. However, marked effects of concentration on this 
parameter were revealed when the test session was limited to 60s. A specific effect of 
midazolam on bout duration may have been limited to the early part of the test session. 
This possibility is discussed later with respect to the results of Experiment 10. 
In Experiment 9 midazolam had a dramatic effect on the intrabout lick rate for 
both sucrose and Intra-lipid in the 20-min session. There was a dose related decrease in 
the intrabout lick rate following midazolam administration. It has been shown previously 
that the benzodiazepine receptor agonist CDP also decreased the rate of eating for food 
pellets and powder (Cooper and Francis, 1979b). These results are consistent with the 
motor effects of benzodiazepine agonists when administered peripherally. Midazolam 
has muscle relaxant effects which probably interfered with the execution of the lick cycle 
and thus led to a reduction in the rate of licking within bouts. This possibility could be 
tested by using an electromyograph to measure muscle movements under midazolam 
treatment. The decrease in intrabout lick rate caused by midazolam may seem counter-
intuitive because this drug also increases the initial rate of licking when integrated over 
time. One explanation is that midazolam may have dual effects on ingestive behaviour. 
The effect of midazolam on the initial rate of licking may be related to changes in 
palatability, whereas the effect on the intrabout lick rate may be due to the muscle relaxant 
effects of the drug. It is possible that the mechanisms involved in these two effects may 
be different and further work is required to examine their neurochemical and anatomical 
bases. However, caution must be exercised in interpreting the effects of midazolam on 
intrabout lick rate because in the previous chapter it was shown that this parameter may 
also be affected by manipulating the concentration of the test solution. 
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There was no effect of midazolam on the latency to engage in drinking. This is the 
time from the shutter opening to the time that the animal makes the first lick. Latency 
could provide a measure of malaise or sedation, because if the rat was prevented from 
approaching the lick spout, this would be reflected in a longer latency. The lack of effect 
of midazolam on latency suggests that any sedation induced by the drug did not impair 
locomotor behaviour to the extent that it made it difficult for the animal to approach the 
lick spout. However, it has also been suggested that latency may. also reflect the 
motivation to feed. Increased motivation to feed might result in a shorter latency. 
Therefore, the results of experiment 9 may indicate that midazolam was not altering 
motivation to engage in licking. This result contrasts with previous reports of the effect of 
benzodiazepine receptor agonists on latency to feed. Cooper and Francis (1979b) found 
that CDP reduced latency to consume food pellets and powder suggesting that it may 
increase the motivation to feed. This discrepancy may have been due to the difference 
between the food types used. The conclusion to be drawn from this is that many different 
factors may influence the latency to feed, and so interpreting changes in this measure may 
be problematic. 
The results of Experiment 9 showed that the effects of midazolam were evident in 
the initial period of ingestion, and so Experiment 10 was designed to examine the 
microstructure of licking in the first 60s of drinking for both sucrose and Intra-lipid. An 
increase in the rate of licking for both sucrose and Intra-lipid was evident after the first 
few seconds of licking for these nutrients. For 1% sucrose and 1% Intra-lipid, the rate of 
licking under the vehicle condition declined over the 60s. The decline in the rate of licking 
was attenuated by treatment with midazolam, and this led to an increase in the total 
number of licks during the test session. The effect of midazolam on the rate of licking in 
60s was similar to that obtained when manipulating the concentration of sucrose and 
Intra-lipid in Experiment 8. This suggests that midazolam may have an effect on the 
immediate hedonic response to sucrose and Intra-lipid. This evidence is consistent with 
taste reactivity studies which have shown that midazolam has a rapid effect on the 
ingestive responding to fluids infused directly into the mouth, and provides further 
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evidence that benzodiazepines increase ingestion by enhancing palatability rather than 
affecting satiety processes. 
Midazolam increased the number of licks for both sucrose and Intra-lipid in the 
brief contact test, although for Intra-lipid, no increase in number of licks was observed at 
the 10% concentration due to ceiling effects. The increase in the total number of licks 
caused by midazolam was due to an effect on mean bout duration rather than the number 
of bouts. Midazolam caused a monotonic increase in the size of bouts for sucrose and 
Intra-lipid drinking, but did not systematically affect their number. Midazolam did 
increase bout number for Intra-lipid drinking, but this effect was only evident at the 
lowest concentration and there was no main effect of drug administration on bout 
number. Midazolam has been shown previously to increase the mean bout duration 
(Cooper and Yerbury, 1986b) in rats consuming solid food. Increasing the concentration 
of sucrose and Intra-lipid in Experiment 8 also increased bout duration. This suggests 
that midazolam might be affecting ingestive behaviour by increasing palatability. 
However, the effect of midazolam in Experiment 10 was not the same as the 
effect of manipulating concentration. Midazolam only increased mean bout duration, 
whereas increasing concentration affected both mean bout duration and bout number. 
This was not so in Experiment 8 when increasing concentration increased mean bout 
duration but did not affect bout number. The discrepancy between the effects of 
manipulating concentration in Experiment 10 (increase in mean bout duration and bout 
number) and the results obtained in Experiment 8 (selective increase in mean bout 
duration) may have been due to differences in the protocol. In Experiment 10, the rats 
were trained to consume all concentrations of sucrose and Intra-lipid over a period of 
approximately 10 days, whereas in Experiment 8 rats were trained on one concentration 
and then had access to the other concentrations for 2 days only. The effect of 
manipulating concentration on bout number in Experiment 10 may have been due to the 
experience the rats had with the test fluids. Repeated exposure to the test fluids may have 
affected an underiying process separate from palatability, which was then reflected in 
changes in bout number. It is possible that changes in bout number may be indicative of 
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changes in incentive salience. An increase in bout frequency means that an animal is 
returning to a stimulus more often and so may be indicative of an increase in the salience 
of that stimulus. Testing of this hypothesis requires investigation of the effects of 
manipulations which are thought to affect salience attribution on licking microstructure. 
The possibility that bout frequency may reflect changes in incentive salience is discussed 
further in Chapters 7 and 8 and in the General Discussion. 
The intrabout lick rate was reduced following administration of midazolam in the 
60s test. This is consistent with the effect of midazolam observed in Experiment 9. 
However, manipulating the concentration of Intra-lipid also decreased the intra-bout lick 
rate. This was not so for sucrose. In the previous chapter it was shown that manipulating 
fluid concentration can affect the rate of licking within bouts for both sucrose and Intra-
lipid. Taken together, this evidence suggests that the rate of licking within bouts may be 
affected by properties of the ingested solution such as viscosity and so may not provide a 
pure measure of motoric deficits. 
In Experiment 10 the latency to engage in drinking was not affected by 
midazolam. This is consistent with the lack of effect of midazolam on latency observed in 
Experiment 9. 
In summary, midazolam increased the initial rate of licking for both sucrose and 
Intra-lipid in a 20-min test, and increased mean bout duration over a range of 
concentrations in a brief contact test. The effect of midazolam on sucrose and Intra-lipid 
consumption was similar to the effects obtained when manipulating concentration. This is 
consistent with the possibility that benzodiazepine.agonists enhance palatability. The data 
also demonstrate that the increase in palatability caused by midazolam is not limited to 
prototypic taste stimuli but also applies to Intra-lipid drinking. 
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The effects of the imidazobenzodiazepine Ro 15-4513 on the 
microstructure of licking for either sucrose or Intra-lipid 
6.1 Introduction 
In addition to the category of benzodiazepine receptor agonists, there is another 
class of drugs which also bind with high affinity to benzodiazepine receptors, but 
produce effects that are opposite to those associated with classical agonists (Braestrup et 
al., 1982). Members of this latter category are referred to as inverse agonists. Instead of 
inducing hyperphagia, inverse agonists exhibit anorectic properties. Dose-related 
reductions in food intake in rats following administration of a number of benzodiazepine 
receptor inverse agonists have been shown in several studies (Cooper, et al., 1985; 
Cooper et al., 1989). A consequence of these opposing actions is that control over eating 
behaviour can be exerted bidirectionally through drug actions at benzodiazepine 
receptors. Agonists enhance food consumption, whereas inverse agonists reduce intake. 
In both cases, the effects of these two types of drugs can be blocked by selective 
benzodiazepine receptor antagonists (Cooper, 1986b; Cooper and Moores, 1985b). 
There has been a considerable amount of research into the behavioural and 
pharmacological characteristics of benzodiazepine-induced hyperphagia. Evidence 
suggests that benzodiazepine agonists may increase food intake by enhancing palatability 
(Berridge & Pecina, 1995). This hypothesis is supported by the results reported in 
Chapter 5 of this thesis. Investigation of the change in the rate of licking for sucrose and 
Intra-lipid solutions over a 20-min test (Experiment 9) showed that midazolam may 
increase food intake by increasing the initial rate of licking. Microstructural analysis in a 
brief contact test then showed that this initial stimulation of licking is due to an increase 
mean bout duration as opposed an increase in bout number (Experiment 10). The effects 
of midazolam were found to be similar to the effects obtained when manipulating 
concentration. This is consistent with the possibility that this drug alters palatability. 
Chapter 6 145 
In contrast, less is known about the behavioural characteristics of the anorectic 
effects of inverse agonists. The aim of Experiment 11 was to provide information 
concerning the behavioural mechanisms responsible for the anorectic action of 
benzodiazepine receptor inverse agonists. The effect of the inverse agonist Ro 15-4513 
on licking for sucrose and Intra-lipid in a brief contact test was examined and compared 
with the effects of manipulating concentration, and with the effects of midazolam. A brief 
contact test was used because it had been shown previously that this procedure allows 
rapid evaluation of the effects of drug manipulations on the licking responses to ingested 
fluids. It was predicted that the effects of Ro 15-4513 on the rate of licking and bout 
structure would be the inverse of the effects of increasing concentration. 
Experiment 11: Microstructural analysis of the effect of Ro 1S-4S13 on drinking for 
sucrose and Intra-lipid in a brief contact test 
6.2 Method 
6.2.1 Animals 
Twenty naive non-deprived adult male hooded Lister rats (Charles River, U.K.) 
weighing 300-350 g at the beginning of training were used. They were housed in pairs in 
plastic cages in a room with a constant room temperature of 21+2 °C, and were 
maintained under a 12h light:dark cycle (lights on at 08.00). Rats were allowed ad lib 
access to food pellets, (SDS RMI (E), Cambridge, U.K.) and water, except during 
testing. All testing was carried out in the light phase between 09.00 and 13.00h. 
6J^ Drugs 
The benzodiazepine partial inverse agonist Ro 15-4513 (ethyl-8-azido-5,6-
dihydro-5-methyl-6-oxo-4H-imidazo[ 1,5a][ 1,4]benzodiazepine-carboxylate) (Roche, 
Basel, Switzerland) was ultrasonically dispersed in distilled water to which Tween 80 
(BDH Chemicals Ltd. Poole, England) had been added. It was injected i.p. in a volume 
of 1 ml/kg, 20-min prior to experimentation. The doses used, were 0.3, 1 and 3 mg/kg of 
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Ro 15-4513, or its vehicle. These doses were chosen because it had been previously 
shown that 1-10 mg/kg of Ro 15-4513 is sufficient to induce a significant reduction in 
food intake (Cooper et al., 1989). 
6.2.3 Test meal 
Rats had access to various concentrations of sucrose solutions (granulated cane 
sugar) or Intra-lipid emulsions (Pharmacia Ltd, Milton Keynes, U.K.) which were made 
up freshly each day. The Intra-lipid emulsions were made up by diluting a 20% 
commercial preparation with tap water and the sucrose solution was made up to volume 
each day using tap water. 
6.2.4 Apparatus 
Testing was carried out using the MS80 multistation lickometer described in detail 
in the Chapter 4 (Section 4.2.3). 
6.2.5 Procedure 
Training Twenty rats were divided into two groups (n = 10 per group). 
Each group was well familiarized with the test apparatus and procedure. This involved 
placing each rat in the test chamber where they had access either to sucrose (1, 3 10 and 
30%) or to Intra-lipid (1,3 and 10%) solutions in a random order. Each concentration 
was presented for 60s, and a 10s interval intervened between subsequent presentations. 
This procedure was followed until steady baseline levels of licking were observed across 
days (approximately 10 days). Two days prior to testing each animal received a sham 
injection of distilled water to familiarize it with the injection procedure. 
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Testing Following the training period rats received i.p. injections of Ro 
15-4513 (0.3, 1 and 3 mg/kg) or vehicle. 20-min after injection of Ro 15-4513 the rats 
were placed in the lickometer chamber where they had access to all concentrations of 
either sucrose (1,3, 10 and 30%) or Intra-lipid (1,3 and 10%). Each concentration was 
presented for a total duration of 60s. The order of presentation was randomised. A 
repeated-measures design was used in which each animal was tested at each dose. 
Injections were counterbalanced and 48h elapsed between treatments to avoid carry-over 
effects. 
6.2.6 Data analysis 
The lick time data were analyzed as described in the Chapter 4 (section 4.2.5) 
using Dilog software written by Ross Henderson followed by further processing using a 
Microsoft Excel spreadsheet. The effect of Ro 15-4513 on the rate of licking at each 
concentration of sucrose and Intra-lipid was analyzed using a one-way repeated-measures 
ANOVA. 
Various microstructural variables were also examined: the total number of licks, 
mean bout duration, number of bouts, intrabout lick rate (licks per second within bouts) 
and latency to engage in drinking (time from shutter opening to first lick). The 
microstructural data were analyzed using a two-way repeated-measures ANOVA, with 
drug dose and concentration of fluid as factors. Where there was no significant 
interaction between the two main factors, the main effect of drug treatment collapsed 
across fluid concentration was considered. Post hoc comparisons to determine any 
significant differences between doses were made using a Dunnett's t-test. Statistical tests 
were performed using Super Anova and Statview SE+graphics (Abacus Concepts Inc., 
Berkeley, CA). A result was considered statistically significant if p < 0.05. 
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6.3 Results 
Rate of licking 
Ro 15-4513 had a significant effect on the rate of licking for the 1% (F 3,27 = 
3.61, p < 0.05) and 30% sucrose concentrations (F 3,27 = 7.77, p < 0.001). There was 
no effect of Ro 15-4513 on the rate of licking at the 3% (F 3,27 = 1 -4, n.s.) or the 10% 
concentrations of sucrose (F 3,27 = 1.83, n.s.). Fig 6.1a shows the effect of Ro 15-4513 
(0.3-3 mg/kg) on the rate of licking for the 30% concentration of sucrose. Ro 15-4513 
decreased the rate of licking after the first second. Ro 15-4513 caused a steeper rate of 
decline of licking compared with the vehicle control condition. 
The results for Intra-lipid drinking were similar to those obtained for sucrose 
drinking. There was a significant effect of Ro 15-4513 on the rate of licking for the 3% 
(F 2,18 = 3.38, p < 0.05) and 10% concentrations of Intra-lipid (F 2,18 = 4.71, p < 
0.01). There was no effect of Ro 15-4513 on the rate of licking for the 1% Intra-lipid 
concentration (F 2,13 = 1.8, n.s.). The results for the 10% concentration of Intra-lipid 
drinking for comparison with sucrose are shown in Figure 6.1b. The graph shows that 
Ro 15-4513 caused a significant decrease in the rate of licking after the first second of 
drinking and led to a steeper decline in the rate of licking over the 60s. 
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Figure 6.1 The average number of licks per second at 1 s 
intervals as a function of increasing dose of Ro 15-4513 (0.3-3 
mg/kg) for a) 30% sucrose and b) 10% Intra-lipid in a brief contact 
test. Each dose is plotted separately. 
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Number of licks 
A two-way repeated-measures ANOVA revealed that for sucrose drinking there 
was a significant main effect of both drug (F 3,27 = 4.23, p < 0.01) and concentration 
(F 3,27 = 138.58, p < 0.001) on the total number of licks. The main effect of drug on the 
number of licks for sucrose is shown in Figure 6.2. Ro 15-4513 decreased the number 
of licks in the test session. As shown in Table 6.1 increasing sucrose concentration had 
the opposite effect to increasing dose of Ro 15-4513, leading to an increase in the number 
of licks. Ro 15-4513 also significantly decreased the number of licks for Intra-lipid (F 
3 27 = 6.35, p < 0.01) (Figure 6.2). An increase in the concentration of Intra-lipid led to 
an increase in the number of licks (F 2,18 = 84.13, p < 0.001) (Table 6.1). There were 
no significant interactions between drug dose and concentration, for either sucrose (F g^ gi 
= 1.1, n.s.) or Intra-lipid (F 5 54 = 1.7, n.s.). The total number of licks for sucrose and 
Intra-lipid decreased as a function of increasing dose of Ro 15-4513. In contrast, 
increasing the concentration of both sucrose and Intra-lipid led to a monotonic increase in 
the number of licks. 
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Figure 6.2. Total number of licks for sucrose and Intra-lipid 
drinking in a brief contact test as a function of increasing dose of 
Ro-154513 (0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly 
different from vehicle * p < 0.05 ** p < 0.01 (Dunnett's t-test). 
Table 6.1 Main effect of fluid concentration on total number of licks 
Total licks ± S.E.M. 
Fluid 1% 3% 10% 30% 
Sucrose 25.4± 5.9 85.6± 10.2 239.6± 11.1 295.1± 10.3 
Intra-lipid 91.9± 10.2 196.2±9.6 311.5+ 9.5 
n = 10 animals per group 
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Microstructural analysis 
Mean bout duration Ro 15-4513 significantly decreased mean bout duration 
for sucrose drinking (F 3 27 = 3.2, p < 0.05) (Figure 6.3a). Post hoc analysis showed 
that the 1 mg/kg dose of Ro 15-4513 significantly decreased mean bout duration. The 
effect of Ro 15-4513 on Intra-lipid drinking was similar to that observed for sucrose 
drinking. An increase in the dose of Ro 15-4513 led to a significant reduction in mean 
bout duration for Intra-lipid drinking (F 3 27 = 7.8, p < 0.001). In addition to a main 
effect of drug there was also a significant main effect of concentration on mean bout 
duration for both sucrose and Intra-lipid drinking (Table 6.2). Mean bout duration was an 
increasing function of concentration for both sucrose (F 3,27 = 43.1, p < 0.001) and 
Intra-lipid (F 2,18 = 8.0, p < 0.01) drinking. There was no significant drug-
concentration interaction for sucrose drinking (F 9,81 = 0.8, n.s.), but there was a 
significant interaction for Intra-lipid drinking (F 6,54 = 3.1, p < 0.05) (Figure 6.3b). 
This interaction probably occurred because the effect of Ro 15-4513 was less marked at 
the 1 % concentration, perhaps due to floor effects. There was a trend towards decreasing 
mean bout duration following Ro 15-4513 administration at 1% Intra-lipid, but because 
the mean bout duration under the vehicle condition was only 2s on average, arty further 
reduction may have been precluded. 
Table 6.2 Main effect of fluid concentration on mean bout duration 
Mean bout duration (s) ± S.E.M. 
Fluid 1% 3% 10% 30% 
Sucrose 0.9± 0.2 1.5+ 0.1 3.2+ 0.3 3.3± 0.2 
Intra-lipid 2.1±0.2 3.5+ 0.4 9.2+ 1.7 
n = 10 animals per group 
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Figure 6.3 Mean bout duration for a) for sucrose and b) Intra-
lipid drinking in a brief contact test as a function of increasing dose 
of Ro 15-4513 (0.3-3 mg/kg) + S.E.M. Asterisk indicates 
significantly different from vehicle * p < 0.05 (Dunnett's t-test). 
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Number of bouts Ro 15-4513 did not significantly affect the number of 
bouts for sucrose drinking (F 3,27 = 0.23, n.s.) (Figure 6.4). In contrast, Table 6.3 
shows that an increase in sucrose concentration led to a significant increase in bout 
number (F 3 27 = 36, p < 0.001). There was no significant drug-concentration 
interaction (F 9,81 = 1.4, n.s.). The number of bouts for Intra-lipid drinking was 
significantly affected by manipulating both drug dose (F 3,27 = 3.3, p < 0.05) and 
concentration (F 2,18 = 4, p < 0.05), although there was no significant interaction 
between these two factors (F 5,54 = 1-7, n.s.). Ro 15-4513 increased the number of 
bouts for Intra-lipid drinking (Figure 6.4). An increase in the Intra-lipid concentration 
also led to an increase in bout number (Table 6.3). 
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Figure 6.4 Number of bouts for sucrose and Intra-lipid drinking 
in a brief contact test as a function of increasing dose of Ro 15-4513 
(0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly different 
from vehicle ** p < 0.01 (Dunnett's t-test). 
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Table 6.3 Main effect of fluid concentration on number of bouts 
Number of bouts + S.E.M. 
Fluid 1% 3% 10% 30% 
Sucrose 2.6± 0.5 6.6+ 0.7 10.7± 0.8 13.9+ 0.6 
Intra-lipid 6.4± 0.5 9.3± 0.9 9.0+ 0.8 
n = 10 animals per group 
Intrabout lick rate There was no effect of Ro 15-4513 on intrabout lick rate 
for sucrose drinking (F 3^27 = 1.7, n.s.) However, an increase in sucrose concentration 
led to a significant decrease in intrabout lick rate (F 3 27 = 7.8, p < 0.001) (Table 6.4.). 
The rate of licking within bouts for Intra-lipid was significantly decreased by Ro 15-4513 
(F 3,27 = 6.0, p < 0.01) (Figure 6.4). Decreasing Intra-lipid concentration also decreased 
the rate of licking within bouts (F 2,18 = 5.4, p < 0.01) (Table 6.4). There were no 
significant drug-concentration interactions observed for either sucrose (F g^ g] = 1.5, 
n.s.) or Intra-lipid drinking (F 6,54 = 2.1, n.s.) 
Chapter 6 156 
o 
3 
0 
(S 
Sucrose Lipid 
Figure 6.6 Intrabout lick rate for sucrose and Intra-lipid drinking 
in a brief contact test as a function of increasing dose of Ro 15-
4513 (0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly 
different from vehicle * p < 0.05 ** p < 0.01 (Dunnett's t-test). 
Table 6.4 Main effect of fluid concentration on intrabout lick rate 
Intrabout lick rate (l/s) ± S.B.M. 
Fluid 1% 3% 10% 30% 
Sucrose 7.0± 0.2 7.3± 0.1 6.8± 0.1 6.6± 0.06 
Intra-lipid 6.6± 0.1 6.3±0.1 6.2±0.1 
n = 10 animals per group 
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Latency The latency to engage in sucrose drinking was significantly 
affected by both drug dose (F 3^ 27 = 3.0, p < 0.05) and concentration (F 3,27 = 4.2, p 
< 0.01). Figure 6.7 shows that increasing the dose of Ro 15-4513 led to an increase in 
the latency. In contrast, an increase sucrose concentration led to a decrease in latency 
(Table 6.5). There was no main effect of drug on latency for Intra-lipid drinking (F 3 27 = 
1.6, n.s.), although there was a trend for the latency to increase with increasing dose of 
Ro 15-4513 (Figure 6.7). There was a significant decrease in latency when Intra-lipid 
concentration was increased (F 2,18 = 7.02, p < 0.01) (Table 6.5). There were no 
significant drug-concentration interactions for either sucrose (F 9,81 = 0.7, n.s.) or Intra-
lipid drinking (F 5 54 = 0.9, n.s.). 
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Figure 6.7 Latency for sucrose and Intra-lipid drinking in a 
brief contact test as a function of increasing dose of Ro 15-4513 
(0.3-3 mg/kg) + S.E.M. Asterisk indicates significantly different 
from vehicle ** p < 0.01 (Dunnett's t-test). 
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Table 6.5 Main effect of fluid concentration on latency 
Latency (s) ± S.E.M. 
Fluid 1% 3% 10% 30% 
Sucrose 25.2± 5.6 23.6± 8.4 6.4± 1.6 5.0± 0.7 
Intra-lipid 20.4± 5.9 5.8 ±1.7 3.1±0.9 
n = 10 animals per group 
6.4 Discussion 
Experiment 11 showed that the benzodiazepine receptor inverse agortist Ro 15-
4513 reduced the total number of licks for a range of concentrations of both sucrose and 
Intra-lipid in a brief contact test. This result is consistent with earlier findings which have 
demonstrated an anorectic effect of this compound (Cooper et al., 1985; Cooper et al., 
1989). Rate analysis showed that the effect of Ro 15-4513 was evident within the first 
few seconds of licking. Additionally, microstructural analysis indicated that the decrease 
in the number of licks brought about by Ro 15-4513 was due to a reduction in mean bout 
duration as opposed to reduction in bout number. The effect of Ro 15-4513 on licking 
was the converse to that obtained when concentration was increased. 
In the present experiment, Ro 15-4513 decreased the rate of licking over the 60s 
second test session and this effect was evident after the first second. Increasing the dose 
of Ro 15-4513 also led to a more rapid decline in the rate of licking over 60s. In Chapter 
4 it was shown that an increase in the concentration of sucrose and Intra-lipid led to an 
increase in the rate of licking after the first few seconds. Therefore, the effect of 
increasing the dose of Ro 15-4513 was opposite to that observed when increasing 
concentration. This suggests that Ro 15-4513 may have acted to reduce the palatability of 
the ingested fluids. 
There is further evidence which supports this interpretation, based on the effects 
of Ro 15-4513 on the microstructure of licking for sucrose and Intra-lipid. The decrease 
in the number of licks was due to a decrease in the duration of bouts rather than a 
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decrease in their number. Ro 15-4513 significantly decreased mean bout duration for 
sucrose drinking but did not affect the number of bouts. Therefore, following Ro 15-
4513 administration rats took the same number of bouts but these bouts were shorter. For 
Intra-lipid drinking, Ro 15-4513 also decreased mean bout duration although this effect 
was more pronounced at higher concentrations due to floor effects at lower 
concentrations of Intra-lipid. Ro 15-4513 actually increased the number of bouts for 
Intra-lipid. However, the increase in bout number was not sufficient to overcome the 
decrease in mean bout duration because there was an overall decrease in the total number 
of licks. The reason for this increase is not clear, but one possibility is that there was a 
compensatory increase in bout number which occurred as a result of the decrease in bout 
duration. The results from previous experiments suggest that in brief contact test mean 
bout duration provides a measure of palatability (See Chapter 4; Davis and Smith 1992). 
Therefore the data from Experiment 11 suggest that Ro 15-4513 may reduce palatability. 
It is also possible that the decrease in the number of licks caused by Ro 15-4513 
occurred as a result of this drug affecting the ability of the rats to perform the necessary 
motor patterns to lick properly. This possibility was examined by measuring the rate of 
licking within bouts. The intrabout lick rate has been shown to be affected by moving the 
drinking spout further away from an animal but not by manipulating concentration 
(Davis and Smith, 1992). Therefore, intrabout lick rate has been suggested to provide a 
measure of motor incapacitation. The effect of Ro 15-4513 administration in Experiment 
11 on this measure was dependent on the type of test fluid. There was no significant 
effect of Ro 15-4513 on intrabout lick rate for sucrose drinking. However, Ro 15-4513 
dose-dependently reduced the rate of licking within bouts for Intra-lipid drinking. This 
suggests that Ro 15-4513 may be having a deleterious effect on the motor control of 
licking and that licking for Intra-lipid may be more sensitive to these effects. However, 
the results also suggest that the possible motor impairing effects of Ro 15-4513 cannot 
account for the anorectic effect of this compound because Ro 15-4513 reduced the 
number of licks for both sucrose and Intra-lipid but only affected the intrabout lick rate 
for Intra-lipid. One problem with interpreting the effect of Ro 15-4513 on intrabout lick 
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rate is that it was also shown in Experiment 11 that manipulating concentration affected 
this variable. Increasing the concentration of sucrose and Intra-lipid led to a decrease in 
the intrabout lick rate. This suggests that intrabout lick rate may not only reflect changes 
in motor capacity but also other factors related to changes in concentration. Therefore, the 
effects of Ro 15-4513 on intrabout lick rate should be interpreted with caution. 
The latency to engage in sucrose drinking was significantly increased by Ro 15-
4513 administration. There was a trend towards an increase in latency for Intra-lipid 
drinking although this did not reach significance. This suggests that Ro 15-4513 may 
have affected either the rat's motor capacity, or motivation to drink. However, there was 
also a significant effect of fluid concentration on latency. Increasing concentration led to a 
decrease in the latency to engage in drinking; It has been suggested that olfactory cues 
may be responsible for effects of concentration on latency. Using a brief contact test, 
Rhinehart-Doty and colleagues (Rhinehart-Doty, Schumm, Smith and Smith, 1994) 
found an inverse relationship between sucrose concentration and latency in a brief contact 
test. They went on to demonstrate that i f olfactory cues were masked, this relationship 
was no longer evident. This suggests that the animals were using olfactory cues to decide 
when to engage in drinking. It is possible that the effect of Ro 15-4513 on latency was 
due to an effect on these olfactory cues. The rats may have been discriminating between 
the test fluids on the basis of olfaction and Ro 15-4513 may have affected this 
discrimination. 
The proposal that the anorectic effect of Ro 15-4513 results from a change in 
palatability fits in with the notion of bidirectional control of ingestive behaviour mediated 
by specific benzodiazepine receptors, as first proposed by Cooper (1985b). According to 
this theory, the effects of benzodiazepine receptor inverse agonists on feeding should be 
opposite to that of classical agonists. It has recently been argued that benzodiazepine 
receptor agonists may exert their effects on feeding behaviour by modulating palatability 
(Berridge and Pecina, 1995). This conclusion is supported by the effect of midazolam on 
the microstructure of licking for sucrose and Intra-lipid reported earlier in Chapter 5. In 
Experiment 10, midazolam increased the number of licks by increasing the mean bout 
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duration. This effect is consistent with the proposal that midazolam enhances palatability. 
The effect of Ro 15-4513 on sucrose and Intra-lipid consumption was the opposite to that 
observed as a result of midazolam administration. In the experiment reported in this 
chapter, Ro 15-4513 decreased the total number of licks by decreasing the mean bout 
duration. This result consistent with the proposed bidirectional control of feeding, 
because it suggests that benzodiazepine receptor inverse agonists decrease consumption 
as a consequence of a reduction in the palatability of ingested foods. 
In summary, Ro 15-4513 decreased the number of licks for sucrose and Intra-
lipid in a brief contact test. The decrease in total licks was due to a decrease in mean bout 
duration. This suggests that Ro 15-4513 may reduce intake by reducing palatability. 
These data support the proposal that ingestive behaviour can be affected bidirectionally at 
the level of the benzodiazepine receptor. Ro 15-4513 may induce some motor 
impairments because the rate of licking for Intra-lipid was slowed following drug 
treatment. However, this effect cannot account for the decrease in number of licks also 
observed. Ro 15-4513 reduced the latency to engage in drinking and this may have been 
to an effect on olfactory cues related to the test fluids. 
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The effects of morphine and naloxone on the microstructure of 
licking for Intra-lipid 
7.1 Introduction 
There is much evidence to suggest a role for endogenous opioids in the control of 
food intake. Opioid agonists have been shown to increase food intake under a variety of 
experimental conditions (Martin, Wikler, Fades and Pescor, 1963; Gosnell et al., 1983; 
Morley et al., 1982; Sanger and McCarthy, 1980). Conversely, many studies have 
shown that opioid antagonists inhibit food intake (Cooper, 1980b; Holtzman, 1974, 
1975; Margules et al., 1978). The effectiveness of intracerebroventricular injections of 
opioid agonists in increasing food intake suggests a central site of action for these drugs 
on ingestive behaviour (Gosnell et al., 1986; Levine, Grace and Billington, 1991; Morley 
and Levine, 1983). This is supported by the finding that the quaternary form of 
naloxone, which does not pass the blood brain barrier, is ineffective in tests of ingestive 
behaviour (Brown and Holtzman, 1981; Cooper and Turkish, 1983). 
Research into the behavioural mechanisms underlying the effects of opioids on 
ingestive behaviour suggests that they alter ingestive behaviour by modulating reward or 
palatability. For example, opioid agonists have been shown to increase preference for 
saccharin over water in water-deprived rats (Calcagnetti and Reid, 1983). Opioid 
antagonists on the other hand reduce saccharin preference (Cooper, 1983b; Le Magnen et 
al., 1980; Siviy and Reid, 1983). Additionally, opioid antagonists decrease sucrose 
sham feeding in rats (Kirkham, 1990; Kirkham and Cooper, 1988a,b; Rockwood and 
Reid, 1982). The effects of morphine in the taste reactivity test also supports the 
hypothesis that opioid agonists increase food intake by altering palatability. Morphine has 
been shown to enhance positive hedonic responding to sucrose in rats (Doyle et al., 
1993; Rideout and Parker, 1996). The results of these studies suggest that the 
determination of palatability may depend on endogenous opioid activity. 
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The explanations which have been put forward to account for the effects of 
opioids on ingestive behaviour are similar to those developed to explain the effects of 
benzodiazepines. Opioid receptor agonists and benzodiazepines have similar effects in 
taste preference, sham feeding and taste reactivity tests. This suggests that both classes of 
drug may affect palatability mechanisms. The similarities between the effects of opioids 
and benzodiazepines on ingestive behaviour makes the suggestion of a putative 
interaction between the two appealing. It has been proposed that the hedonic response to 
food-stuffs may be affected by benzodiazepine receptor ligands, which then leads to the 
release of endogenous opioid peptides (Cooper, 1983a). 
The aim of the experiments reported in this chapter was to investigate this 
hypothesis further by comparing the effects of benzodiazepine receptor ligands on the 
microstructure of licking with those of the opioid agonist morphine and the opioid 
antagonist naloxone. The effects of benzodiazepine receptor ligands on the pattern of 
licking for sucrose and Intra-lipid have been reported in previous chapters. In Experiment 
10, it was shown that the benzodiazepine receptor agonist midazolam increased the 
number of licks for sucrose and Intra-lipid in a brief contact test by increasing the mean 
bout duration. The benzodiazepine receptor inverse agonist Ro 15-4513 had the opposite 
effect in Experiment 11, reducing the total number of licks by decreasing mean bout 
duration. These results are consistent with the hypothesis that benzodiazepines alter food 
intake by enhancing palatability. 
I f the effects of benzodiazepines on palatability are mediated by changes in the 
release of endogenous opioids then we should expect the effects of morphine on 
responding for Intra-lipid to be similar to that of midazolam, and the effects of naloxone 
should be similar to the effects of Ro 15-4513. Such similarities would also provide 
further evidence to support a possible interrelation between opioids and benzodiazepines 
in the control of ingestion. Experiment 12 was designed to examine the effect of 
morphine (0.3-3 mg/kg) administration on the licking responses for three concentrations 
of Intra-lipid in a brief contact test. The effect of naloxone (0.3-3 mg/kg) was then 
investigated under the same conditions (Experiment 13). 
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7.2 Method 
7.2.1 Animals 
Twenty one naive non-deprived adult male hooded Lister rats (Charles River, 
U.K.) weighing 300-350 g at the beginning of training were used. They were housed in 
pairs in plastic cages in a room with a constant room temperature of 21+2 °C, and were 
maintained under a 12h light:dark cycle (lights on at 08.00). Rats were allowed ad lib 
access to food pellets, (SDS RMI (E), Cambridge, U.K.) and water, except during 
testing. Al l testing was carried out in the light phase between 09.00 and 13.00h. 
7.2.2 Drugs 
Morphine sulphate (Macfarland Smith, Edinburgh, U.K.) was dissolved in 
distilled water and injected subcutaneously (s.c.) in a volume of 1 ml/kg, 60-min prior to 
experimentation. The doses were 0.3, 1 and 3 mg/kg of morphine or its vehicle. These 
doses were chosen because it had been previously shown that morphine can stimulate 
intake in non-deprived rats over this dose range (Sanger and McCarthy, 1980). An 
injection-test period of 60-min was used because morphine has been shown to decrease 
food intake up to 60-min following injection effect, probably due to the sedative effects 
of this drug (Lesham, 1988). Increases in intake are then observed once the initial 
sedative effect has worn o f f Naloxone hydrochloride, at doses of 0.3, 1 and 3 m/kg 
(Sterling Winthrop, U.K.) was dissolved in distilled water and injected i.p. in a volume 
of 1 ml/kg, 20-min prior to testing. This dose range was used because previous studies 
have demonstrated a decrease in food intake in nort-deprived rats using similar doses 
(Cooper, 1980). 
7.2.3 Test meal 
Rats had access to various concentrations of Intra-lipid emulsions (Pharmacia 
Ltd, Milton Keynes, U.K.) which were made up freshly each day. The Intra-lipid 
emulsions were made up by diluting a 20% commercial preparation with tap water. 
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7.2.4 Apparatus 
Testing was carried out using the MS80 multistation lickometer described in detail 
in the Chapter 4 (Section 4.2.3). 
7.2.5 Procedure 
Experiment 12: Microstructural analysis of the effect of morphine on drinking for Intra-
lipid in a brief contact test 
Training Ten rats were first well familiarized with the test apparatus and 
procedure. This involved placing each rat in the test chamber were they had access to a 
range of Intra-lipid emulsions (1,3 and 10%) in a random order. Each concentration was 
presented for 60s and a 10s interval intervened between subsequent presentations. This 
procedure continued until steady baseline levels of licking were observed across days 
(approximately 10 days). Two days prior to testing each rat received a sham injection of 
distilled water to familiarize it with the injection procedure. 
Testing Following the familiarization period rats received s.c. injections of 
morphine (0.3, 1 and 3 mg/kg) or vehicle. 60-min after injection of morphine the rats 
were placed in the lickometer chamber where they had access to all concentrations of 
Intra-lipid (1,3 and 10%). Each concentration was presented for a total duration of 60s. 
The order of presentation was randomised. A repeated-measures design was used in 
which each rat was tested at every dose. Injections were counterbalanced and 48h 
elapsed between treatment to avoid carry-over effects. 
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Experiment: 13: Microstructural analysis of the effect of naloxone on drinking for 
sucrose and Intra-lipid in a brief contact test 
Training Eleven rats were familiarized with the test procedure and apparatus 
according to the procedure described for Experiment 12. 
Testing Following the familiarization period rats received i.p. injections of 
naloxone (0.3, 1 and 3 mg/kg) or vehicle. 20-min after injection of naloxone the rats 
were placed in the lickometer chamber where they had access to all concentrations of 
Intra-lipid (1, 3 and 10%). Each concentration was presented for a total duration of 60s. 
The order of presentation was randomised. A repeated-measures design was used in 
which each rat was tested at every dose. Injections were counterbalanced and 48h elapsed 
between treatment. 
7.2.6 Data analysis 
The lick time data were analyzed as described in the Chapter 4 (Section 4.2.5) 
using Dilog software written by Ross Henderson followed by further processing using a 
Microsoft Excel spreadsheet. The main effect of drug treatment on the rate of licking at 
each concentration of Intra-lipid was analyzed using a one-way repeated-measures 
ANOVA. 
Various microstructural variables were also examined: the total number of licks, 
mean bout duration, number of bouts, intrabout lick rate (licks per second within bouts) 
and latency to engage in drinking (time from shutter opening to first li.ck). The 
microstructural data were analyzed using a two-way repeated-measures ANOVA, with 
drug dose and fluid concentration as factors. Where there was no significant interaction 
between the two main factors, the effect of drug collapsed across concentration was 
considered. Post hoc comparisons to determine any significartt differences between doses 
were made using a Dunnett's t-test. Statistical tests were performed using Super Anova 
and Statview SE+graphics (Abacus Concepts Inc., Berkeley, CA). A result was 
considered statistically significant if p < 0.05. 
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7.3 Results 
Experiment: 12: Microstructural analysis of the effect of morphine on drinking for Intra-
lipid in a brief contact test 
Rate of licking 
A one-way repeated-measures ANOVA showed that there was a significant effect 
of morphine on the rate of licking at the 1 % Intra-lipid concentration (F 3,30 = 3.48, p < 
0.05). There was no effect of morphine administration on the rate of licking at the 3% (F 
330 = 1-36, n.s.) or the 10% concentration of Intra-lipid (F 330 = 0.85, n.s.). The effect 
of morphine on the rate of licking for the 1% concentration of Intra-lipid is shown in 
Figure 7.1. There was a decrease in the initial rate of licking as a result of treatment with 
morphine (0.3-3 mg/kg). After 20s of licking, morphine (3 mg/kg) stimulated a higher 
rate of licking relative to the control vehicle condition. This higher rate of licking was 
then maintained for the remainder of the test session. 
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Figure 7.1 The average number of licks per second at 1 s 
intervals as a function of increasing dose of morphine (0.3-3 m/kg) 
for 1% Intra-lipid in a brief contact test. Each dose is 
plotted separately 
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Number of licks 
There was a significant main effect of pretreatment with morphine on the total 
number of licks for Intra-lipid (F 330 = 3.2, p < 0.05). Figure 7.2 shows the effect of 
morphine on the number of licks. Increasing the dose of morphine led to an increase in 
the total number of licks. There was also a main effect of concentration (F 2,20 = 56.2, p 
< 0.001), with total licks increasing as a function of increasing concentration (Table 7.1). 
However, there was no significant drug-concentration interaction (F 6,60 = 1 -8, n.s.). 
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Figure 7.2 The number of licks for Intra-lipid drinking in a 
brief contact test as a function of increasing dose of morphine (0.3-
3 mg/kg) + S.E.M. Asterisk indicates significantly different from 
vehicle * p < 0.05 (Dunnett's t-test). 
Table 7.1 Main effect of Intra-lipid concentration on total number of licks 
Total licks + S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 114.7± 11.5 198.5± 13.7 282.9± 11.1 
n = 10 animals per group 
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Microstructural analysis 
Mean bout duration There was a significant main effect of drug on mean bout 
duration (F 3,30 = 4.7, p < 0.01) (Figure 7.3). However, the effect of morphine on this 
parameter was opposite to the effect on total number of licks shown in Figure 7.2. 
Increasing the dose of morphine led to a significant decrease in the mean bout duration. 
Table 7.2 shows that an increase in concentration led to an increase the duration of bouts 
(F 2,20 = 9.7, p < 0.001). There was no significant interaction between drug and 
concentration on mean bout duration (F 6,60 = 1> n-s ). 
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Figure 7.3 Mean bout duration for Intra-lipid drinking in a brief 
contact test as a function of increasing dose of morphine (0.3-3 
mg/kg) + S.E.M. Asterisk indicates significantly different from 
vehicle * p < 0.05 ** p < 0.01 (Dunnett's t-test). 
Table 7.2 Main effect of Intra-lipid concentration on mean bout duration 
Mean bout duration (s) + S .E.M. 
Concentration 1% 3% 10% 
Intra-lipid 1.5± 0.1 1.9±0.2 2.6± 0.3 
n = 10 animals pei • group 
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Bout number The increase in the total number of licks was probably due to an 
effect on bout number rather than bout duration. Morphine dose-dependently increased 
bout number (F 3,30 = 26.9, p < 0.001) (Figure 7.4). A post hoc test revealed that the 
1 mg/kg and 3 mg/kg doses of morphine produced a significant increase in bout number 
(p < 0.01). Manipulating the concentration of Intra-lipid also had significant effects on 
bout number (F 2,20 = 37.9, p < 0.001). An increase in Intra-lipid concentration led to 
an increase in the number of bouts (Table 7.3). No significant interactions were observed 
between drug dose and concentration on bout number (F 5,60 = 1-5, n.s.). 
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Figure 7.4 Number of bouts for Intra-lipid drinking in a brief 
contact test as a function of increasing dose of morphine (0.3-3 
mg/kg) + S.E.M. Asterisk indicates significantly different from 
vehicle * p < 0.05 ** p < 0.01 (Dunnett's t-test). 
Table 7.3 Main effect of Intra-lipid concentration on bout number 
Number of bouts ± S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 9.9± 0.8 16.0± 1.2 17.6± 0.9 
n = 10 animals per group 
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Intrabout lick rate As shown in Figure 7.5, there was a significant main 
effect of drug on the rate of licking within bouts (F 3,30 = 22.3, p < 0.001), although a 
Dunnett's t-test showed that only the 3 mg/kg dose differed significantly from the vehicle 
condition (p < 0.01). Manipulating concentration also significantly affected the intrabout 
lick rate (F 2,20 = 32.8, p < 0.001). Increasing concentration led to a decrease in the 
intrabout lick rate (Table 7.4). The lack of a significant interaction term showed that the 
effect of morphine was constant at all levels of concentration (F 6,60 = 1 -7, n.s.). 
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Figure 7.5 Intrabout lick rate for Intra-lipid drinking in a brief 
contact test as a function of increasing dose of morphine (0.3-3 
mg/kg) + S.E.M. Asterisk indicates significantly different from 
vehicle ** p < 0.01 (Dunnett's t-test). 
Table 7.4 Main effect of Intra-lipid concentration on intrabout lick rate 
Intrabout lick rate (l/s)+ S. E.M. 
Concentration 1% 3% 10% 
Intra-lipid 7.2± 0.1 6.8± 0.1 6.6+ 0.07 
n = 10 animals per group 
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Latency Morphine did not significantly affect the latency to engage in 
drinking (F 3,30 = 1.2, n.s.). However, there was a trend towards a decrease in latency 
with increasing dose of morphine (Figure 7.6). There was a significant main effect of 
concentration on latency (F 2,20 = 3.9, p < 0.05). Table 7.5 shows that there was an 
inverse relationship between latency to engage in drinking and concentration. There was 
no significant drug-concentration interaction observed for this parameter (F 6,60 = 0.8, 
n.s.). 
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Figure 7.6 Latency for Intra-lipid drinking in a brief contact 
test as a function of increasing dose of morphine (0.3-3 mg/kg) + 
S.E.M. 
Table 7.5 Main effect of Intra-lipid concentration on latency 
Latency (s) ± S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 32.4±8.1 15.2±6 5.9± 1.4 
n = 10 animals pei group 
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Experiment: 13: Microstructural analysis of the effect of naloxone on drinking for 
sucrose and Intra-lipid in a brief contact test 
Rate of licking 
There were no significant effects of naloxone on the rate of licking over 60s for 
either the 1% (F 3,30 = 1.65, n.s.), 3% (F 3,30 = 1.8, n.s.), or 10% concentration of 
Intra-lipid (F 3,30 = 1-47, n.s.). Figure 7.7 shows the effect of naloxone on 1% Intra-
lipid for comparison with the effects of morphine. 
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Figure 7.7 The average number of licks per second at 1 s 
intervals as a function of increasing dose of morphine (0.3-3 m/kg) 
for 1% Intra-lipid in a brief contact test. Each dose is plotted 
separately. 
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Number of licks 
As shown in Figure 7.8, naloxone brought about a decrease in the total number of 
licks (F 3,30 = 5.2, p < 0.01). Post hoc analysis showed that only the 3 mg/kg dose of 
naloxone significantly decreased the number of licks (p < 0.01). There was a main effect 
of manipulating Intra-lipid concentration on the total number of licks (F 2,20 = 83.7, p < 
0.(X)1). An increase in concentration led to an increase in the total number of licks (Table 
7.6). There was no significant drug-concentration interaction (F 6,60 = 0.8, n.s.). 
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Figure 7.8 The number of licks for Intra-lipid drinking in a 
brief contact test as a function of increasing dose of naloxone (0.3 -
3 mg/kg) + S.E.M. Asterisk indicates significantly different from 
vehicle ** p < 0.01 (Dunnett's t-test). 
Table 7.6 Main effect of Intra-lipid concentration on total licks 
Total licks + S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 32.6±6.1 97.6± 13.( 3 238.7+ 11.8 
n = 11 animals pei • group 
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Microstructural analysis 
Mean bout duration Figure 7.9 shows the effect of naloxone on the mean bout 
duration. Naloxone did not significantly affect mean bout duration (F 3,30 = 0.4, n.s.). 
There was a significant main effect of concentration on mean bout duration (F 2,20 = 
42.2, p < 0.001). An increase in concentration of Intra-lipid led to a monotonic increase 
in the mean bout duration (Table 7.7). There was no interaction between drug and 
concentration on mean bout duration (F 6,60 = 0-6, n.s.). 
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Figure 7.9 Mean bout duration for Intra-lipid drinking in a brief 
contact test as a function of increasing dose of naloxone (0.3-3 
mg/kg) + S.E.M. 
Table 7.7 Main effect of Intra-lipid concentration on mean 
bout duration 
Mean bout duration (s) ± S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 1.0±0.09 1.4±0.1 2.5±.0.2 
n = 11 animals per group 
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Bout number Naloxone significantly deceased the number of bouts in the 
test session (F 3,30 = 7.9, p < 0.001) (Figure 7.10). Post hoc analysis showed that the 
3 mg/kg dose significantly reduced bout number (p < 0 01). Therefore, the decrease in 
the number of licks was due to a decrease in the number of bouts as opposed to their 
duration. The main effect of concentration (F 2,20 = 44.3, p < 0.001) is presented in 
Table 7.8. An increase in concentration led to an increase in bout number. There was no 
significant drug-concentration interaction (F 6,60 = 1 > n.s.). 
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Figure 7.10 Number of bouts for Intra-lipid drinking in a brief 
contact test as a function of increasing dose of naloxone (0.3-3 
mg/kg) + S.E.M. Asterisk indicates significantly different from 
vehicle ** p < 0.01 (Dunnett's t-test). 
Table 7.8 Main effect of Intra-lipid concentration on bout number 
Number of bouts + S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 4.2± 0.5 8.5± 1.0 14.3± 0.8 
n = 11 animals per group 
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Intrabout lick rate Figure 7.11 shows the effect of naloxone on the intrabout 
lick rate. For this parameter, there was a significant main effect of both drug (F 3,30 = 
8.3, p < 0.001) and concentration (F 2,20 = 8.6, p < 0.01) but no drug-concentration 
interaction (F 6,60 = ' -4, n.s.). At all doses, naloxone significantly decreased the rate 
of licking within bouts. Increasing concentration also led to a decrease in the intrabout 
lick rate (Table 7.9). 
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Figure 7.11 Intrabout lick rate for Intra-lipid drinking in a brief 
contact test as a function of increasing dose of naloxone (0.3-3 
mg/kg) + S.E.M. Asterisk indicates significantly different from 
vehicle ** p < 0.01 (Dunnett's t-test). 
Table 7.9 Main effect of Intra-lipid concentration on intrabout lick rate 
Intrabout lick rate (l/s)+ S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 7.2±0.1 7.0 ±0 .1 6.8± 0.04 
n = 11 animals per group 
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Latency Figure 7.12 shows that the latency to start drinking was not 
significantly affected by pretreatment with naloxone (F 3,30 = 2.1, n.s.). However, there 
was a main effect of concentration on this parameter (F 2,20 = 3.5, p < 0.05), although 
this effect was only marginally significant (Table 7.10). An increase in concentration led 
to a decrease in the latency. 
Naloxone (mg/kg) 
Figure 7.12 Latency for Intra-lipid drinking in a brief contact 
test as a function of increasing dose of naloxone (0.3-3 mg/kg) + 
S.E.M. 
Table 7.10 Main effect of Intra-lipid concentration on latency 
Latency (s) ± S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 50.3± 10.1 50.9± 13.9 18.3± 7.7 
n = 10 animals per group 
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7.4 Discussion 
The results of Experiment 12 showed that morphine increased the total number of 
licks for Intra-lipid in a brief contact test. These data are consistent with previous findings 
showing that morphine can increase the consumption of fats (Gosnell, Krahn and 
Majchrzak, 1990). The number of bouts for Intra-lipid increased following morphine 
administration. There was a compensatory reduction in mean bout duration. Therefore, 
the increase in the number of licks observed following treatment with morphine was due 
to an increase in bout number rather than bout duration. The results of Experiment 13 
showed that the effects of naloxone on responding for Intra-lipid were the opposite to that 
observed for morphine. Naloxone decreased the number of licks for Intra-lipid by 
decreasing bout number. There was no effect of naloxone on mean bout duration. 
The effects of morphine and naloxone on the microstructure of licking for Intra-
lipid contrast with the effects of benzodiazepine ligands reported in Chapters 5 and 6. 
Morphine and midazolam both increased the total number of licks for Intra-lipid in a brief 
contact test but did so in different ways. Midazolam increased the mean bout duration, 
whereas morphine increased the number of bouts. Conversely, Ro 15-4513 and naloxone 
both decreased the number of licks. Ro 15-4513 did so by decreasing mean bout 
duration, whereas naloxone decreased the number of bouts. Therefore, despite 
similarities in the taste preference, sham feeding and taste reactivity test, the effects of 
benzodiazepines and opioids can be dissociated using microstructural analysis. This 
suggests that contrary to previous assertions, the effects of benzodiazepine receptor 
ligands and opioid receptor ligands on ingestive behaviour are not exactly the same. 
Although these results do not rule out the possibility of an interaction between 
benzodiazepines and opioids in the control of ingestive behaviour, they do indicate that 
the specific nature of any interaction requires further investigation. 
The lack of effect of morphine and naloxone on mean bout duration does not 
provide evidence to support the hypothesis that these drugs affect palatability 
mechanisms. Mean bout duration has been shown to be sensitive to changes in the 
hedonic properties of ingested fluids (Davis and Smith, 1992), but this measure was not 
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affected by opioid administration. It is unlikely that the effects of morphine and naloxone 
can be explained by appealing to satiety mechanisms because the effects of these drugs 
were obtained in a brief contact test where the influence of postingestive factors is 
minimal. In addition, the ability of opioids to increase the consumption of preferred foods 
and influence sham feeding suggests that reward mechanisms may be important. In 
Chapter 5, it was suggested that changes in bout number may be indicative of changes in 
incentive salience. Following this argument, the effect of morphine and naloxone on bout 
number may mean that these drugs are not affecting palacability but incentive salience 
attribution. Morphine may have increased bout number by increasing the ability of the 
test fluid to maintain the rat's interest, whereas naloxone may have reduced bout number 
by decreasing the salience of the test fluid, thus making the rats more distractible. 
Although there is no direct evidence for this hypothesis, such a conclusion is supported 
by the results of a recent study by Badiani and colleagues (Badiani, Leone, Noel and 
Stewart, 1995). The effects of injection of the \i opioid agonist DAMGO into the ventral 
tegmental area (VTA) on feeding were found to be similar to the effects of morphine 
observed in Experiment 12. DAMGO increased the amount of time spent eating food 
pellets due to an increase in the number of feeding bouts. In a further experiment, 
DAMGO also increased the time spent gnawing when non-food objects (e.g. balsa 
wood) were available in addition to food items. This led Badiani and colleagues (1995) to 
conclude that DAMGO may increase the incentive salience directed towards stimuli. It is 
possible that the effects of systemic administration of morphine and naloxone on Intra-
lipid drinking obtained in Experiments 12 and 13 were due to effects on incentive salience 
as a result of binding at opioid receptors in the VTA. In support of this interpretation, 
some investigators have found that the ability of opioid agonists to enhance feeding 
behaviour is more reliable following repeated injection (Levine and Billington, 1989). 
The effects of concentration on bout number were similarly only observed following 
repeated exposure to the test fluids. This observation may add to the argument that 
opioids affect incentive salience since it has been argued that the attribution of salience 
depends on previous exposure to the effects of a reinforcer. 
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The mechanisms involved in the effects of morphine and naloxone on licking 
patterns are not clear, but some speculations can be made. It has been suggested that 
opioids interact with the dopaminergic system at the level of the VTA. In support of this 
proposal, opioid receptors have been identified in close proximity to dopaminergic cell 
bodies (Sesack and Pickel, 1992). Electrophysiological studies have also shown that 
morphine and other opioid agonists can increase the rate of dopaminergic cell firing 
(Gysling and Wang, 1983; Mathews and German, 1984). In vivo dialysis studies have 
confirmed that administration of opioids can modulate the release of dopamine into the 
nucleus accumbens (Di Chiara and Imperato, 1988; Spanangel et al., 1990). An 
interaction between opioids and dopamine in the control of feeding behaviour is 
suggested by the finding that injection of opioid agonists into the VTA stimulates feeding 
(Badiani et al., 1995; Mucha and Iversen, 1986; Noel and Wise, 1995). Predictably, 
injection of naloxone into the VTA has been found to decrease consumption of a palatable 
apple juice (Segall and Margules, 1989). The effects of injection of opioids into the 
nucleus accumbens has also been examined. Injection of morphine into the nucleus 
accumbens has been shown to increase food consumption in rats (Majeed et al., 1986; 
Mucha and Iversen, 1986). Taken together, these data suggest that binding of opioids in 
the VTA may influence feeding behaviour by interacting with mesolimbic dopamine 
projections. Significantly, such an interaction would be consistent with the proposal that 
opioids may alter incentive salience attribution. It has recently been suggested that 
dopamine may mediate the incentive motivation effects of reinforcers (Robinson and 
Berridge, 1993; Berridge, Vernier and Robinson, 1989). An obvious prediction from this 
is that drugs which influence dopamine transmission should affect bout number. This 
possibility remains to be fully tested, but evidence gathered to date appears to suggest 
that this may be the case. Schneider, Davis, Watson, and Smith (1990) have shown that 
the dopamine D2 receptor antagonist raclopride reduces the number of bouts for rats sham 
drinking sucrose. Al Nasar and Cooper (1994) have also shown that the selective Di 
agonist A-68930 reduces feeding by decreasing bout frequency without affecting bout 
duration. I f the effects of morphine are due to release of dopamine then it would also be 
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predicted that administration of dopamine antagonists should block increases in bout 
number. This possibility has not been tested, but a functional interaction between 
dopamine and opioids in the control of ingestive behaviour has been suggested by the 
results of a study conducted by Evans and Vaccarino (1990). These authors found that 
the feeding induced by morphine could be blocked by pretreatment with the dopamine 
antagonist flupenthixol. 
An alternative explanation for the results obtained in the present experiments is 
that administration of morphine and naloxone led to non-specific motor effects which 
then affected the pattern of licking for Intra-lipid. This possibility was examined in the 
present experiments by measuring changes in both the intrabout lick rate and the latency 
to start drinking. The highest dose of morphine (3 mg/kg) significantly reduced the 
intrabout lick rate. This may suggest that at this dose, morphine was disrupting the rat's 
ability to perform the necessary movements to lick normally. Such an effect on intrabout 
lick rate may have consequently interfered with the pattern of licking causing the rats to 
break up runs of licks which may have resulted in an increase in bout number. However, 
this explanation is unsatisfactory because the effect on intrabout lick was not dose-
related. Conversely, the effect of morphine on bout number was dose-related, with 
increasing doses of morphine leading to a monotonic increase in the number of bouts. 
This suggests that the effect of morphine on intrabout lick rate cannot account for the 
changes also observed in bout number. 
Naloxone also reduced the intrabout lick rate. This effect was not dose-related 
because significant decreases in the rate of licking within bouts were observed at all doses 
used. It is feasible that the decrease in intrabout lick rate caused by naloxone resulted in a 
decrease in the number of licks and subsequently the number of bouts. Arguing against 
this conclusion is the observation that a significant effect on number of licks and bout 
number was only observed under the highest dose of naloxone (3 mg/kg), whereas the 
intrabout lick rate was reduced by the same amount at all doses. This suggests that 
although naloxone may induce non-specific effects, these cannot explain the effects on 
bout structure which were also observed. 
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There were no significant effects of morphine on the latency to engage in 
drinking, but there were certain trends observed in the data. There was a tendency for 
morphine to dose-dependently reduce the latency to start drinking. This result is similar to 
the effect of DAMGO injected into the VTA reported by Badiani and colleagues (1995). 
These authors found that DAMGO significantly decreased the latency to start feeding. As 
mentioned previously in this thesis, effects on latency are difficult to interpret. However, 
the tendency of morphine to decrease this measure may be indicative of an increase in the 
motivation to feed. 
There was no effect of naloxone on latency. An increase in latency at the highest 
dose of naloxone was observed, but this did not reach significance. The lack of effect of 
naloxone on latency is consistent with previous reports that naloxone does not affect meal 
initiation (Kirkham and Blundell, 1984). Although not significant, the increased latency 
seen following administration of the 3 mg/kg dose of naloxone may have reflected an 
avoidance of the test fluid at this dose. It has been shown that when paired with the 
presence of a fluid or place a rat prefers, naloxone causes subsequent avoidance of that 
food or place (Frenk and Rogers, 1979; Stolerman and D'Mello, 1978). Therefore, the 
putative aversive properties of naloxone could have caused the changes in the number of 
licks and bout number obtained in Experiment 14. However, Lesham (1984) has 
suggested that the aversive effects of naloxone cannot totally account for its anorectic 
effect and so it is unlikely that the effect of naloxone on latency can be explained by the 
aversive properties of naloxone. 
The results of the present studies do not allow firm conclusions to be drawn 
concerning the receptor subtypes involved in the effects of opioids on licking behaviour. 
The )i receptor subtype may be implicated in the effects of morphine, but the lack of 
selectivity of naloxone means that this drug does not provide any information about 
which receptor subtype is mediating its effects. Studies using specific opioid receptor 
ligands suggest the involvement of 6 and K subtypes in the control of feeding 
behaviour (Gosnell et al., 1983; Jackson and Cooper, 1985; Morley and Levine, 1983). 
However, the results of such studies have also highlighted some interesting differences in 
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the involvement of opioid receptor subtypes across different experimental situations 
which may have some bearing on the interpretation of the results from Experiments 13 
and 14. Noel and Wise (1995) have shown that injection of the selective opioid agonist 
DAMGO and the selective 5 opioid agonist DPDE into the VTA enhanced feeding 
responses. However, these authors have also shown that intra-VTA injection of K 
selective agonist U-50 488H did not significantly affect feeding responses (Noel and 
Wise, 1993). The lack of effect of U-50 488H is compatible with the observation that 
injection of this compound into the VTA does not alter dopamine release into the nucleus 
accumbens (Di Chiara and Imperato, 1988). This evidence suggests that the effects of fX 
and 5 receptor agonists, but not k agonists, may be mediated by the mesolimbic dopamine 
system. I f the effects of morphine and naloxone on licking behaviour are due to 
alterations on dopamine transmission then it would be predicted that these effects would 
also be observed following lo. and 5 agonist administration but not K agonist treatment. 
In summary, a microstructural analysis of the effects of morphine on Intra-lipid 
drinking in brief contact test showed that this drug increased the number of licks for 
Intra-lipid by increasing bout number. Naloxone had the opposite effect and decreased 
the number of licks by decreasing bout number. A comparison of the effects of morphine 
and naloxone on licking patterns with the effects of benzodiazepine ligands revealed that 
these drugs had different effects on licking patterns. Therefore, although benzodiazepine 
and opioids may have similar effects in taste preference, sham feeding and taste reactivity 
tests, they can be differentiated in terms of their effects on licking behaviour. These 
results suggest that further investigation of a putative interaction between benzodiazepines 
and opioids in the control of food intake is warranted. 
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Interactions between naloxone and midazolam determined 
using microstructural analysis of licking for Intra-lipid 
8.1 Introduction 
It has been proposed that benzodiazepine-induced hyperphagia may be related to 
endogenous opioid activity (Britton et al., 1981; Cooper, 1983a). Evidence from 
biochemical studies would appear to support this suggestion. For example, 
benzodiazepine agonists have been shown to modulate the release of enkephalins in the 
brain (Duka et al., 1979; Wuster et al., 1980). The increase in enkephalin release caused 
by benzodiazepine receptor agonists has also been blocked by naloxone (Duka et al., 
1979). 
Potential interactions between the effects of benzodiazepines and opioids 
specifically on ingestive behaviour has been examined by investigating the effects of 
opioid antagonists on increases in food intake caused by benzodiazepine agonists. In 
several studies it has been shown that the opioid antagonist naloxone can block 
benzodiazepine-induced hyperphagia (Birk and Noble, 1981; Britton et al., 1981; Naruse 
et al., 1989; Stapleton et al., 1979). This evidence suggests that benzodiazepines may 
affect ingestive behaviour by causing the release of endogenous opioid peptides which 
then act at opioid receptors. Importantly for this hypothesis it has also been shown that 
opioid agonists can increase food intake under a variety of experimental conditions 
(Martin et al., 1963; Morley et al., 1982; Sanger and McCarthy, 1980). However, in the 
previous chapter it was shown that the effects of opioid receptor ligands on the 
microstructure of licking for Intra-lipid are not the same as the effects of benzodiazepine 
receptor ligands. Hence, some additional investigation of potential interactions between 
benzodiazepines and opioids is warranted. The aim of Experiment 14 was to use a 
microstructural approach to examine in greater detail potential benzodiazepine/opioid 
interactions in the control of ingestion. 
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One problem with previous studies in this area has been that opioid antagonists 
decrease food intake when administered alone, and this has not been rigorously 
controlled for. In some studies, attenuation of the hyperphagic effects of benzodiazepines 
may have been due to subtraction of drug effects, rather than a specific interaction. To 
overcome this problem, the opioid antagonist naloxone was administered at doses which 
are ineffective when administered alone. 
Another criticism of previous studies has been that the effect of opioid antagonists 
on feeding behaviour induced by benzodiazepine agonists has only been assessed using 
intake measures. This raises the possibility that any attenuation of benzodiazepine effects 
on ingestive behaviour may have been due to a non-specific interaction resulting from 
effects on motor capacity, rather than a specific effect on appetite. A microstructural 
approach was adopted in Experiment 14 to allow the specificity of any interaction 
between opioids and benzodiazepines to be investigated. 
It has been suggested that benzodiazepine receptor agonists increase food intake 
by enhancing palatability (Berridge and Pecina, 1995). In support of this, the 
benzodiazepine receptor agonist midazolam has been shown to increase the total number 
of licks in a brief contact test by increasing the duration of bouts for sucrose and Intra-
lipid drinking (Chapter 5). I f the palatability effects of midazolam are dependent on 
opioid peptide release, then naloxone should block the increase in mean bout duration 
induced by midazolam. This prediction was tested in Experiment 14 by examining the 
effect of pretreatment with naloxone (0.1 and 0.3 mg/kg) on the microstructure of licking 
for Intra-lipid under midazolam. 
In Chapter 5, it was also shown that midazolam decreased the rate of licking 
within bouts, probably as a result of the muscle relaxant effects of this drug. An 
additional aim of Experiment 14 was to examine whether naloxone blocks both the 
palatability and muscle relaxant effects of midazolam. Therefore, the effect of 
pretreatment with naloxone on the decrease in intrabout lick rate caused by midazolam 
was also examined. 
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Experiment 14: Microstructural analysis of the effect of naloxone on drinking induced by 
midazolam in a brief contact test 
8.2 Method 
8.2.1 Animals 
Ten non-deprived adult male hooded Lister rats (Charles River, U.K.) weighing 
300-350 g at the beginning of training were used. They were housed in pairs in plastic 
cages in a room with a constant room temperature of 21+2 °C, and were maintained 
under a 12h lightidark cycle (lights on at 08.00). Rats were allowed ad lib access to food 
pellets, (SDS RMI (E), Cambridge, U.K.) and water throughout. All testing was carried 
out in the light phase between 09.00 and 13.00h. 
8.2.2 Drugs 
Naloxone hydrochloride at doses of 0.1 and 0.3 mg/kg (Sterling Winthrop, 
U.K.) was dissolved in distilled water and injected i.p. in a volume of 1 ml/kg 20-min 
prior to testing. These doses were selected to be non-effective when administered alone. 
In Experiment 12, it was shown that a dose of 0.3 mg/kg did not affect licking 
responses. Midazolam maleate (Roche, Basel, Switzerland) was prepared for injection by 
dissolving in distilled water. Midazolam was administered i.p. in a dose of 1.8 mg/kg, 
15-min prior to testing. The vehicle used in control injections was distilled water. 
8.2.3 Test meal 
Rats had access to various concentrations of Intra-lipid emulsions (Pharmacia 
Ltd, Milton Keynes, U.K.) which were made up freshly each day. The Intra-lipid 
emulsions were made up by diluting a 20% commercial preparation with tap water. 
8.2.4 Apparatus 
Testing was carried out using the MS80 multistation lickometer described in detail 
in the Chapter 4 (Section 4.2.3). 
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8.2.5 Procedure 
Training Ten rats were well familiarized with the test apparatus and 
procedure. This involved placing each rat in the test chamber were they had access to a 
range of Intra-lipid emulsions (1,3 and 10%) in a random order. Each concentration was 
presented for 60s and a 10s interval intervened between subsequent presentations. This 
procedure continued until steady baseline levels of licking were observed across days 
(approximately 10 days). Two days prior to testing each rat received a sham injection of 
distilled water to familiarize it with the injection procedure. 
Testing Following the initial familiarisation period the rats received i.p. 
injections of drugs. A repeated-measures design was used in which rats had injections 
of vehicle/vehicle, 0.1 mg/kg naloxone/vehicle, 0.3 mg/kg naloxone/vehicle, 
vehicle/midazolam, 0.1 mg/kg naloxone/midazolam, 0.3 mg/kg naloxone/midazolam. 
After injection of drugs, the rats were placed in the lickometer chamber where they had 
access to all concentrations of Intra-lipid (1,3 and 10%). Each concentration was 
presented for a total duration of 60s. The order of presentation was randomised. A 
period of 48h elapsed between each series of injections to ensure dispersal of drugs and 
injections were counterbalanced across rats. 
8.2.6 Data analysis 
The lick time data were analyzed as described in the Chapter 4 (Section 4.2.5) 
using Dilog software written by Ross Henderson followed by further processing using a 
Microsoft Excel spreadsheet. Various microstructural variables were examined: the total 
number of licks, mean bout duration, number of bouts, intrabout licks rate (licks per 
second within bouts) and latency to engage in drinking (time from shutter opening to 
first lick). 
The microstructural data were analyzed using a two-way repeated-measures 
ANOVA, with drug dose and fluid concentration as factors. Where there was no 
significant interaction between the two main factors, the effect of drug collapsed across 
concentration was considered. Post hoc comparisons to determine any significant 
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differences between doses were made using a Dunnett's t-test. Statistical tests were 
performed using Super Anova and Statview SE+graphics (Abacus Concepts Inc., 
Berkeley, CA). A result was considered statistically significant if p < 0.05. 
8.3 Results 
Number of licks 
A two-way repeated-measures ANOVA showed that for the total number of licks 
there were significant main effects of both drug (F 5,45 = 5.2, p < 0.001) and 
concentration (F 2,18 = 314.8, p < 0.001), but no significant interaction (F 10,90 = 1.4, 
n.s.). Post hoc analysis showed that only the vehicle/midazolam condition differed 
significantly from the control vehicle/vehicle condition (p < 0.01). As shown in Figure 
8.1, midazolam increased the number of licks compared to the control vehicle/vehicle 
condition. When administered alone, naloxone did not significantly effect the number of 
licks. However, pretreatment with naloxone significantly attenuated the increase in the 
number of licks caused by midazolam (Figure 8.1). Post hoc analysis showed that the 
naloxone/midazolam conditions differed significantly from the vehicle/midazolam 
condition (p < 0.05). The effect of concentration on the total number of licks is shown in 
Table 8.1. An increase in concentration led to an increase in the total number of licks. 
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Naloxone/midazolam (mg/kg) 
Figure 8.1 The effect of naloxone (0.1 and 0.3 mg/kg) and 
midazolam (1.8 mg/kg) on the number of licks for Intra-lipid 
drinking in a brief contact test + S.E.M. Asterisk indicates 
significantly different from vehicle/vehicle condition ** p < 0.01. 
+ indicates significantly different from vehicle/midazolam condition 
p < 0.05 (Dunnett's t-test). 
Table 8.1 Main effect of Intra-lipid concentration on total licks 
TotalIicks + S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 96.9± 11.8 217.9± 12.4 318.8+ 5.2 
n = 10 animals pei • group 
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Microstructural analysis 
Mean bout duration There were significant effects of both drug (F 5,45 = 8.2, 
p < 0.001) and concentration (F 2,18 = 25.9, p < 0.001) on mean bout duration, but no 
interaction between these two factors (F 10,90 = 1-6, n.s.). Administration of naloxone 
alone had no significant effect on the mean bout duration. Post hoc analysis showed that 
midazolam significantly increased mean bout duration (p < 0.01). Pretreatment with 0.3 
mg/kg of naloxone blocked the increase in mean bout duration stimulated by midazolam 
(p < 0.01). Increasing the concentration of Intra-lipid led to an increase in mean bout 
duration (Table 8.2). 
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0 /0 0.1/0 0.3/0 0/1.8 0.1/1.8 0.3/1.8 
Naloxone/midazolam (mg/kg) 
Figure 8.2 The effect of naloxone (0.1 and 0.3 mg/kg) and 
midazolam (1.8 mg/kg) on mean bout duration for Intra-lipid 
drinking in a brief contact test + S.E.M. Asterisk indicates 
significantly different from vehicle/vehicle condition ** p< 0.01. 
-I- indicates significantly different from vehicle/midazolam condition 
p < 0.01 (Dunnett's t-test). 
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Table 8.2 Main effect of Intra-lipid concentration on mean bout duration 
Mean bout duration (s) ± S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 1.9± 0.3 2.9+ 0.2 4.4± 0.4 
n = 10 animals per group 
Number of bouts As can be seen in Figure 8.3, the number of bouts was not 
significandy affected by drug treatment (F 5,45 = 0.8, n.s.). However, there was a main 
effect of concentration on bout number which is shown in Table 8.3. Increasing 
concentration led to an increase in bout number (F 2,18 = 42.1, p < 0.001). There was 
no interaction between drug treatment and concentration on the number of bouts (F 10,90 
= 1.8, U.S.). 
15 n 
10H 
3 5H 
0/0 0.1/0 0.3/0 0/1.8 0.1/1.8 0.3/1.8 
Naolxone/midazolam (mg/kg) 
Figure 8.3 The effect of naloxone (0.1 and 0.3 mg/kg) and 
midazolam (1.8 mg/kg) on bout number for Intra-lipid 
drinking in a brief contact test + S.E.M. 
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Table 8,3 Main effect of Intra-lipid concentration on bout number 
Number of bouts + S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 6.9± 0.7 11.6± 0.7 13.3± 0.5 
n = 10 animals per group 
Intrabout lick rate Figure 8.4 shows the effect of drug administration on the 
rate of licking within bouts. A two-way repeated-measures ANOVA revealed a main 
effect of both drug (F 5^ 45 = 8.3, p < 0.001) and concentration (F 2,18 = 13.8, p < 
0.001) on intrabout lick rate, although there was no significant interaction (F 10,90 = 
1.7, n.s.). Post hoc analysis showed that naloxone administered by itself did not 
significantly affect the intrabout lick rate. However, administration of midazolam caused 
a significant reduction in the rate of licking within bouts (p < 0.01). The reduction in 
intrabout lick rate brought about by midazolam was not reversed by pretreatment with 
naloxone. Post hoc tests showed that the naloxone/midazolam conditions did not differ 
significantly from the vehicle midazolam condition but did differ significantly from the 
control vehicle/vehicle condition (p < 0.01). Increasing concentration led to a decrease 
the intrabout lick rate (Table 8.4). 
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Figure 8.4 The effect of naloxone (0.1 and 0.3 mg/kg) and 
midazolam (1.8 mg/kg) on intrabout lick rate for Intra-lipid 
drinking in a brief contact test + S.E.M. Asterisk indicates 
significantly different from vehicle/vehicle condition ** p < 0.01 
(Dunnett's t-test). 
Table 8.4 Main effect of Intra-lipid concentration on intrabout lick rate 
Intrabout lick rate (1/s) ± S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 7.1±0.1 6.7±0.1 6.5± 0.05 
n = 10 animals per group 
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Latency There was no main effect of drug on the latency to engage in 
drinking (F 5,45 = 1.3, n.s.). However, as shown in Figure 8.5 there were certain 
trends in the data. There was a tendency towards an increase in the latency following 
administration of naloxone alone or in combination with midazolam, although this did not 
reach significance. A main effect of concentration on latency was obtained (F 2,18 = 8, p 
< 0.01). There was an inverse relationship between concentration and latency, with 
higher concentrations leading to a shorter latency to drink. There were no significant 
drug-concentration interactions (F 10,90= 1-5, n.s.). 
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Figure 8.5 The effect of naloxone (0.1 and 0.3 mg/kg) and 
midazolam (1.8 mg/kg) on Latency for Intra-lipid drinking in a 
brief contact test + S.E.M. 
Table 8.5 Main effect of Intra-lipid concentration on latency 
Latency (s). f S.E.M. 
Concentration 1% 3% 10% 
Intra-lipid 32.2± 7.4 5.4± 1.2 8.2± 3. 
n = 10 animals pei • group 
Chapters 196 
8.4 Discussion 
In Experiment 14, it was shown that midazolam increased the number of licks for 
Intra-lipid in a brief contact test and that this was due to an increase in the mean bout 
duration. This result confirms previous findings reported in Chapter 5. When 
administered alone, naloxone did not affect the number of licks for Intra-iipid. However, 
pretreatment with naloxone did block the increase in the number of licks caused by 
midazolam. This result is consistent with previous reports of the ability of naloxone to 
block the effects of benzodiazepine agonists on food intake in rats and hamsters (Birk and 
Noble, 1981; Britton et al., 1981; Naruse et al., 1989; Stapleton et al., 1979). Naloxone 
significantly attenuated the increase in total number of licks by selectively inhibiting the 
increase in mean bout duration produced by midazolam. Midazolam also decreased the 
rate of licking within bouts. At the doses of naloxone used in the present experiment, no 
effect on intrabout lick rate was obtained. When administered in conjunction with 
midazolam, naloxone did not reverse the effects of this drug on intrabout lick rate. There 
was no main effect of drug adminstration on the latency to engage in drinking, although 
there was a tendency for naloxone to increase the latency. 
The increase in mean bout duration stimulated by midazolam is consistent with the 
proposal that benzodiazepines enhance palatability because mean bout duration has been 
shown to increase monotonically with increasing concentration of Intra-lipid in a brief 
contact test (Experiment 8). Adminstration of low doses of naloxone blocked the effect of 
midazolam on mean bout duration. This suggests that endogenous opioid peptides may 
be involved in the palatability effects of benzodiazepine agonists. 
It has been suggested that naloxone may act as a G A B A A antagonist, and so the 
effect of naloxone may have been due to an action of naloxone at the G A B A A receptor 
complex. However, it is unlikely that this explanation can account for the effects of 
naloxone on mean bout duration because there is no evidence that naloxone binds to the 
G A B A A receptor at the doses used in Experiment 14 (Goldinger, 1981; Gruol, Barker 
and Smith, 1980). A more plausible explanation is that the enhancement of palatability by 
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caused by midazolam is due to release of endogenous opioids and that this release is 
blocked by pretreatment with naloxone. 
The results of Experiment 14 do not provide any information concerning the 
neural substrate for benzodiazepine/opioid interactions in the determination of palatability. 
However, the PBN may be a likely candidate. In Chapter 3 it was shown that direct 
administration of midazolam into the PBN resulted in a significant increase in the 
consumption of a palatable wet mash diet. This suggests that a population of 
benzodiazepines receptors in the PBN may be important for the effects of 
benzodiazepines agonists on feeding. In support of this, analysis of the distribution of the 
opioid receptor subtypes in that rat and human brain has revealed that \i and K receptors 
are also localised in the PBN (Mansour, Khachaturian, Lewis, Akil and Watson, 1988). 
In addition, the evoked responses of gustatory neurons in the PBN have been found to be 
sensitive to morphine (Hermann and Novin, 1980). It has also been shown that feeding 
elicited by electrical stimulation of the LH can be affected by opioid microinjection of 
naloxone into the PBN (Carr, Bak and Simon, 1990). This evidence suggests that the 
PBN may be well placed to mediate benzodiazepine/opioid interactions. There is some 
evidence which points to a connection between the PBN and the lateral hypothalamus 
(LH), maybe opioid-dependent, which may be important for interactions between 
benzodiazepines and opioids in the control of ingestion. For example, Touzani and 
colleagues (Touzani, Tramu, Nahon and Velley, 1993) have demonstrated that a 
projection from the lateral hypothalamus to the PBN is immunoreactive to 
alpha-neoendorphin antisera. Direct injection of morphine into the PBN has been shown 
to alter saccharin preference, which is in turn affected by lesions of the LH (Moufid-
Bellancourt and Velley, 1994; Touzani and Velley, 1990). Although the possibility of the 
PBN being involved in benzodiazepine/opioid interactions remains to be thoroughly 
tested, further examination of the contribution of the PBN to the control of eating 
behaviour may prove to be useful in bringing together much of the neuropharmacological 
data. 
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It is not clear from Experiment 14 which opioid receptor subtype is involved in 
the effects of naloxone. However, evidence from previous studies indicates that activity 
at the 5 subunit may be important. Jackson and Sewell (1985) showed that the 
hyperphagic effect of diazepam in rats was blocked by the selective 5 antagonist ICI 154, 
129. 
The results from Experiment 13, reported in Chapter 7, showed that when 
administered alone, naloxone (0.3-3 mg/kg) decreased the number of licks for Intra-lipid 
by decreasing the number of bouts. It was suggested that this effect of naloxone may 
have occurred as a result of alterations in incentive salience. Consideration of the results 
of both Experiments 13 and 14, suggests that opioid peptides may play multiple roles in 
the control of feeding. The ability of naloxone to block the increase in mean bout duration 
induced by midazolam obtained in Experiment 14 suggests that opioids may be involved 
in the palatability effects of benzodiazepines. However, the decrease in bout number 
obtained at higher doses of naloxone in Experiment 13 also suggests that these drugs may 
have a role to play in incentive salience attribution. It is possible that the opioids affect 
both palatability and incentive salience and these effects depend on different receptor 
subtypes located in distinct brain areas. Further work is required to examine the neural 
and pharmacological basis of the effects of opioid peptides on food reward. 
The results of Experiment 14 suggest that the inhibitory action of naloxone is 
specific to the palatability effects of midazolam. The decrease in intrabout lick rate 
produced by midazolam was not blocked by naloxone. This result is in agreement with 
the report that the muscle relaxant effects of chlordiazepoxide are not antagonized by 
naloxone (File, 1982). Agmo and colleagues (Agmo, Gal van, Heredia and Morales, 
1995) also showed recently that naloxone did not block the motor impairment induced by 
chlordiazepoxide and diazepam in a rotorod test. Therefore, endogenous opioids may be 
important for the palatability effects of benzodiazepines but not for the motor effects of 
these drugs. 
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There was no effect of naloxone or midazolam on the latency to start drinking. 
These data agree with the results of Experiments 10 and 13 and have been discussed in 
previous chapters. 
In summary, the results of Experiment 14 showed that the increase in total 
number of licks for Intra-lipid stimulated by midazolam in a brief contact test was blocked 
by pretreatment with naloxone. This effect of naloxone was due to a selective attenuation 
of mean bout duration. The decrease in intrabout lick rate brought about by midazolam 
was not reversed by naloxone. These results suggest that endogenous opioid peptides 
may be involved specifically in the palatability effects of benzodiazepine receptor 
agonists. 
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General discussion 
9.1 Introduction 
The aim of the experiments reported in this thesis was to provide new information 
concerning the neural and behavioural mechanisms involved in the effects of 
benzodiazepine receptor ligands on ingestion. The purpose of this chapter is to examine 
whether these aims have been fulfilled and discuss the implications of the results 
obtained. This discussion is divided into five sections. The first section deals with the 
findings reported in Chapters 2 and 3 and the conclusions which can be drawn 
concerning the potential neural substrate for benzodiazepine-induced hyperphagia. The 
second section discusses the effects of benzodiazepine ligands on the microstructure of 
licking behaviour (Chapters 5 and 6), and what these results reveal about the behavioural 
mechanisms underlying benzodiazepine effects on ingestion. The third section is 
concerned with evaluating the findings reported in Chapters 7 and 8 and what they 
signify for the hypothesis that the effects of benzodiazepines on ingestive behaviour are 
related to endogenous opioid activity. Proposals for future work which may help to 
elucidate further the neural and behavioural bases for benzodiazepine effects in ingestion 
are then presented in the fourth section. Finally, the clinical implications of this work will 
briefly be discussed in section five. 
9.2 Neural mechanisms 
The aim of the experiments reported in Chapters 2 and 3 was to identify potential 
brain sites important for the effects of benzodiazepines on ingestive behaviour. Systemic 
adminstration of drugs does not provide any information concerning the location of the 
receptor populations responsible for mediating any observed effect. Therefore, a 
microinjection procedure was employed in the experiments reported in Chapters 2 and 3. 
This involved injecting the benzodiazepine receptor agonist midazolam directly into the 
brain to determine potential sites of action of this drug on feeding behaviour. 
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9.2.1 Brainstem sites 
Brainstem sites may be important for the effects of benzodiazepines on ingestive 
behaviour. For example, Berridge (1988) has shown that the increase in hedonic 
reactions observed following benzodiazepine adminstration is retained in the chronic 
decerebrate rat preparation. This suggests that the receptor population(s) responsible for 
the effects of benzodiazepines on the hedonic reaction to tastants may be located in the 
brainstem. It is possible that the effects of benzodiazepines in the taste reactivity test are 
related to the hyperphagic effects of these drugs. Hence, a brainstem receptor population 
may also be important for mediating the effects of benzodiazepine on food intake. This 
possibility was investigated in Experiments 1 and 2. 
The results of Experiment 1 showed that direct administration of midazolam into 
the IVth ventricle significantly increased intake of a palatable wet mash diet in non-
deprived rats. This increase was blocked by pretreatment with the selective 
benzodiazepine receptor antagonist flumazenil (Experiment 2). These data suggest that 
benzodiazepine receptors located in the vicinity of the IVth ventricle may be important for 
mediating the hyperphagic effects of benzodiazepines. 
9.2.2 Tlie role of tlie PBN 
Microinjection of drugs into a ventricle does not provide specific information 
concerning the location the receptor population(s) responsible for mediating a behavioural 
effect. The aim of the Experiments reported in Chapter 2 was to assess the contribution of 
brainstem structures to benzodiazepine effects on food intake. The target for this work 
was the parabrachial nucleus (PBN) of the pons. The PBN was chosen because it is close 
to the rVth ventricle and contains a population of benzodiazepine receptors (Higgs et al., 
1993). Additionally, this nucleus forms part of the taste projection system. It has been 
hypothesised that benzodiazepine-induced hyperphagia may be related to changes taste 
processing, and so it was thought that the PBN would be a prime candidate to mediate the 
effects of benzodiazepines on food intake. 
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In Experiment 3, direct injection of midazolam into the PBN resulted in a 
significant and dose-related increase in the consumption of a palatable wet mash diet and 
a 3% sucrose solution. This hyperphagic effect was blocked by pretreatment with 
flumazenil. However, in cases where midazolam was injected to sites outside the PBN, 
no effect on intake was observed. These results indicate that benzodiazepine receptors 
located in the PBN may constitute a population of receptors responsible for mediating the 
effects of benzodiazepine on ingestive behaviour. 
Evidence from Experiment 6 suggests that the benzodiazepine receptor population 
in the PBN may be specific for the effects of benzodiazepine agonists on ingestive 
behaviour. Intra-PBN midazolam had no effect on locomotor activity. This result 
contrasts with the effects of systemically administered benzodiazepines which cause a. 
hyperlocomotion at low doses and a hypolocomotion at high doses. Further work is 
required to test the hypothesis that benzodiazepine receptors in the PBN are specific for 
the effects of these drugs on ingestion (see section 9.6). However, a molecular basis for 
such a dissociation may be provided by the diversity observed in the G A B A A receptor 
complex. Benzodiazepine receptors in the PBN may be coupled to a G A B A A receptor 
subtype, and allosteric modulation of this subtype may lead to specific effects on 
ingestive behaviour. Testing of this hypothesis awaits the development of compounds 
specific for particular subunit combinations. 
9.2.3 Implications for the neural control of ingestion 
The results of the experiments reported in Chapters 2 and 3 have implications for 
traditional views of the neural control of ingestive behaviour. It has been suggested that 
the brain functions in a hierarchical fashion, whereby top level components exert control 
over low level structures (see Grill and Berridge, 1985, for discussion). Within this 
framework it is assumed that the extent to which neural integration occurs is greater in 
structures near or at the top of the hierarchy. This model rests on the premise that the 
hierarchy is constructed along anatomical lines, with the cortex exerting control over 
more caudal structures assumed to be much less sophisticated in their integrative 
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capacities. The results presented in Chapters 2 and 3, taken in conjunction with the 
findings of Grill and Norgren (1978a,b) and Berridge (1988), have important 
implications for this classical view of brain functioning. Thus, the effects of CDP on 
ingestive responding in the intact and decerebrate rat have been shown to be identical. 
Additionally, direct stimulation of the brain stem with benzodiazepine receptor agonists 
has been shown to result in normal taste reactivity and ingestive responses. Therefore, it 
appears that brainstem circuitry is capable of performing the complex integrations 
necessary for responding normally to taste stimuli. This is at odds with the assumption 
that the control of complex behaviours can only occur in more rostral brain structures. 
The results from Chapters 2 and 3 suggest that the hierarchical view of the neural 
control of ingestion and other behaviours needs to be reevaluated. Alternative possibilities 
might include a two-way hierarchy involving reciprocal connections between higher and 
lower level components, or distributed processing of information. However, assessment 
of these alternative models requires the formation of testable hypotheses based on 
theoretical advances which unfortunately are some way off. 
9.2.4 Conclusions 
In summary, the results presented in Chapters 2 and 3 of this thesis suggest that 
benzodiazepine receptors located in the brainstem, possibly in the PBN, may constitute 
an important site of action for the effects of these drugs specifically on ingestive 
behaviour. 
9.3 Behavioural mechanisms 
Analysis of changes in the rate of licking for fluids and the examination of licking 
behaviour at a microstructural level provides information concerning the factors 
determining intake (Davis and Levine, 1977; Davis and Smith, 1992). The aim of the 
experiments in Chapters 5 and 6 was to use a microstructural approach to investigate the 
behavioural mechanisms involved in the effects of benzodiazepines on ingestive 
behaviour. 
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Manipulating the concentration of a solution is assumed to change its palatability 
which is then thought to be reflected in specific changes in the microstructure of 
ingestion. On the basis of evidence from taste preference, sham feeding and taste 
reactivity studies, it has been suggested that the effects of benzodiazepines on ingestive 
behaviour are due to changes in palatability (Berridge and Pecina, 1995). The aim of the 
experiments reported in Chapter 5 was to compare the effects of midazolam on licking 
behaviour with the effects of increasing in concentration. The rationale was that any 
similarity between the effects of midazolam and increasing concentration would be 
consistent with the view that midazolam enhances palatability. 
Control over ingestive behaviour can be exerted bidirectionally at the level of the 
benzodiazepine receptor (Cooper, 1985b). The aim of the experiments reported in 
Chapter 6 was to examine this hypothesis by investigating whether the effects of the 
benzodiazepine inverse agonist Ro 15-4513 are opposite to those of midazolam at the 
microstructural level. 
An additional aim of the Experiments reported in Chapter 5 and 6 was to examine 
the generality of the effects of benzodiazepine on ingestion by investigating the effects of 
midazolam and Ro 15-4513 on the ingestion of either fats or carbohydrates. 
9.3.1 What can microstructural analysis tell us? 
One problem with models of ingestive behaviour based on microstructural 
analysis has been that experimental validation of these models has been limited to the 
study of carbohydrates. Before any drug effects could be examined in this thesis, it was 
necessary to establish whether the effects of manipulating carbohydrate concentration on 
the microstructure of licking were the same as the effects observed when manipulating fat 
concentration. The effect of manipulating the concentration of a carbohydrate (sucrose) 
and a fat (Intra-lipid) on the rate and microstructure of licking are described below. The 
aim of these experiments was to determine if changes in various microstructural 
parameters can provide reliable information concerning the factors involved in influencing 
intake of both fats and carbohydrates. 
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Initial rate of licking 
In Experiment 7, the initial rate of licking increased monotonically with increasing 
concentration of both sucrose and Intra-lipid. This contrasted with the relationship 
between concentration and intake which varied non-monotonically, probably due to an 
increase in the strength of an inhibitory negative feedback signal at higher concentrations. 
These results suggest that the initial rate of licking reflects changes in the palatability of 
both sucrose and Intra-lipid. 
Mean bout duration 
In the 20-min test employed in Experiment 7 there was no clear relationship 
between fluid concentration and mean bout duration. However, when the test session 
was limited to 60s, mean bout duration was found to vary monotonically with 
concentration of both sucrose and Intra-lipid. The effect of fluid concentration on mean 
bout duration was therefore dependent on the length of the test session. This suggests 
that it is important to consider the length of the test session when interpreting changes in 
the microstructure of licking. Providing the test session is kept short, mean bout duration 
provides a reliable measure of changes in the palatability of both sucrose and Intra-lipid. 
However, in longer term tests, mean bout duration may be affected by factors other than 
palatability. 
Whether changes in mean bout duration in a brief contact test reflect changes in 
the palatability of all fats is not clear. Davis and colleagues (1995) did not find that mean 
bout duration increased with increasing the concentration of com oil. One explanation for 
this finding is that mean bout duration may provide a measure of changes in taste 
palatability but not the palatability associated with other orosensory factors such as 
texture. Further investigation of the effect of manipulating the concentration of different 
fats on mean bout duration is required to elucidate more precisely what changes in this 
parameter indicate (see section 9.6). 
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Number of bouts 
There were no systematic effects of concentration on the number of bouts for 
sucrose and Intra-lipid in the 20-min (Experiment 7) or 60s test sessions (Experiment 8). 
This suggests that changes in bout number do not provide information concerning 
changes in palatability. 
Although manipulating concentration in Experiment 8 did not significantly affect 
bout number, in experiments reported in later chapters, in which the effects of 
manipulating both concentration and drug dose were measured, increasing concentration 
led to a monotonic increase in bout number. This discrepancy may have been due to 
differences in the protocols used in the different experiments. In Experiment 8, the rats 
were trained on one concentration of sucrose and Intra-lipid and then had access to all 
concentrations in a random order. In later experiments, the rats were trained to consume 
all concentrations of sucrose and Intra-lipid over a prolonged training period before the 
main effects of drug dose and concentration were investigated. Changes in bout number 
may have reflected changes in an underlying process dependent on the rats having 
previous experience of the test fluids. The question is: What could that process be? 
It has already been suggested in this thesis that manipulating concentration alters 
the palatability of ingested fluids, which is then reflected in changes in mean bout 
duration. However, besides their affective properties, sucrose and Intra-lipid also act as 
incentives, i.e. they are targets for motivated behaviour (Toates, 1986). The effect of 
concentration on bout number may have been due to changes in incentive motivation. If a 
change in incentive motivation is to account for the effect of concentration on bout 
number then two important questions must be addressed. First, is it predicted that a 
change in incentive motivation should lead to an effect on bout number? Second, is the 
process of incentive motivation affected by previous experience with the stimuli? In 
answering both questions it is necessary to discuss the concept of incentive salience 
(Berridge, 1996; Toates, 1986). 
Incentive salience refers to the attractiveness of a stimulus or its ability to direct 
approach behaviour. The attribution of incentive salience results from a three-stage 
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process that first involves activation of the neural substrate responsible for mediating 
pleasure. Second, pleasure is associated with the stimulus via associative learning. Third, 
salience is attributed to the representation associated with the stimulus. Incentive 
motivation theory predicts that because an increase in the concentration of sucrose and 
Intra-lipid increases positive affect, it should also result in an increase in incentive 
salience. An increase in incentive salience would result in an increase in instrumental 
behaviour directed towards the stimulus which might be manifested in an increase in bout 
number. For example, an increase in the attractiveness of the stimulus might mean that 
the animal returns to it more often, thus increasing the number of bouts. Importantly, this 
process would be dependent on previous exposure with the stimuli because experience 
would be necessary for the attribution of salience. Although there is no direct evidence to 
support this conclusion, it is reasonable that changes in incentive salience might be 
reflected in changes in bout number. To test this hypothesis it would be necessary to 
examine the effect of manipulations which are thought to affect incentive salience (e.g. 
changes in dopamine transmission), and establish if these manipulations affect bout 
number (see section 9.6). 
Intrabout lick rate 
There was a significant effect of fluid concentration on intrabout lick rate in 
Experiment 7. This result was unexpected because it had been hypothesised that the 
intrabout lick rate is relatively constant across a range of experimental conditions. For 
example, it has been shown that the rate of licking within bouts is not affected by 
manipulating concentration, but is altered by moving the drinking spout progressively 
further away from a rat (Davis and Smith, 1992). Consequently, it has been suggested 
that the intrabout lick rate may provide a measure of changes in motor capacity. The 
results of Experiment 7 do not support the suggestion that intrabout lick rate provides a 
pure measure of motor dysfunction, because this parameter was also influenced by 
manipulating concentration. It is conceivable that changes in viscosity at higher 
concentration disrupted the rat's ability to perform the necessary movements to lick 
Chapter 9 208 
properly. The conclusions which can be drawn from these results are that changes in 
intrabout lick rate must be interpreted with caution and additional work is required to 
investigate the conditions under which this measure is disrupted. 
Latency 
Changes in latency may provide a measure of motor deficits induced by an 
experimental manipulation. The rationale for this is that if a treatment induces a motor 
impairment then this might prevent an animal from approaching the lick spout. From this 
it would be predicted that manipulating concentration would have no effect on the latency 
to start drinking. However, in Experiment 7, manipulating concentration did have an 
effect on latency. There was a decrease in latency with increasing sucrose concentration. 
This suggests that latency may also be sensitive to factors associated with changes in 
concentration, such as palatability. One explanation for the effect of concentration on 
latency is that changes in this parameter also reflect changes in the motivation to drink. 
There is evidence to suggest that the basis for this effect may be olfactory cues. 
Using a brief contact test, Rhinehart-Doty and colleagues (1994) found an inverse 
relationship between concentration and latency and that this relationship was no longer 
evident when olfactory cues were masked. It is possible that the animals learned that 
certain olfactory cues were associated with highly palatable (more concentrated) solutions 
and that this influenced the time taken before drinking commenced. The conclusion from 
this is that the latency to engage in drinking may be influenced by palatability via 
olfactory learning. Therefore, changes in latency may not only reflect motor impairments 
but also changes in palatability. However, the results from Chapter 4 also suggest that the 
effect of concentration on latency is not reliable because no effect of manipulating 
concentration was observed in Experiment 8. The conclusion to be drawn from these 
results is that many factors may lead to a change in latency and so any effect on latency 
may be difficult to interpret unless considered in conjunction with changes in other 
parameters. 
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9.3.2 Conclusions 
The results from Chapter 4 showed that manipulating concentration had similar 
effects on the pattern of licking for both sucrose and Intra-lipid. This suggests that the 
microstructural approach can provide information concerning the factors involved in 
controlling intake of carbohydrate and at least one source of fat, i.e. Intra-lipid. The data 
suggest that the initial lick rate can provide information concerning changes in 
palatability. In a brief contact test, changes in mean bout duration also reflect changes in 
palatability. The effect of manipulating concentration in naive versus experienced animals 
suggests that changes in bout number may be indicative of changes in incentive salience, 
although this hypothesis requires further validation. Intrabout lick rate was not found to 
be as resistant to changes in concentration as previously suggested. Although this 
measure may provide information concerning impairment of motor acts required in 
ingestion, some caution needs to be exercised in interpreting changes in intrabout lick 
rate. Similarly, the latency to engage in drinking may be influenced by many factors 
including motor impairment but also changes in motivation which may be related to 
olfactory learning. Therefore, changes in latency should be interpreted with respect to 
changes in other parameters. 
9.3.3 Effects of benzodiazepine ligands on microstructural 
parameters 
Midazolam had similar effects on the pattern of licking of both sucrose and Intra-
lipid. This is the first detailed demonstration of the effects of benzodiazepine on the 
ingestion of a fat. The results suggest that the effects of benzodiazepines in ingestive 
behaviour are not limited to prototypic taste stimuli but may also extend to the 
consumption of fats. However, although microstructural analysis revealed similarities in 
the effects of midazolam on sucrose and Intra-lipid drinking, had intake been the only 
measure a different conclusion would have been reached because midazolam increased 
intake of sucrose but not Intra-lipid. This highlights the value of microstructural analysis 
and shows that benzodiazepine agonists may affect patterns of ingestion without actually 
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increasing intake. Therefore, it is not benzodiazepine-induced hyperphagia per se, but the 
processes which may, or may not, lead to increases in food intake which require study. 
Some evidence as to the mechanisms involved can be gleaned from the results of 
experiments in Chapter 5. 
Midazolam increased the initial lick rate for sucrose and Intra-lipid in a 20-min 
test. This is consistent with the hypothesis that benzodiazepine agonists affect the hedonic 
evaluation of ingested foods, and is in agreement with the effect of midazolam in other 
tests of palatability, including the sham feeding preparation and taste reactivity paradigm. 
The increase in palatability caused by midazolam did not result in an increase in intake for 
Intra-lipid drinking because the increase in the initial lick rate led to faster accumulation of 
Intra-lipid in the GI tract; This may have then led to a stronger negative feedback signal 
which brought ingestion to a close more quickly. This suggests that changes in 
palatability can be dissociated from changes in intake. Increases in palatability need not 
lead to an increase in intake. Further evidence to support an effect of midazolam on 
palatability comes from the effect of this drug in the brief contact test employed in 
Experiment 10. Midazolam increased the total number of licks for sucrose and Intra-lipid 
by increasing the mean bout duration. 
Midazolam also decreased the intrabout lick rate. This effect is consistent with the 
known muscle relaxant effects of midazolam. Midazolam did not affect latency to engage 
in drinking which may indicate that it was not affecting the rat's ability to access the spout 
or its motivation to drink. 
The effects of the benzodiazepine receptor inverse agonist Ro 15-4513 on the 
pattern of licking in a brief contact test was found to be the opposite to the effects of 
increasing concentration. Ro 15-4513 decreased the number of licks for sucrose and 
Intra-lipid by decreasing mean bout duration. This suggests that Ra 15-4513 was 
decreasing palatability. The proposal that the effects of Ro 15-4513 results from a change 
in palatability fits in with the notion of bidirectional control of ingestive behaviour 
mediated by specific benzodiazepine receptors, as first proposed by Cooper (1985b). 
According to this theory the effects of benzodiazepine receptor inverse agonists on 
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feeding should be opposite to that of classical agonists. The results reported in Chapter 5 
suggest that benzodiazepine agonists influence ingestive behaviour by increasing 
palatability. The effects of Ro 15-4513 on licking patterns is consistent with the proposed 
bidirectional control of feeding, since they confirm that benzodiazepine receptor inverse 
agonists decrease consumption as a consequence of a reduction in the palatability of 
ingested foods. 
It might be expected that the receptor population mediating benzodiazepine-
induced changes in palatability should be located in brain regions with associations with 
orosensory systems. In Chapter 3 it was suggested that the PBN may contain 
benzodiazepine receptors responsible for mediating the effects of benzodiazepines on 
ingestive behaviour. The PBN makes a connection with the pontomedullary parvocellular 
reticular formation (PCRt) (Herbert, Moga, and Saper, 1990). The PCRt may integrate 
viscerosensory and orosensory inputs for the modulation of oromotor systems involved 
in the control of licking behaviour (Ter Horst, Liem, and van Willigen, 1991). A 
connection between the PBN and PCRt might provide the neural basis for 
benzodiazepine-induced changes in licking behaviour although this remains to be 
thoroughly investigated. 
9.3.4 Benzodiazepines and taste palatability? 
The effects of benzodiazepines ligands on licking patterns suggests that these 
drugs exert bidirectional control over ingestive behaviour by modulating palatability. The 
possibility that benzodiazepine receptors in the PBN may mediate the effects of 
midazolam and Ro 15-4513 on licking behaviour suggests that these effects may be 
related specifically to taste palatability because the PBN forms part of the gustatory 
system. The stimulatory properties of fats may be related to oral tactile mechanisms rather 
than gustatory mechanisms. In support of this, it has been shown that in human 
psychophysical experiments, texture is the stimulus dimension which correlates most 
with fattiness (Mela, 1988). It is interesting therefore that midazolam and Ro 15-4513 
affected ingestion of both sucrose and Intra-lipid. This result may suggest that the effects 
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of benzodiazepines on ingestion are related to the palatability associated with both taste 
and other orosensory factors. However, because there has been no systematic attempt to 
examine the taste stimulating properties of fats, it is not clear at this time whether 
gustatory mechanisms play a role in the control of Intra-lipid intake. The mechanisms 
involved in Intra-lipid consumption may be different from those involved in the intake of 
other fats such as corn oil. For example, Davis et al., (1995) did not find that mean bout 
duration varied as a function of concentration of corn oil concentration, whereas mean 
bout duration for Intra-lipid drinking in Experiment 8 did increase monotonically as a 
function of concentration. It could be that changes in mean bout duration reflect changes 
in gustatory rather than somatosensory stimulation. Additional work is required to 
examine whether the effect of manipulating concentration on bout duration is related 
specifically to gustatory stimulation, before any firm conclusions can be drawn 
concerning the specificity of benzodiazepine effects specifically on taste stimuli (see 
section 9.6). 
9,3.5 Conclusions 
A microstructural analysis of licking behaviour revealed that midazolam increased 
the initial rate of licking for both sucrose and Intra-lipid in a 20-min test. In a brief contact 
test, midazolam increased the number of licks for sucrose and Intra-lipid by increasing 
the duration of bouts. This evidence is consistent with the hypothesis that benzodiazepine 
agonists enhance palatability. The benzodiazepine receptor inverse agonist had the 
opposite effect to midazolam in a brief contact test. Ro 15-4513 decreased the number of 
licks for sucrose and Intra-lipid by decreasing mean bout duration. These data suggest 
that Ro 15-4513 reduces palatability, and are consistent with the notion of bidirectional 
control of ingestive behaviour at the level of the benzodiazepine receptor. The data also 
suggest that the effects of benzodiazepine on ingestive behaviour are not limited to 
prototypical taste stimuli but also extend to the consumption of at least one fat: Intra-lipid. 
Chapter 9 213 
9.4 Benzodiazepine/opioid interactions 
The effects of benzodiazepines on ingestive behaviour may be related to release of 
endogenous opioid peptides (Cooper, 1983a). This proposal is based on two lines of 
evidence. First, it has been noted that the effects of benzodiazepine receptor ligands on 
ingestive behaviour are similar to the effects of opioids (Cooper and Higgs, 1994). 
Second, it has been demonstrated that the effects of benzodiazepines on food intake can 
be blocked by pretreatment with opioid antagonists (Birk and Noble, 1981; Britton et al., 
1983; Naruse et al., 1989). The aim of the experiments reported in Chapters 7 and 8 was 
to use a microstructural approach to examine the proposed interaction between 
benzodiazepines and opioids in the control of ingestive behaviour in more detail. 
Microstructural analysis of the effects of morphine and naloxone on the licking 
patterns for Intra-lipid in a brief contact test was performed (Chapter 7). Morphine and 
naloxone affected the total number of licks for Intra-lipid by altering bout number. 
Morphine increased the number of licks by increasing bout number and naloxone 
decreased the number of licks by decreasing bout number. These effects contrasted with 
the effects of benzodiazepine ligands on licking behaviour obtained in Chapters 5 and 6. 
The results do not support the argument that the effects of benzodiazepines and 
opioids on ingestive behaviour are similar, and therefore have implications for the 
proposed interaction between benzodiazepines and opioids. The lack of similarity 
between the effects of opioids and benzodiazepines on licking behaviour does not rule out 
an interaction, but indicates that any putative interaction requires further investigation. A 
detailed examination of benzodiazepine/opioid interactions on ingestion was carried out in 
Chapter 8. 
The effect of pretreatment with the opioid antagonist naloxone on the licking 
patterns induced by midazolam was examined in Experiment 14. Midazolam increased the 
total number of licks by increasing mean bout duration which is consistent with an effect 
of this drug on palatability. Naloxone attenuated the increase in the total number of licks 
brought about by midazolam by selectively attenuating the increase in mean bout 
duration. The fact that naloxone blocked this increase in mean bout duration suggests that 
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opioid peptides may be involved in the effects of benzodiazepines agonists on ingestive 
responding. 
Naloxone did not block all the effects of midazolam on licking microstructure 
because the decrease in intrabout lick rate caused by midazolam was not reversed by 
pretreatment with naloxone. This suggests that opioid peptides maybe involved 
selectively in mediating the effects of benzodiazepines on palatability. 
The effects of morphine and naloxone on licking patterns deserve further attention 
because they do not support the hypothesis that opioid peptides influence palatability. 
Morphine has been shown to enhance ingestive responding in the taste reactivity test thus 
suggesting that it may influence the hedonic evaluation of food stuffs. However, closer 
examination of the literature indicates that this effect is not very robust, and is obtained in 
some studies (Doyle et al., 1993) but not others (Parker et al., 1992). An alternative 
hypothesis to explain the effects of opioids on licking behaviour is that the effect of these 
, drugs reflects changes in incentive salience attribution. The results of Chapter 4 suggest 
that changes in bout number may be indicative of changes in incentive salience and so the 
effects of morphine and naloxone on bout number may be due to an effect on incentive 
salience attribution. However this hypothesis is tentative and requires further testing (see 
section 9.6) 
The results presented in this thesis demonstrate that it is possible to 
pharmacologically affect bout number without affecting mean bout duration and vice 
versa. Such a double dissociation supports the notion that these measures reflect different 
underiying processes with different neural substrates. This is similar to the distinction 
drawn by Berridge (1996) who has also suggested that separate neural systems are 
responsible for mediating wanting (incentive salience) versus liking (palatability). It is 
possible that microstructural analysis of licking behaviour is a method which allows the 
neural basis of these two processes to be investigated and suggest that further use of this 
method may provide information concerning the neural controls of wanting and liking. 
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9.5 Summary 
The experiments reported in this thesis suggest that receptors located in the 
brainstem, more specifically in the PBN may be responsible for mediating the effects of 
benzodiazepines on food intake. Location of benzodiazepine receptors in an area involved 
in taste processing is consistent with the subsequent finding that benzodiazepines alter 
ingestive behaviour by modulating palatability. The results also suggest these effects may 
be dependent to some degree at least on release of opioid peptides. 
9.6 Future work 
There are a number of experiments which arise from the current work which 
would help to elucidate further the brain and behavioural mechanisms involved in the 
effects of benzodiazepines on ingestive behaviour. 
The results of experiments reported in Chapter 3 suggest that the PBN may be an 
important site of action for the effects of benzodiazepines on food intake. This possibility 
could be examined further by investigating the effects of lesions of the PBN on 
benzodiazepine-induced hyperphagia. I f an intact PBN is necessary for the effects of 
benzodiazepines on ingestive behaviour then lesioning the PBN would be predicted to 
abolish the ability of systemically administered benzodiazepine agonists to stimulate a 
hyperphagia. However, i f the PBN is merely sufficient for benzodiazepine effects on 
ingestion, then lesioning the PBN would not be expected to block all forms of 
benzodiazepine-induced enhancement of ingestive behaviour. This would suggest that 
other brain sites are involved which need to be identified. This possibility could be 
examined by performing a cannula-mapping study. Other brain sites known to be 
involved in feeding behaviour such as the NTS, hypothalamus and amygdala, are 
possible candidates for such a study. 
It would also be of interest to extend the pharmacological and behavioural 
investigation of the role of the PBN in benzodiazepine-induced hyperphagia. First, by 
examining the effect of administration of other agonists and inverse agonists into this 
area. Second, it is important to determine if the hyperphagic effect of intra-PBN 
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midazolam is due to an enhancement of palatability by examining the effect of injection 
into the PBN in the sham feeding and taste reactivity paradigm. 
The microstructural analysis of sucrose and Intra-lipid drinking carried out in 
Chapter 4 raises some interesting questions concerning the processes reflected in changes 
in microstructural parameters. Increasing Intra-lipid concentration in chapter 4 was found 
to increase mean bout duration suggesting that changes in mean bout duration may reflect 
changes in palatability associated with changes in concentration of this fat. However, 
Davis et al., (1995) did not find that changes in the concentration of corn oil led to 
changes in mean bout duration. To resolve this discrepancy it would be necessary to 
examine the effect of manipulating the concentration of other fats to determine if Intra-
lipid is a special case. The effect of Intra-lipid concentration on mean bout duration may 
be related to the taste properties of this fat. This hypothesis could be tested by examining 
the response of gustatory neurones to different concentrations of this fat. 
In Chapter 4 it was suggested that changes in bout number may reflect changes in 
incentive salience, but that this proposal needed further validation. There is evidence to 
suggest that dopamine is involved in incentive salience attribution (Berridge et al., 1989; 
Robinson and Berridge, 1993). Therefore, it would be useful to examine whether drugs 
which affect dopamine transmission alter bout number in a brief contact test. It would be 
predicted that dopamine receptor antagonists would decrease the number of licks in a 
brief contact test by decreasing bout number. 
It was also shown in Chapter 4 that the intrabout lick rate was influenced by 
changes in the concentration of sucrose. In subsequent chapters it was shown that under 
some circumstances changes in intrabout lick rate are observed following increases in 
Intra-lipid concentration. This indicates that further experiments are required to clarify the 
factors involved in influencing intrabout lick rate. It is possible that viscosity influences 
this parameter. One way of examining this proposal would be to add an agent which 
thickened the fluids without affecting their taste properties, such as guar gum. It is also 
possible that palatability factors affect the intrabout lick rate. Therefore, it would be of 
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interest to look at how lick rate varies both within bouts of drinking and across test 
sessions. 
Following on from microstructural investigation of the effects of systemically 
administered benzodiazepines it would be revealing to look at the effects of these drugs 
administered into brain sites such as the PBN. In Chapter 5, systemically administered 
midazolam increased mean bout duration, but also decreased the intrabout lick rate. In 
Chapter 3 it was hypothesised that the receptor population in the PBN might be specific 
for the effects of benzodiazepines on ingestive behaviour. Convergence of these two 
hypotheses would predict that intra-PBN midazolam would have a specific effect on 
mean bout duration but would not affect the intra-bout lick rate. However, this 
hypothesis remains to be tested. 
The experiments presented in Chapter 8 provide evidence to suggest an interaction 
between benzodiazepines and opioids in the determination of palatability. Further studies 
could identify the specific opioid receptor subtypes responsible for mediating these 
effects. This could be done by using specific opioids receptor antagonists to block the 
effects of midazolam on mean bout duration. It would also be interesting to examine the 
possibility that the interaction between opioid and benzodiazepines may occur in the PBN 
by investigating the effects of direct injection of opioid antagonists into the PBN on the 
hyperphagic effects of benzodiazepines. It was suggested in Chapter 8 that opioids may 
have several effects on ingestive behaviour. Therefore, it would be of interest to compare 
the effects of receptor selective opioid ligands on the microstructure of licking to see if 
differences in the effects of these ligands can be highlighted. 
Chapter 9 218 
9.7 Clinical implications 
The experiments in this thesis suggest that the effects of benzodiazepines on 
ingestive behaviour may be due to changes in the palatability of ingested foods and this 
effect may occur early in the processing of taste stimuli. Drug action at specific 
benzodiazepines receptor populations in the brainstem may affect the processes involved 
in assigning hedonic value to food items and therefore modulate normal patterns of 
ingestion. This suggests that the acceptability of ingested foodstuffs may depend on drug 
action at benzodiazepine receptors. 
Benzodiazepines may also have an important role to play in the understanding and 
treatment of eating disorders such as obesity and bulimia and anorexia. Changes in 
endogenous benzodiazepine levels may lead to alterations in benzodiazepine receptor 
function which then results in abnormal ingestive patterns. This suggests that the 
development of new drugs targeted at benzodiazepines receptor subtypes specific for 
ingestive behaviour could hold the key for therapeutic advances in the treatment of eating 
disorders. Selective inverse agonists may be especially useful in the treatment of obesity. 
One reason for the high incidence of obesity in Western cultures may be the easy access 
which people have to vast range of highly palatable food items which often leads to 
overconsumption. Selective attenuation of the palatability associated with these foods 
may aid people who for health reasons are required to reduce their weight. 
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